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Abstract 
 
The i-motif is an alternative DNA secondary structure motif formed in sequences rich 
in cytosine, consisting of four strands, stabilised by hemi-protonated cytosine-
cytosine+ base pairs. The motif forms in sequences complimentary to the G-quadruplex 
however, far less is known about the i-motif and most research to date has focused on 
its application in nanotechnology. Despite this, recent progress in the field has 
indicated that the i-motif may be a possible therapeutic target in certain cases. In order 
to study this structure in more detail a chemical tool box of ligands and conditions is 
needed, which can be used to probe its potential biological function. 
 
Herein the effect of small molecule ligands and cations has been investigated. A 
previously identified i-motif binding compound BisA has been characterised in detail 
with a range of biophysical experiments, showing that it does bind to the i-motif but 
causes the DNA to condense. A high throughput screen has been carried out finding a 
number of potential new i-motif binding ligands and, through a range of experiments, 
two lead compounds mitoxantrone and tilorone have been identified with 
micromolar affinities from which novel i-motif binding analogues and structure 
activity relationships can be developed. Finally, the effect of cations on the i-motif has 
been studied, including a wider selection from across the periodic table than has 
previously been investigated. This has shown that at neutral pH, silver (I) ions have the 
ability to induce i-motif formation and that this is reversible in the presence of cysteine. 
While at acidic pH, copper (II) ions have the ability to induce hairpin formation 
reversibly in the presence of EDTA. This could enable the formation of multiple 
structures from the same oligonucleotide sequence in response to different conditions. 
The combination of these results should provide useful tools to further study the i-
motif structure. 
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sodium cacodylate and 100 mM NaCl at pH 5.5. 
Figure 3.11: Example FRET melting curves for human telomeric i-motif with increasing 
concentration of hit methylbenzethonium chloride. [DNA] = 200 nM hTeloC, 
buffer = 10 mM sodium cacodylate and 100 mM NaCl at pH 5.5. 
Figure 3.12: Example FRET melting curves for human telomeric i-motif with increasing 
concentration of hit benzalkonium chloride. [DNA] = 200 nM hTeloC, buffer 
= 10 mM sodium cacodylate and 100 mM NaCl at pH 5.5. 
Figure 3.13: Example FRET melting curves for human telomeric i-motif with increasing 
concentration of hit Pamoic acid. [DNA] = 200 nM hTeloC, buffer = 10 mM 
sodium cacodylate and 5 mM NaCl at pH 5.5. 
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Figure 3.14: Example FRET melting curves for human telomeric i-motif with increasing 
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Figure 3.15: Example CD titration of human telomeric i-motif with increasing 
concentration of cetylpyridinium chloride. [DNA] = 10 µM hTeloC, buffer = 
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Figure 3.16: Example CD titration of human telomeric i-motif with increasing 
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10 mM sodium cacodylate and 100 mM NaCl at pH 5.5. 
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Figure 3.23: Example CD titration of human telomeric i-motif with increasing 
concentration of tilorone. [DNA] = 10 µM hTeloC, buffer = 10 mM sodium 
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Figure 3.24: Normalised average change in CD at 270 nm for tilorone with human 
telomeric i-motif, fitted with 1 to1 and 2 to 1 binding models. Error bars show 
the standard deviation across 2 repeats. [DNA] = 10 µM hTeloC, buffer = 10 
mM sodium cacodylate and 100 mM NaCl at pH 5.5. 
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Figure 3.25: Change in melting temperature with increasing concentration of tyrothricin 
with human telomeric i-motif (hTeloC), c-Myc i-motif, human telomeric G-
quadruplex (hTeloG) and duplex DNA. Error bars show the standard deviation 
across 2 repeats. DNA = 200 nM, buffer = 10 mM sodium cacodylate and 100 
mM or 5 mM NaCl. Two points are shown where biphasic melting curves were 
observed. 
Figure 3.26: Change in melting temperature with increasing concentration of 
mitoxantrone with human telomeric i-motif (hTeloC), c-Myc i-motif, human 
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standard deviation across 2 repeats. DNA = 200 nM, buffer = 10 mM sodium 
cacodylate and 100 mM or 5 mM NaCl. 
Figure 3.27: Change in melting temperature with increasing concentration of tilorone 
with human telomeric i-motif (hTeloC), c-Myc i-motif, human telomeric G-
quadruplex (hTeloG) and duplex DNA. Error bars show the standard deviation 
across 2 repeats. DNA = 200 nM, buffer = 10 mM sodium cacodylate and 100 
mM or 5 mM NaCl. Two points are shown where biphasic melting curves were 
observed. 
Figure 3.28: Change in melting temperature with increasing concentration of tamoxifen 
with human telomeric i-motif (hTeloC), c-Myc i-motif, human telomeric G-
quadruplex (hTeloG) and duplex DNA. Error bars show the standard deviation 
across 2 repeats. DNA = 200 nM, buffer = 10 mM sodium cacodylate and 100 
mM or 5 mM NaCl. 
Figure 3.29: Change in melting temperature with increasing concentration of 
bromocriptine mesylate with human telomeric i-motif (hTeloC), c-Myc i-
motif, human telomeric G-quadruplex (hTeloG) and duplex DNA. Error bars 
show the standard deviation across 2 repeats. DNA = 200 nM, buffer = 10 mM 
sodium cacodylate and 100 mM or 5 mM NaCl. 
Figure 3.30: Change in melting temperature with increasing concentration of 
pararosaniline with human telomeric i-motif (hTeloC), c-Myc i-motif, human 
telomeric G-quadruplex (hTeloG) and duplex DNA. Error bars show the 
standard deviation across 2 repeats. DNA = 200 nM, buffer = 10 mM sodium 
cacodylate and 100 mM or 5 mM NaCl. 
Figure 3.31: Sensorgrams of initial binding response tests for a) mitoxantrone and b) 
tilorone with human telomeric i-motif. The sensorgrams are normalised with 
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respect to a blank cell containing no DNA. Running buffer = 10 mM sodium 
cacodylate, 100 mM NaCl and 0.05% tween 20 at pH 5.5. 
Figure 3.32: Sensorgrams of initial binding response tests for a) bromocriptine and b) 
pararosaniline with human telomeric i-motif. The sensorgrams are 
normalised with respect to a blank cell containing no DNA. Running buffer = 
10 mM sodium cacodylate, 100 mM NaCl and 0.05% tween 20 at pH 5.5. 
Figure 3.33: Sensorgrams of initial binding response tests for a) tyrothricin and b) 
tamoxifen with human telomeric i-motif. The sensorgrams are normalised 
with respect to a blank cell containing no DNA. Running buffer = 10 mM 
sodium cacodylate, 100 mM NaCl and 0.05% tween 20 at pH 5.5. 
Figure 3.34: Example sensorgram for mitoxantrone with human telomeric i-motif. The 
sensorgrams are double referenced by subtracting the response on the blank 
flow cell containing no DNA and by subtracting blank injections of just buffer. 
Running buffer = 10 mM sodium cacodylate, 100 mM NaCl and 0.05% tween 
20 at pH 5.5. 
Figure 3.35: Example SPR binding curve for mitoxantrone with human telomeric i-motif. 
Running buffer = 10 mM sodium cacodylate, 100 mM NaCl and 0.05% tween 
20 at pH 5.5. 
Figure 3.36: Example sensorgram for tilorone with human telomeric i-motif. The 
sensorgrams are double referenced by subtracting the response on the blank 
flow cell containing no DNA and by subtracting blank injections of just buffer. 
Running buffer = 10 mM sodium cacodylate, 100 mM NaCl and 0.05% tween 
20 at pH 5.5. 
Figure 3.37: Example binding curve for tilorone with human telomeric i-motif. Running 
buffer = 10 mM sodium cacodylate, 100 mM NaCl and 0.05% tween 20 at pH 
5.5. 
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concentration of AgNO3 at pH 7.4. [DNA] = 200 nM, buffer = 10 mM sodium 
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cacodylate and 5 mM NaCl. Figure adapted from Henry Day et. al. by 
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1.1 DNA Secondary Structure 
 
The iconic double helix structure of DNA was first suggested by James Watson and 
Francis Crick in 1953 (figure 1.1a).1 Since then, research efforts have focused on 
whether DNA can form other structures and what role they may play in biology. This 
lead to the identification of now well-known structures including B-, A- and Z-form 
duplexes, hairpins, triplexes, 3-way and 4-way junctions and quadruplexes, illustrating 
that DNA may exist in many different structural forms.2 The G-quadruplex structure in 
particular (figure 1.1b), has seen some of the most extensive investigation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: a) Watson and Crick base pairing and the structure of B-form DNA. PDB ID: 
1BNA,3 b) Hoogsteen base pairing in a G-tetrad and the structure of a G-quadruplex 
PDB ID: 2LBY.4 
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These are four stranded structures formed from sequences with a repeating series of 
guanine bases that form a G-tetrad using Hoogsteen hydrogen bonding. These tetrads 
are able to stack on top of one another forming the G-quadruplex stabilised by 
monovalent cations.5 Sequences capable of forming these structures have been found 
throughout telomeric and promoter regions of the genome, while Balasubramanian 
and co-workers have been able to identify their existence in living human cells.6–9 Some 
G-quadruplex binding ligands have been shown to be effective inhibitors of telomerase 
and have been used to both up regulate and down regulate oncogene expression.10,11 
Proteins have also been discovered which bind to G-quadruplex structures indicating 
a natural biological role for the structure.12–14 
 
1.2 i-Motif DNA 
 
First proposed in 1993 by Gehring, Leroy and Guéron, the i-motif is another four 
stranded structure formed from sequences rich in cytosine, which are complimentary 
to G-quadruplex forming sequences.15 The structure forms readily under acidic 
conditions and is stabilised by hemi-protonated cytosine-cytosine+ base pairs, forming  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: The structure of tetrameric i-motif DNA. a) A hemi-protonated cytosine-
cytosine+ base pair, b) the top view of d(TC5) c) side view of d(TC5) showing the major 
groove, d) side view of d(TC5) showing the minor groove. PDB ID: 225D.15 Figure 
adapted from Henry Day et. al. (see appendix).16 
 
a) 
b) 
c) d) 
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two parallel duplexes that intercalate with one another in an antiparallel orientation 
(figure 1.2).15 Due to a reliance on acidic pH for the stability of the structure, there is 
still some skepticism in the field whether the i-motif can form under physiological 
conditions. Therefore, the majority of i-motif research so far has focused on its 
potential uses in nanotechnology. The ability of the i-motif to rapidly fold and unfold in 
response to changes in pH has enabled it to be used in pH sensing,17,18 logic operations 
for computation,19–21 nanomachines22,23 and nano-scale assembly.24,25 However, much 
less is known about the natural occurrence of these structures and whether they have 
a role to play in biology. 
 
1.2.1 Structure and Topology of i-Motif DNA 
 
The first i-motifs identified were intermolecular structures consisting of four separate 
strands of cytosine.15 Hemi-protonated cytosine base pairs were identified as early as 
196226 and evidence of hairpin secondary structures in cytosine rich sequences was 
observed in 1989.27 Despite this, the identification of an intercalated tetrameric 
structure was surprising and the intercalated (i) motif is still one of the only structures 
of this type to have been identified. Sequences with two stretches of cytosines can also 
form dimeric i-motif structures where two hairpins intercalate.28 More interestingly, 
from a biological perspective, natural sequences with four stretches of cytosines 
separated by other bases can fold into an intramolecular i-motif structure (figure 1.3). 
Since the original i-motif discovery, a number of crystal structures of intermolecular i-
motifs have been reported,29–33 however, there as yet no published examples of 
intramolecular i-motif crystal structures. 
 
 
 
 
 
 
 
 
 
Figure 1.3: Tetrameric, dimeric and intramolecular i-motif structures. 
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  a)     b)      c)        d) 
 
 
 
 
 
 
 
 
 
Figure 1.4: A comparison of 3'E & 5'E i-motif structures. a) an NMR structure of 
d(5mCCT3CCT3ACCT3CC) PDB ID: 1A83,34 b) a schematic diagram of this 3'E i-motif, c) 
an NMR structure of the human telomeric i-motif d(CCCTA25mCCCTA2CCCUA2CCCT) 
PDB ID: 1EL2,35 d)a schematic diagram of this 5'E i-motif. Figure adapted from Henry 
Day et. al. (see appendix).16 
 
The intercalation of the i-motif structure can occur in different ways to form two 
different topologies. One in which the outermost cytosine pair are from the 3' end of 
the sequence and another where the outermost pair are from the 5' end. First labelled 
R-form and S-form,36 they were later re-named 3'E and 5'E respectively.37,38 A third 
topology denoted T-form is also possible in which the outermost C-C+ pair are not 
intercalated but this is less stable.39 As will be discussed, there are several competing 
factors affecting i-motif stability so whichever of these topologies is favoured for any 
given i-motif will be a compromise of these multiple effects, depending on sequence 
(figure 1.4). 
 
As well as the 3'E and 5'E classifications, intramolecular i-motifs have also been 
classified by Laurence Hurley and co-workers based upon the length of the loop 
regions.40 i-Motifs with short loops have been described as class I while those with long 
loops have been denoted class II (figure 1.5). Of the i-motifs they classified as class I or 
class II, it was shown that the class II i-motifs were more stable, which they 
hypothesised was due to interactions between bases in the loop regions providing a 
stabilising effect. However, John Brazier’s group have since identified a class I i-motif 
in the HIF-1α gene promoter which has unexpectedly high stability, with a transitional 
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pH (the pH at which half the DNA is folded and half unfolded) close to neutral (pHT = 
7.2).41 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5: A schematic diagram illustrating the difference between short looped Class I 
and longer looped Class II i-motif structures. In this example, the class I i-motif is from 
the promoter region of the Retinoblastoma oncogene (Rb) and the Class II i-motif is 
from the P1 promoter region of B-cell lymphoma 2 (Bcl-2).40 
 
1.2.2 Stability of i-Motif DNA 
 
Most investigations into i-motif stability are driven by the quest to find a natural 
sequence that is able to form an i-motif structure under physiological conditions of pH 
and temperature. It has been shown that the i-motif can form at neutral pH at low 
temperature (T = 4 °C) but this in itself isn’t particularly physiologically relevant.42 
Molecular crowding is another important consideration. The cellular and nuclear 
environment is more akin to a gel than simple aqueous conditions and simulation of 
this crowded environment can be achieved using high molecular weight polyethylene 
glycol polymers.43 Under these conditions it has been shown that G-quadruplex and i-
motif structures are both favoured and duplex and single stranded DNA are actively 
disfavoured.44,45 This is due to an increase in pKa of the N3 position of cytosine which 
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needs to be protonated. This makes protonation more favourable at neutral pH and 
hence the corresponding i-motif is easier to form.46,47  
 
Another key factor affecting the favourability of formation of both i-motif and G-
quadruplex structures, is their respective destabilising effects on the remaining double 
helical strand. It has been suggested that a minimum spacing of five base pairs of 
unwound DNA is needed between the i-motif structure and the start of the double helix 
in order to maintain the stability of each structure.48 What may facilitate this is the 
negative superhelical stress that is induced in the DNA single strand when it is 
unwound for transcription. Formation of an alternative secondary structure such as 
the i-motif, can relieve this superhelical stress and hence stabilise the DNA structure 
as a whole.49 Laurence Hurley’s group were able to show this effect by placing the i-
motif and G-quadruplex forming sequences from the c-Myc oncogene promoter into a 
supercoiled plasmid which simulated the negative superhelicity generated during 
transcription.49 Using enzymatic and chemical footprinting methods they showed the 
formation of both G-quadruplex and i-motif structures at neutral pH. This indicates a 
plausible mechanism for the formation of i-motif structures under physiological 
conditions during transcription. 
 
Under physiological conditions there are a range of different cations present at varying 
concentrations. Therefore, the effect of cation concentration on i-motif stability is an 
important factor to assess. The effects of Na+, K+ and Mg2+ on the formation of the i-
motif in the c-jun proto-oncogene have been studied.50 Saxena and co-workers showed 
that initially in solutions of 100 mM Na+ at pH 5.7, only duplex DNA was present. 
However, in solutions of 100 mM K+ at the same pH, i-motif and G-quadruplex 
structures were favoured. When 10 mM Mg2+ and 100 mM Na+ were assessed in 
combination, all 3 structures - duplex, G-quadruplex and i-motif were found. Later, 
Mergny and co-workers showed that at pH 4.8, (close to the pKa of cytosine) increasing 
the concentration of sodium chloride to 100 mM destabilised i-motif structure, but that 
a further increase in concentration to 300 mM did not destabilise the structure any 
further.51 This effect they showed, was due to the lowering of the pKa of the N3 of 
cytosine in low salt conditions, making i-motif formation more favourable at that pH in 
low salt rather than high salt concentration. They also showed, that in the presence of 
100 mM NaCl at pH 6.4, there was no effect on i-motif stability with the addition of 5 
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mM Mg2+, Ca2+, Zn2+, Li+ or K+ ions. Other recent studies have continued to show a 
decrease in the stability of the i-motif in the presence of a high concentration of cations. 
In particular, Sung Eun Kim and co-workers have shown that Li+ ions promote 
unfolding of the i-motif without hindering the folding of the i-motif.52 They suggest this 
is due to the small ionic radius of Li+ (0.7 Å) which is small enough to fit between the 
cytosine-cytosine+ base pairs (1.8 Å,35) but does not have the ability to facilitate 
cytosine base pairing itself and hence disrupt the structure. Aside from these few 
experiments, little has been done to look at the effect of cations on i-motif DNA. 
Therefore, this topic has been studied as part of this thesis and will be discussed in 
detail in chapter 4. 
 
1.3 Biological Significance 
 
Recently, there has been increasing interest in the potential biological significance of 
the i-motif. Due to the complimentarity of i-motif forming sequences with G-
quadruplex forming sequences, initial research has so far looked at the telomeric and 
oncogene promoter regions where G-quadruplexes have already been well 
characterised. The results of some of these studies are described in this section and 
show that the i-motif may have potential as a therapeutic target.  
 
1.3.1 Telomeric Regions of Eukaryotic DNA 
 
The telomeric regions of eukaryotic DNA are the repeating sequences of linear double 
and single stranded DNA at the end of chromosomes and they are rich in guanine bases 
with the repeat sequence 5'-d(TTAGGG)n-3'. They include a single stranded overhang 
of the same sequence at the 3' end which is known to form G-quadruplexes.53 Normally 
the telomeric DNA sequence is in a complex with several proteins and forms a cap to 
the chromosome which protects the DNA from degradation during cell division. This is 
known as the telomere. In fact, the telomeres act like a “replication clock” which defines 
how many times the cell can divide.54 During each replication, a portion of the telomere 
is lost, until eventually there is no telomere left and replication would damage the 
coding DNA region at which point senescence is triggered. The enzyme telomerase is 
able to regenerate the telomeric repeat region. In normal healthy cells, this enzyme is 
switched off, conversely, in over 85% of cancers, telomerase is over expressed.54,55 This 
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is one mechanism by which cancer cells can become immortal, enabling them to divide 
uncontrollably.  
 
It has already been demonstrated that stabilisation of G-quadruplex structures in the 
human telomere can inhibit telomerase.56 In fact, there are now a large number of G-
quadruplex binding ligands which are also potent telomerase inhibitors.57 The 
complimentary strand of the human telomeric DNA sequence is rich in cytosine with 
the ability to form an intramolecular i-motif structure and was one of the first 
intramolecular i-motifs to be discovered.58 It has the sequence 5'-d(CCCTAA)n-3' and 
forms a class I type of structure with short loop sequences consisting of the 3 TAA bases 
that sit between the repeating cytosine tracts, this is defined as a 3:3:3 loop topology.35 
Loop topology is the number of bases forming the loops between cytosine tracts for 
example in figure 1.5, Rb has a loop topology of 2:4:2 while Bcl-2 has a loop topology 
of 8:5:7 VEGF and RET both have 2:3:2 loop topologies but different sequences.40 
 
Targeting of the human telomeric i-motif has also been shown to inhibit telomerase 
(figure 1.6).59 Using carboxyl-modified single walled carbon nanotubes which bind 
specifically to i-motif structures, Xiaogang Qu and co-workers showed they were able 
to inhibit telomerase and induce telomere uncapping, resulting in a DNA damage 
response and apoptosis (see section 1.3.2).59 There are several proteins which have 
been shown to bind to the C-rich sequence of telomeric DNA however, it is not certain 
whether these proteins are able to bind to the i-motif structure or whether they only 
bind to single stranded DNA.60,61 
 
 
 
 
 
 
 
 
Figure 1.6: A schematic illustration of the binding of carboxyl-modified single-walled 
carbon nanotubes (SWNTs) to the human telomeric i-motif and the resultant inhibition 
of telomerase which may be as a result of corresponding G-quadruplex formation. 
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1.3.2 Gene Promoter Regions 
 
One of the most well studied i-motifs is that of the sequence within the promoter region 
of the c-Myc oncogene.62 This gene codes for a transcription factor with a variety of 
different functions in the control of cell cycle progression and cell growth.63 Its 
dysregulation is one of several characteristic hallmarks of cancer. The c-Myc promoter 
region consists of seven nuclease hypersensitive elements or NHEs. The NHE III1 is of 
particular interest as this is responsible for approximately 90% of c-Myc 
transcription.64 The NHE III1 is rich in cytosine bases and is therefore able to form an 
i-motif structure, it is also in this C-rich region that the transcription factor binding 
sites for Sp1 and heterogeneous ribonucleoprotein K (hnRNP K) are found.63 The c-
Myc promoter i-motif has a relatively high transitional pH of 6.6.40 In vitro the sequence 
forms an i-motif with a 5:5:5 loop topology, neither class I or class II, utilising eight 
cytosine base pairs.62 However, Laurence Hurley’s group have shown that under 
conditions of negative superhelical stress, such as those generated during 
transcription, the c-Myc i-motif can form at neutral pH with a class II 6:2:6 loop 
topology and only using 6 cytosine base pairs.49 The reason for this is, as yet, unknown 
but the presence of longer loops may provide additional stability or may be part of any 
possible biological role of the i-motif. 
 
The P1 promoter of the B-cell lymphoma 2 (Bcl-2) oncogene has been shown to form a 
stable i-motif (pHT = 6.6) with a large 8:5:7 loop topology (class II).40,65 Bcl-2 is over 
expressed in many cancers and works to protect the cell against apoptosis.66,67 
Interestingly, for the same reason Bcl-2 is under expressed in neurodegenerative 
diseases such as Alzheimer’s and Parkinson’s resulting in an increase in cell death.68 
Laurence Hurley and co-workers have studied the Bcl-2 i-motif in detail and recently 
showed that the i-motif structure is in fact in dynamic equilibrium with a hairpin 
structure that is more flexible than the i-motif (figure 1.7).69 Hurley’s group have also 
identified ligands which bind to the Bcl-2 i-motif and flexible hairpin structures using 
a high throughput screen. They went on to show that stabilisation of the i-motif with 
the ligand IMC-48 (see section 1.3.3) resulted in an increase in gene transcription, 
conversely the hairpin ligand IMC-76 (see section 1.3.3) resulted in a decrease in gene 
transcription. The effects on gene expression were seen at both the transcription level 
and the translation level and is the first evidence for a possible biological function for 
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the i-motif.69 This result is particularly interesting as it was previously hypothesised 
that formation of the i-motif is likely to down regulate gene expression in a similar way 
to G-quadruplexes, by preventing the binding of transcription factors to the single 
strand. In fact, Laurence Hurley’s group also identified a natural transcription factor 
(hnRNP LL) which binds to the two lower loops of the i-motif and then unfolds the 
structure to activate transcription (see section 1.2.3).70 The hnRNP LL protein is 
analogous to the hnRNP K protein which binds to the c-Myc promoter and it has now 
been hypothesised that unlike the G-quadruplex, the i-motif may be an “on switch” for 
gene transcription, acting as a scaffold to enable more favourable binding of 
transcription factors to the c-rich sequence. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7: A schematic illustration to show the dynamic equilibrium between the i-
motif structure and a flexible hairpin structure in the Bcl-2 promoter region and the 
effect of compounds IMC-48 and IMC-76 on gene expression. 
 
Largely thanks to the work of Laurence Hurley and co-workers, c-Myc and Bcl-2 are 
the two most well studied promoter i-motif sequences. Despite this, there is still a lot 
of work needed to cement the i-motif as a possible therapeutic target. However, an 
increasing number of i-motif forming gene promoter sequences have been identified 
and more are currently under investigation. These are most often in promoter regions 
where the complimentary G-quadruplex structures have already been characterised. 
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A range of different i-motif forming sequences from promoter regions have been listed 
in Table 1.1. Many such as retinoblastoma (Rb),71,72 vascular endothelial growth factor 
(VEGF),73 c-ki-ras,74 c-kit,75,76 n-Myc77 and RET78 are part of promoters for oncogenes 
which are over expressed in a variety of different cancers. The proximity of the 
potential i-motif structures to important transcription start sites offers circumstantial 
evidence for an involvement in gene expression and, even if they do not form naturally, 
could be investigated as potential targets for ligands. Like G-quadruplexes however, 
the i-motif should not be considered as a solely cancer related target. The identification 
of an i-motif forming sequence in the insulin-linked polymorphic region (ILPR),28,79,80 
and a possible i-motif structure in the fragile X chromosome repeat sequence,81 show 
that the i-motif could be investigated in the context of other diseases such as diabetes 
or fragile X syndrome.  
 
Due to the complimentary nature of G-quadruplex and i-motif sequences, a logical 
starting point to look for new i-motifs is in those promoter regions where G-
quadruplexes have already been characterised. John Brazier and co-workers have 
started to do just this. They examined the cytosine rich strands of c-KIT, c-myb, hTERT, 
PDGF-A and HIF-1α, all of which already contain known G-quadruplexes in their G-rich 
strands.41 They showed that all of these sequences were able to form i-motifs at pH 5.0. 
More interestingly, they showed that PDGF-A and HIF-1α were able to form unusually 
stable i-motifs even at pH 7.0 with Tm’s of 32 and 27°C respectively. This is surprising 
as both these sequences form what would be described as class I i-motifs with short 
loop sequences under Hurley’s earlier classification system.40 This goes against 
previous evidence which suggests that class II i-motifs with longer loops are more 
stable.40 However, these particular sequences do have much longer cytosine stretches 
able to form up to 10 (PDGF-A) and 7 (HIF-1α) cytosine base pairs which may be 
responsible for this extra stability. It is also not yet clear what the precise folding 
topology of these i-motifs are and depending on which cytosines are used for the core 
i-motif structure, they may in fact have longer loops than expected, with the loops 
containing cytosines or they may have long flanking regions at the 3' and 5' ends which 
could also have a stabilising effect. 
It has been shown that there are over 376,000 putative G-quadruplex forming 
sequences in the human genome,82,83 with 43% of all gene and 69% of oncogene 
promoters containing a possible G-quadruplex.84 It is conceivable therefore that there 
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could be at least as many putative i-motif forming sequences. However, the stability of 
the i-motif is much more variable with length and composition of the sequence and no 
precise folding rules have yet been formulated. The example of Bcl-2 and of other 
sequences that are able to form multiple hairpin or i-motif structures adds another 
layer of complexity to the possible biological role of the i-motif. While G-quadruplexes 
are generally favoured within shorter sequences forming compact structures, the 
stability of longer looped i-motifs and their possible dynamic nature indicates that i-
motifs may require longer sequences to form and it may be the case that there are i-
motif forming sequences in regions where G-quadruplexes are less stable or their 
formation is not possible at all.   
 
Name Sequence 5'→3' 
hTeloC d(CCCTAACCCTAACCCTAACCCT)n 
c-Myc d(CCCCACCTTCCCCACCCTCCCCACCCTCCCC) 
Bcl-2 d(CAGCCCCGCTCCCGCCCCCTTCCTCCCGCGCCCGCCCCT) 
Rb d(GCCGCCCAAAACCCCCCG) 
RET d(CCGCCCCCGCCCCGCCCCGCCCCTA) 
VEGF-A d(GACCCCGCCCCCGGCCCGCCCCGG) 
ILPR d(TGTCCCCACACCCCTGTCCCCACACCCCTGT)n 
c-ki-ras d(GCTCCCTCCCTCCCTCCTTCCCTCCCTCCC) 
c-kit d(CCCTCCTCCCAGCGCCCACCCT) 
n-Myc d(ACCCCCTGCATCTGCATGCCCCCTCCCACCCCCT) 
c-myb d(TCCTCCTCCTCCTTCTCCTCCTCCTCCGTGTCCTCCTCCTCC) 
hTERT d(CCCCGCCCCGTCCCGACCCCTCCCGGGTCCCCGGCCCAGCCCCCACCGGGCCCTCCCAGCCCCTCCCC) 
PDGF-A d(CCGCGCCCCTCCCCCGCCCCCGCCCCCGCCCCCCCCCCCCC) 
HIF-1α d(CGCGCTCCCGCCCCCTCTCCCCTCCCCGCGCGCCCGAGCGCGCCTCCGCCCTTGCCCGCCCCCTG) 
c-jun d(TAACCCCCTCCCCCTCCCCCCTTTAAT) 
Th (rat) d(TCTCGTCGCCCTCGCTCCATGCCCACCCCCGCCTCCCTCAGGCAC) 
 
Table 1.1: Example sequences of different i-motif structures forming within the human 
genome, which have been investigated in the literature. hTeloC and ILPR are both 
tandem repeat sequences. 
 
1.3.3 i-Motif Binding Proteins 
 
There are many proteins which are known to bind to C-rich DNA but it is often assumed 
that this is either to the double strand or single strand. A protein has been identified in 
HeLa cell extracts, which is specific for telomeric repeat sequences and sequences with 
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at least 4 cytosine tracts over other cytosine rich sequences in promoter regions and 
d(C22).60 This is circumstantial evidence that the i-motif may affect its binding, either 
to promote or inhibit, however the binding of the protein has only been tested at pH 
7.4 where the i-motif is not expected to form. Guéron and co-workers have investigated 
the binding of yeast proteins to the yeast tetrahymena sequence and vertebrate 
telomeric sequences showing binding from pH 6 to 8 using an electrophoretic mobility 
shift assay (EMSA),85 unfortunately binding across this pH range means it is not clear 
whether the proteins bind to the i-motif, the single strand or both. 
 
The first protein to be identified and characterised as binding to the i-motif structure 
itself, is the transcription factor hnRNP LL.70 In their investigation of the Bcl-2 i-motif, 
Hurley and co-workers used a pull down assay to identify proteins which bind to the 
Bcl-2 i-motif. They identified 35 proteins, including 9 with a role in transcription. 
hnRNP LL was of particular interest as it is a paralog of the RNA binding protein hnRNP 
L, having four DNA binding domains which recognise the sequences CCCGC and CGCCC 
which are found in loops 1 and 3 of the Bcl-2 i-motif. The protein was shown to be 
specific for i-motif over a mutant single strand by EMSA at pH 6.8. Surface plasmon 
resonance was then used to measure the binding affinity of the protein for both the Bcl-
2 i-motif and the Bcl-2 single strand, showing that hnRNP LL had a much stronger 
affinity (Kd = 19.4 pM) for the i-motif than for the single strand (Kd = 69.8 pM). The 
spacing of the CCCGC sequences that are recognised by the protein provides further 
evidence that the i-motif is the natural target of hnRNP LL. Hurley’s group used EMSA 
to assess the binding of hnRNP LL to sequences with between 2 and 17 thymine bases 
between the two recognition sequences. These experiments showed that a spacing of 
13 bases resulted in the strongest binding, this is the same number of bases separating 
the recognition sequences in the natural Bcl-2 sequence. Using circular dichroism and 
bromine footprinting, it has been shown that hnRNP LL works by binding to the two 
lateral loops of the folded i-motif structure, it then unfolds the i-motif within the 
protein active site to enable transcription. The difference in footprinting patterns 
showed that this unfolded form was not the same as the alternative hairpin structure 
identified previously.70 Molecular population dynamics experiments were used to 
show that on short time scales (60 s) the protein favoured binding to the i-motif 
structure, whilst on longer time scales (180 s), binding to the single strand was 
favoured.86 This supports the hypothesis that the function of the i-motif structure is to 
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act as a scaffold to present the recognition sequences of the protein in the most 
kinetically favourable orientation for the protein to bind, after which the protein 
unfolds the structure to the most thermodynamically stable single-strand. 
 
The identification of hnRNP LL is an important discovery in deciphering the possible 
biological function of the i-motif. Is it possible that there are hnRNP type proteins or 
similar which bind to all i-motifs activating transcription? hnRNP K is a transcription 
factor which binds to the C-rich i-motif forming sequence of c-Myc.63 hnRNP K is very 
similar to hnRNP LL but recognises CCCT and TCCC sequences with the same 13 base 
separation which are found in loops 1 and 3 of the c-Myc i-motif.49,87 Hurley and 
colleagues have hinted in their work on Bcl-2, that they have seen similar results for 
the hnRNP K/c-Myc system, but this has not yet been published. However, hnRNP K 
has also been shown to bind to telomeric i-motif forming sequences which also contain 
repeats of CCCT but in this case these recognition sites are within the cytosine core 
rather than the loop regions.61 Lacroix et al. carried out experiments in the pH range 
from 6 to 9.2 showing binding of hnRNP K across this range. It was not ascertainable 
from their results whether hnRNP K bound to the single strand and hence unfolded i-
motif at the lower pH’s or, whether it preferred to bind to the i-motif and hence 
stabilised the i-motif at higher pH’s. The example of hnRNP LL suggests that hnRNP K 
probably binds to the i-motif structure in c-Myc and unfolds it to activate transcription, 
whilst in the telomeric region hnRNP K most likely only binds to the single strand. 
Further investigation of this case could serve to strengthen the hypothesis that the i-
motif in promoter regions can serve to activate transcription, whilst in telomeric 
regions can serve to inhibit protein recognition and binding.  
 
Although the discovery of hnRNP LL and other similar proteins suggests that the i-
motif may have a natural biological function, this is still a subject that is dividing 
opinion in the field and is a long way from being understood. Most recently, Kasturi 
Banerjee and co-workers have identified both G-quadruplex and i-motif forming 
sequences in the promoter region of the tyrosine hydroxylase (Th) gene that co-insides 
with the binding site of hnRNP K and they show that this protein activates transcription 
of the gene.88 However, rather than agree with Hurley’s suggestion that hnRNP K 
activates transcription through binding of the i-motif, they suggest that formation of 
the i-motif blocks the binding of hnRNP K and decreases transcription. They support 
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this hypothesis by showing that the compound TMPyP4 which binds to both G-
quadruplex and i-motif, has an inhibitory effect on transcription.88 It is possible though, 
that since the i-motif is less stable than the G-quadruplex under physiological 
conditions, that TMPyP4 is only binding to the G-quadruplex in this case and that the 
decrease in gene expression is soley through stabilisation of this structure. To fully 
understand the role of the i-motif within the Th promoter, a more specific ligand will 
be needed to deconvolute the possibly contrasting effects of the two structures.  
 
Even if the i-motif turns out not to have a natural role in biology, the fact that this 
structure can form under certain conditions, should enable the i-motif to be targeted 
with small molecules to investigate its biological effect. At the time of writing, there are 
a very small number of i-motif ligands in the literature, this is in stark comparison to 
the G-quadruplex field where many ligands have been identified.89 Despite this, it has 
already been shown that an i-motif specific ligand can inhibit telomerase,59 whilst 
ligands specific for Bcl-2 can control gene expression.69 This suggests that the i-motif 
is a worthwhile target to investigate but a wider range of ligands is required. This is 
one of the areas that will be investigated in this thesis. 
 
1.4 Techniques for Investigating i-Motif – Ligand 
Interactions 
 
In order to discover new i-motif binding ligands, a range of biophysical techniques are 
required to identify and investigate any i-motif – ligand interaction. There are already 
a wide variety of experimental methods that have been developed to study ligand 
interactions with duplex and G-quadruplex DNA.90 However, the application of these 
experiments to study the i-motif, poses its own difficulties. In vitro most i-motif 
structures are only stable under acidic conditions, therefore to be certain that the 
ligand is binding to the i-motif structure, assays must be conducted under acidic 
conditions. This can have a quenching effect on the fluorescence of ligands or labels. It 
can also have an effect on the solubility of the ligand and the charge of the ligand may 
affect its ability to bind to the structure. Despite these potential problems, a number of 
existing methods have been successfully applied to the study of i-motif ligand 
interactions and these techniques will be utilised through out this research. 
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1.4.1 UV Absorbance Spectroscopy 
 
When irradiated, DNA absorbs light at 260 nm. Due to the difference in π-π stacking 
interactions, folded DNA absorbs differently to unfolded DNA. It is therefore possible 
to use UV absorbance to monitor folding or unfolding of the structure. Typically, the i-
motif shows an increase (hyperchromism) in absorbance at 260 nm and a decrease 
(hypochromism) in absorbance at 295 nm when it unfolds.91 
 
UV absorbance can also be used to measure binding affinity for compounds interacting 
with the i-motif. Many DNA binding compounds are UV active due to their planar, 
aromatic structure. If these compounds absorb in a different region of the spectrum to 
the DNA, then by titrating DNA into the sample and monitoring the change in 
absorbance for the compound, a binding affinity can be measured.  This was put to good 
effect by Laurence Hurley and co-workers when they identified the first i-motif binding 
compound, the porphyrin TMPyP4.92 They used the absorbance of TMPyP4 at 425 nm 
which showed significant hypochromism (33%) upon addition of the sequence 
d(AACCC)4 as well as a bathochromic shift indicating a binding event. From this data 
they were able to measure a binding affinity of 45 µM.92 The disadvantage to this 
method is that ligands which absorb in the same region as DNA cannot be assessed as 
it is difficult to deconvolute the change in absorbance that is due to the ligand from that 
which is due to the DNA. 
 
1.4.2 UV Melting and UV Difference Spectroscopy 
 
The difference in absorbance between folded and unfolded DNA can be used in 
conjunction with a thermal peltier system to carry out DNA melting experiments. By 
monitoring the change in absorbance at a particular wavelength (typically 295 nm for 
the i-motif) with increasing temperature, the melting temperature of the DNA 
structure can be measured which is used to describe the stability of the structure.91 By 
comparing melting temperatures of different i-motif sequences, their relative 
stabilities can be compared if performed under the same conditions. This was used 
recently by John Brazier and colleagues in identifying stable i-motifs in sequences 
complimentary to known G-quadruplexes.41 As well as measuring thermal stability 
they also measured the change in UV absorbance with changing pH in order to measure 
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the transitional pH (pHT) at which half the DNA is folded and half unfolded, identifying 
two i-motifs (PDGF-A and HIF-1α) with unusually high pHT as described in section 
1.3.2.41 
 
As well as just simply monitoring the change in UV absorbance at a specific wavelength, 
Mergny and co-workers have shown that by subtracting the complete UV spectrum of 
the folded (low temperature) sample from the spectrum of the unfolded (high 
temperature) sample, a new spectrum is generated which they term the thermal 
difference spectrum (TDS).93 Mergny et al. carried out this experiment for a wide range 
of different structures including AT duplex, GC duplex, Z-DNA, parallel stranded DNA, 
GA DNA duplex, Hoogsteen base paired duplex, i-motif, G-quadruplex and pyrimidine 
triplex DNA. The data was taken between 220 and 330 nm, was normalised so that the 
maximum ΔAbs. = 1 and corrected to ΔAbs. = 0 at 320 nm as DNA should not give any 
absorbance at this wavelength. By testing multiple different sequences which form the 
same type of structure, they were able to show a great deal of similarity between TDS 
spectra of the same structure but clear differences between spectra of different 
structures. They have therefore identified the thermal difference spectrum as a useful  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8: UV thermal difference spectrum of human telomeric i-motif at pH 5.5. High 
(unfolded) T = 95°C, low (folded) T = 20°C. [DNA] = 2.5 µM, buffer = 10 mM sodium 
cacodylate and 5 mM sodium chloride.  
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diagnostic tool to identify the type of DNA structure present in solution.93 The thermal 
difference spectrum of i-motif DNA (figure 1.8) gives a characteristic positive peak at 
240 nm and a negative peak at 295 nm. Thermal difference spectra were used by Jun 
Zhou and co-workers to demonstrate i-motif formation at neutral pH.42 By taking the 
difference between the UV spectrum at 4°C and at 25°C they generated a TDS spectrum 
characteristic of the i-motif. This, in combination with other experiments, showed that 
at low temperature, i-motif formation could occur at neutral pH.42 
 
1.4.3 Fluorescence Emission Spectroscopy 
 
Analogous to UV absorbance titrations, if the potential ligand has fluorescent 
properties, then a binding affinity can be measured by fluorescence emission 
spectroscopy. Fluorescence occurs when a molecule in a singlet excited electronic 
state, transitions back to the ground state, releasing energy in the form of light.94 In 
fluorescence titrations, the ligand is excited at a specific excitation wavelength that has 
been pre-determined for the molecule. The corresponding emission is then monitored 
at a separate emission wavelength as DNA is titrated into the sample. When the ligand 
binds to the DNA a change in fluorescence occurs because the binding effects the 
electronic distribution of the ligand. This change in fluorescence can either be an 
increase or a decrease depending on the fluorescence properties of the compound and 
can depend on the conditions of the experiment such as buffer and pH. If all other 
conditions are kept constant, the change in fluorescence can be assumed to be 
dependent on the binding of the ligand to the DNA and can therefore be used to 
determine binding affinities. The advantage of using this method over UV is that ligands 
which absorb in the same UV region as DNA can still be tested. However, the affinity of 
ligands which are not fluorescent or do not become fluorescent upon binding cannot 
be measured.  The application of fluorescence spectroscopy to measure binding to the 
i-motif poses its own problems due the effect of pH on fluorescence. The i-motif 
generally requires acidic conditions in order to form in vitro, typical experiments are 
carried out at pH 5.5. However, many ligands are no longer fluorescent at this pH due 
to protonation of the compound, causing a change in the energy levels of the 
chromophore. 
 
 
Chapter 1: Introduction 
 
 
 20 
1.4.4  Förster Resonance Energy Transfer 
 
Another method to use fluorescence spectroscopy is to attach fluorophores to the DNA. 
This can enable the monitoring of ligands which are not fluorescent themselves. If two 
different fluorophores are attached to seperate parts of the DNA sequence that move 
into close proximity upon folding, then the effect known as Förster resonance energy 
transfer (FRET) can be exploited. FRET is a physical phenomenon where by the 
fluorescence of one fluorophore (the donor) is transferred to a different fluorophore 
(the acceptor).95 The effect relies on there being a sufficient energy match between the 
excited states of the two fluorophores, this is called resonance. The energy  transfer 
occurs by a non-radiative mechanism that relies on a dipole-dipole interaction 
between the two fluorophores and is distance dependent, typically working in the 
range of 10 - 80 Å.95 The efficiency of energy transfer (ET) can be calculated from the 
change in fluorescence of the donor (equation 1.1) or from the distance between the 
two fluorophores (equation 1.2) and hence the change in fluorescence of the donor can 
be directly related to the distance between the two fluorophores.95 This has already 
been put to use in the study of G-quadruplex ligands for a number of years.96,97 
 
Equation 1.1:    𝐸𝑇 = 1 −
𝐹𝐼𝑑
𝐹𝐼𝑑
0    
Equation 1.2:   𝐸𝑇 =
𝑅0
6
(𝑅6+𝑅0
6)
 
 
Where ET is the FRET efficiency, 𝐹𝐼𝑑  is the fluorescence intensity of the donor, 𝐹𝐼𝑑
0 is 
the fluorescence of the donor in the absence of the acceptor, R is the distance between 
the two fluorophores and R0 is the Förster distance (ET = 0.5).95 
 
In 1999 Jean-Louis Mergny investigated the use of this technique to monitor the folding 
of an intramolecular i-motif.98 Using a dual labelled oligonucleotide with the donor 
fluorophore FAM (6-carboxyfluorescein) attached to the 5' end and the acceptor 
fluorophore TAMRA (6-carboxytetramethylrhodamine) attached to the 3' end (figure 
1.9). When the DNA is unfolded, the two fluorophores are sufficiently far apart for no 
FRET to occur (> 10 nm) but when the DNA folds into the i-motif structure, the two 
fluorophores are brought into close proximity, enabling energy transfer from FAM to 
TAMRA, resulting in a reduction in the fluorescence signal of FAM. This means that the 
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folding or unfolding of the DNA can be monitored by measuring the change in 
fluorescence of FAM at 515 nm (figure 1.10). This has been used recently by Laurence 
Hurley and co-workers who screened a library of compounds and identified i-motif 
stabilising compounds by a decrease in fluorescence and destabilising compounds by 
an increase in fluorescence though he used a different acceptor fluorophore called 
black hole quencher (BHQ).69  
 
 
a)                                                  b) 
 
 
Figure 1.9: Structures of a) donor fluorophore 6-carboxyfluorescein (FAM) and b) 
acceptor fluorophore 6-carboxytetramethylrhodamine (TAMRA). 
 
As well as looking at folding as a result of ligands, the FRET effect can also be used to 
measure a melting temperature of the i-motif. Mergny showed that monitoring the 
fluorescence of FAM with increasing temperature results in a sigmoidal curve from 
which the melting temperature can be determined in an analogous way to UV melting 
curves.91,98 Using this stratergy, Khondaker Rahman and co-workers were able to 
screen over 2000 compounds for interaction with the human telomeric G-quadruplex, 
based on their stabilisation potential (ΔTm).99 This method can also be applied to 
discover i-motif ligands. This was used for the first time by Patrizia Alberti and co-
workers to identify the i-motif binding compound BisA showing that BisA stabilised 
the human telomeric i-motif by +33°C at pH 6.8.100 This technique holds advantages 
over UV melting in that, due to the high fluorescence intensity of FAM, experiments can 
be carried out at much lower DNA and ligand concentrations and ligands which absorb 
in the same UV region as DNA can also be assessed. The disadvantage to this technique 
is that the FRET effect alone does not prove that i-motif formation is occurring, only 
that some form of folding is bringing the two fluorophores close together and i-motif 
formation specifically needs to be shown with a different technique such as UV 
difference or circular dichroism. 
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Figure 1.10: An illustration of Förster resonance energy transfer used in FRET melting 
and FRET titration experiments. 
 
1.4.5  Circular Dichroism 
 
Circular dichroism (CD) is the physical property of an optically active molecule where 
it is able to absorb left and right circularly polarised light differentially. A circularly 
polarised wave is the result of combining two waves which are perpendicular to each 
other and are out of phase by 90°. The summation of left and right circularly polarised 
light results in a plane-polarised light wave.101 By the nature of their different 
glycosidic bond angles, different DNA secondary structures have different optical 
activities and hence exhibit different circular dichroism. CD spectroscopy exploits this 
property by measuring the CD signal of a sample (often quoted in molar ellipticity) with 
changing wavelength. This gives a specific spectrum depending on the type of DNA 
structure and hence can be used as a diagnostic tool to indicate which structure or 
structures may be present in the sample.102 i-Motif DNA structure gives a characteristic 
CD spectrum with a positive peak at 288 nm and a negative peak at 255 nm (figure 
1.11) whereas single stranded DNA gives a spectrum with a positive peak at 275 nm 
and a negative peak at 250 nm and is less optically active, giving a weaker signal. CD 
spectroscopy can therefore be used to monitor folding of single stranded DNA to i-
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motif and vice versa as a result of changing pH, temperature or ligands. Ligands 
interacting with the i-motif do not need to be optically active themselves, as a ligand 
binds to the DNA, as well as possibly affecting the conformation of the DNA structure, 
the ligand itself can become optically active through the process of chirality transfer. 
This results in a new induced CD signal (ICD). In much the same way as with UV and 
fluorescence changes, by measuring the change in CD signal with changing ligand 
concentration, the data can be fitted to obtain a binding constant.11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.11: Example circular dichroism spectra of single stranded and i-motif DNA. 
[DNA] = 10 µM, buffer = 50 mM sodium cacodylate, pH 5.5 (i-motif) or pH 7.4 (ssDNA). 
 
1.4.6  Surface Plasmon Resonance 
 
Surface Plasmon Resonance (SPR) is a very sensitive technique for measuring binding 
affinities by monitoring binding to a target structure attached to a gold film. Using 
oligonucleotides labelled with Biotin (figure 1.12)  at the 5' end of the sequence, the 
DNA structure of interest (i.e. the i-motif) can be attached to a streptavidin coated gold 
chip due to the very high affinity of streptavidin for biotin (Kd ~0.01 pM).103 Laser light 
is passed through a prism onto the underside of the gold at the correct angle to make 
plasmons in the gold surface resonate, creating an interference band in the reflected 
laser light which is detected. Running buffer continuously flows over the surface of the 
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chip and different concentrations of compound are injected into the system. When a 
compound binds to the DNA, it creates a change in the refractive index in the solution 
immediately above the gold surface. This affects the resonance of the gold plasmons 
and in turn moves the position of the interference band within the reflected laser light. 
This is what is measured as the SPR response (figure 1.13). This is a powerful technique 
which can measure very high binding affinities down to picomolar sensitivity. Binding 
affinities can be obtained in two different ways. By testing a range of different ligand 
concentrations in a titration experiment, and monitoring the response at equilibrium 
with ligand concentration, a binding curve can be produced and fitted with standard 
equilibrium binding models.104 Alternatively the SPR sensorgram itself can be fitted 
using a kinetics based model to obtain the association  
 
 
 
 
Figure 1.12: The structure of Biotin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.13: Schematic diagram of a surface plasmon resonance experiment. 
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and dissociation rates, which can be used to obtain the equilibrium binding affinity. 
This technique was used by Laurence Hurley and co-workers in their recent study of 
the Bcl-2 i-motif. They used SPR to determine the strong binding affinity of the 
transcription factor hnRNP LL measuring a Kd of 19.4 pM at pH 6.5.70 
 
Aside from measuring binding affinities, SPR has more frequently been used to monitor 
folding and unfolding of the i-motif under different conditions. Zhi-Xiong Zeng and 
colleagues used SPR to indicate i-motif formation in the human telomeric sequence as 
it inhibited the binding of a single strand binding protein from E. coli.105 Hongwei Xia 
and co-workers showed that the density at which the DNA sequence is grafted to the 
chip is important, as higher densities prevent i-motif formation due to crowding 
effects.106 Finally Xiaogang Qu’s group have used SPR to monitor i-motif folding in a 
DNA nanomachine driven by single-walled carbon nanotubes which selectively induce 
i-motif formation.107,108 Despite this though, SPR has not yet been used to measure the 
affinity of a small molecule ligand for the i-motif.     
 
1.4.7  Gel Electrophoresis 
 
Gel electrophoresis can be used to distinguish between different DNA structures and 
whether a small molecule, peptide or oligonucleotide sequence is bound to the target 
sequence based on their different mobilities through the gel.90,109 This is often termed 
an electrophoretic mobility shift assay (EMSA) and is typically used to determine DNA-
protein interactions.110 Small single stranded sequences are able to move through the 
gel more easily than folded structures. However, small more compact structures are 
able to move through the gel more easily than bigger structures. Finally charged 
sequences such as DNA will move through the gel more rapidly than neutral sequences 
due to the charge repulsion or attraction from the electrodes. As multiple DNA strands 
come together to form a structure, or a protein, peptide or small molecule binds to the 
DNA, a complex is formed with a higher molecular weight which therefore moves more 
slowly through the gel. There can also be some charge neutralisation occurring as, for 
example, a positively charged ligand binds to the negatively charged oligonucleotide. 
This again has the effect of slowing down the movement of the sample through the gel. 
In comparing gel results, it is important that the same control sample is present in one 
of the lanes in each gel which will move consistently under the same conditions. By 
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comparing the relative position of the bands to the control sample it can then be 
determined whether a change has occurred. Gels can be imaged by fluorescence, using 
fluorescently labelled oligonucleotide sequences or dyes, by UV using a dye such as 
ethidium bromide to stain the gel or by radioactivity using 32P-labelled DNA.110 This 
technique has been used in a number of studies to show i-motif formation including at 
neutral pH42 and formation of multiple different i-motifs in the c-Myc promoter 
sequence.62 The EMSA has also been used to show binding of proteins to C-rich single 
stranded DNA60,61 and the i-motif.70 
 
1.5 Existing i-Motif Ligands 
 
1.5.1  TMPyP4 and BisA 
 
The first compound to be investigated as a potential i-motif ligand was the porphyrin 
5,10,15,20-tetra-(N-methyl-4-pyridyl)-porphine TMPyP4 (figure 1.14).92 This 
compound is a known G-quadruplex ligand which has already been shown to decrease 
c-Myc expression,111 inhibit telomerase and tumour growth.112 Hurley and co-workers 
investigated TMPyP4’s interaction with telomeric repeat sequences forming an 
intermolecular i-motif d(CCCAAT)4 and d(AATCCC)4.92 They showed, using an 
electrophoretic shift assay, that not only did TMPyP4 bind to the i-motif but that it 
promoted its formation at pH 4.5. Despite this, TMPyP4 had little effect on the melting 
temperature of the i-motif (ΔTm <20°C) and they measured a relatively weak 
dissociation constant of 45 µM using UV titrations. TMPyP4 has a stronger affinity for 
G-quadruplex (Kd = 0.5 µM) and duplex DNA (Kd = 1.2 µM) in comparison.113 Finally 
Hurley’s group suggested a cooperativity in the binding of TMPyP4 and using NMR 
modelling experiments, indicated that TMPyP4 bound in a 2:1 stoichiometry by 
stacking on the top and bottom of the four stranded structure. The affinity of TMPyP4 
for i-motif may vary however, as its interaction with the intramolecular human 
telomeric i-motif was assessed, giving a Kd of 1 µM, but this result was calculated from 
UV melting data so is not directly comparible.114 A similar sequence where adenines in 
the loops were substituted with thymines was also studied, showing a difference in 
stoichiometry of binding between the mutant (1:2 and 1:1) and natural (just 1:1) 
sequences. This suggests that the adenines in the loop region or the difference between 
the topology of the two i-motif structures can alter the binding of TMPyP4. In their 
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previous work on TMPyP4 with G-quadruplexes Laurence Hurley and co-workers 
showed that TMPyP4 prefers to bind to intermolecular structures over intramolecular 
structures promoting the formation of anaphase bridges, down regulating gene 
expression and inhibiting telomerase.111,112 This may also be the case for i-motif 
structures, but is yet to be explored. 
 
 
 
 
 
 
 
 
 
 
Figure 1.14: The structure of porphyrin 5,10,15,20-tetra-(N-methyl-4-pyridyl)porphine, 
TMPyP4. 
 
The macrocyclic acridine compound BisA (figure 1.15) was the first i-motif interacting 
compound to be identified using Förester resonance energy transfer (FRET)  DNA 
melting in 2001 as described in section 1.4.4.100 In this example, they showed that BisA 
had a significant stabilising effect on both the human telomeric i-motif at pH 6.8 (ΔTm 
= +33°C) and the human telomeric G-quadruplex at pH 7.2 (ΔTm = +15°C). BisA was 
also shown to inhibit telomerase with an IC50 of 0.75 µM but further explorations of 
this ligand were focused on its interaction with other DNA structures. A more detailed 
investigation of BisA’s interaction with i-motif DNA is discussed in chapter 2. 
 
 
 
 
 
 
Figure 1.15: The structure of the macrocyclic acridine BisA. 
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1.5.2 Carboxyl-Modified Single-Walled Carbon Nanotubes  
 
One of the most well-studied and unusual i-motif ligands is carboxyl-modified single-
walled carbon nanotubes (SWNTs figure 1.16a). Investigations by Xiaogang Qu and co-
workers in 2006 used a wide range of experiments including FRET, CD, UV melting and 
NMR to show that SWNTs could inhibit duplex formation and promote human 
telomeric i-motif formation in conditions up to pH 8.0 with a significant stabilisation 
temperature of +22°C at pH 5.5.107 The carboxyl-modified nanotubes were prepared 
by sonicating the SWNTs in a mixture of concentrated sulfuric acid and nitric acid (3:1 
vol/vol) so it is not clear how many acid groups are present on any single carbon 
nanotube.115 This is a particular concern with respect to the pH sensitivity of the i-motif 
structure but Qu et al. state that the pH did not change in their experiments.107 Due to 
their size (diameter = 1.1 nm107), Qu and co-workers hypothesised that the SWNTs 
bind in the 5' major groove of the i-motif, enabling the carboxyl groups to reach into 
the core of the structure and pick up favourable interactions with the hemi-protonated 
cytosine base pairs. Larger carboxyl-modified multi-walled carbon nanotubes 
prepared in the same way, which are too big to fit into the major groove, were also 
tested and shown not to stabilise the i-motif providing further evidence that it is more 
than just the presence of acidic groups having an effect.59 Further studies by the group 
showed that SWNTs accelerated the S1 nuclease cleavage rate and that they are able 
to promote i-motif formation at neutral pH under molecular crowding conditions 
suggesting they may be able to have an effect in vivo.116,117 Most recently, Xiaogang Qu’s 
group carried out an extensive study into the biological effects of SWNTs binding to 
telomeric i-motif in cancer cells.59 They showed that SWNTs, which are specific for i-
motif over other DNA structures, are able to inhibit the activity of telomerase (figure 
1.6), resulting in DNA damage response, displacement of telomere binding proteins, 
telomere uncapping, cell cycle arrest and finally apoptosis. They showed this both in 
vitro with an IC50 of 0.27 ± 0.02 µg.mL-1 and in living K562 and HeLa cancer cells with 
an IC50 of 10.2 ± 0.8 and 7.5 ± 0.45 µg.mL-1 respectively. They were able to show that 
the SWNTs accumulated in the telomeric regions of nuclear DNA using fluorescently 
labelled analogues, which co-localised with a marker for interphase telomeres TRF1.59 
What is not yet clear is whether the resultant telomerase inhibition is due to formation 
of the i-motif directly, or due to the fact that formation of the i-motif and destabilisation 
of the duplex will result in concomitant G-quadruplex formation, which is already 
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shown to inhibit telomerase.118 Qu and co-workers suggest that this may well be the 
case. 
 
 
 
 
 
 
 
 
 
Figure 1.16: Illustrative structures of a) carboxyl-modified single-walled carbon 
nanotubes, SWNTs, b) carboxyl-modified graphene quantum dots, GQDs. 
 
Carboxyl-modified graphene quantum dots (GQDs figure 1.16 b) have also been 
investigated as a logical extension of work on SWNTs.119 These were also shown to 
both stabilise and promote i-motif formation at up to pH 8.0 by end stacking 
interactions with the loops. This was shown for both telomeric and c-Myc i-motif 
sequences with stabilisation of +20 °C and +16 °C respectively, dependent on 
concentration, but again the precise number of carboxyl groups on each GQD is not 
certain so maintaining pH is an important consideration.120 
 
1.5.3 Bcl-2 Specific Ligands 
 
Two of the most promising ligands for deciphering a potential biological function for 
the i-motif are the compounds IMC-48 and IMC-76 (figure 1.17) which were identified 
by Laurence Hurley and co-workers in 2014.69 Having already shown that the Bcl-2 i-
motif forming sequence is in dynamic equilibrium between the i-motif structure and a 
flexible hairpin structure, they used a FRET based high throughput screen to screen 
the National Cancer Institute (NCI) Diversity set of 1990 compounds for interaction 
with Bcl-2 i-motif based on changes in fluorescence at pH 5.8. IMC-48 showed a 
decrease in fluorescence and was hence identified as an i-motif stabilising compound, 
whereas IMC-76 showed an increase in fluorescence and hence was identified as an i-
motif destabilising compound. In FRET studies, the two compounds were shown to be 
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very specific for the Bcl-2 i-motif sequence in comparison to a Bcl-2 mutant sequence, 
the c-Myc i-motif, the VEGF i-motif, the Bcl-2 G-quadruplex and the BcL-2 duplex 
sequence. Some changes in fluorescence were seen for the VEGF i-motif but both 
compounds were found to have stronger affinities for Bcl-2 (IMC-48 Kd = 0.49 µM, IMC-
76 Kd = 1.01 µM) than VEGF (IMC-48: Kd = 4.7 µM, IMC-76: Kd = 5.73 µM). NMR studies 
showed that IMC-48 favoured the formation of i-motif structure while IMC-76 
favoured the formation of the hairpin structure. This was confirmed by circular 
dichroism and bromine footprinting experiments. The NMR also showed that the two 
compounds were antagonistic towards one another. 
 
 
 
 
 
 
Figure 1.17: The structures of the Bcl-2 specific ligands a) IMC-48 and b) IMC-76. 
 
IMC-48 did not bind to the c-Myc i-motif, however, when the c-Myc sequence was 
mutated so that the central loop had the same sequence as Bcl-2, binding did occur. 
This demonstrated that the central loop is the binding site for IMC-48. Mutations to the 
Bcl-2 lateral loops also did not affect IMC-48 binding. As well as the observed 
structural antagonistic effects, IMC-48 and IMC-76 also had opposite effects on Bcl-2 
gene expression. It has previously been hypothesised that, like the G-quadruplex, 
stabilisation of the i-motif structure would act as a block to the “transcription 
machinery” and hence result in a decrease in gene expression. In contrast, Hurley and 
co-workers showed that treatment with IMC-48 actually increased Bcl-2 gene 
expression whereas IMC-76, favouring the hairpin, decreased gene expression. This 
effect was seen both at the level of transcription and translation, with the antagonistic 
relationship between IMC-48 and IMC-76 also apparent. As discussed earlier, these 
effects on gene expression were shown to be due to the presence of a transcription 
factor, hnRNP LL, which binds specifically to the i-motif and unfolds the structure in 
order to activate transcription.70 Importantly, by binding to the central loop of the i-
motif, IMC-48 does not interfere with the binding mode of hnRNP LL and increases 
gene expression by increasing the amount of i-motif available for hnRNP LL to bind to. 
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Conversely, IMC-76 decreases gene expression by reducing the amount of i-motif 
structure available for hnRNP LL to bind. Molecular population dynamics experiments 
showed that IMC-48 favoured the i-motif structure over short time periods (60 s) but 
over longer periods (180 s) favoured unfolding of the structure to the single strand.86 
This is similar to the effect of hnRNP LL (see section 1.3.3) and indicates that IMC-48 
may have an activating effect on transcription of its own through unfolding of the i-
motif after binding. Hurley’s group also tested four smaller compounds (figure 1.18) 
where the positively charged piperidine unit was kept constant and the amide linked 
group was varied.69 Each of these compounds were shown to stabilise the i-motif by 
FRET whilst IMC-42 was also tested for its effect on Bcl-2 expression and shown to 
increase expression to a level comparable with IMC-48 in MCF-7 cells.  This suggests it 
is the positively charged piperidine that is important in stabilising the i-motif, most 
likely through interactions with the negative phosphate backbone, whilst the rest of 
the molecule binds to the central loop through Van der Waals and stacking interactions. 
 
 
 
 
 
 
 
 
Figure 1.18: The structures of Bcl-2 binding piperidine derivatives including IMC-42. 
 
Finally, Hurley and co-workers demonstrated, that in cells resistant to the 
chemotherapy drugs etoposide (B95.8 cells) and cyclophosphamide (GRANTA-519 
cells), co-dosing with IMC-76 caused chemosensitisation to the drugs as a result of 
reduced Bcl-2 expression. Caspase-3 activity was monitored as a marker for apoptosis 
resulting in a 2.5-fold and a 1.9-fold increase in each case.121 The antagonistic effect of 
IMC-48 was also apparent as when IMC-76 and IMC-48 were used in a 1:1 ratio with 
cyclophosphamide the chemosensitisation did not occur. Chemosensitisation to 
etoposide was also observed in vivo in a resistant lymphoma severe combined 
immunodeficient (SCID) mouse model with GRANTA-519 lymphoma xenografts. 
Treatment with 6 – 8 mg/kg of IMC-76 resulted in a 20% decrease in Bcl-2 mRNA level 
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and a greater 48% decrease at a dose of 10 mg/kg. This was also observed at the 
protein level. Co-treatment of the mice with 10 mg/kg of IMC-76 and etoposide 
resulted in a 65% inhibition of tumour growth. 
 
1.5.4 Other i-Motif Ligands  
 
There are very few other i-motif ligands of note and most have not been investigated 
to the same extent as those discussed previously. In most cases they show weak 
affinities for the i-motif and poor selectivity over other DNA structure types. For 
example the phenanthroline derivatives (figure 1.19) have each been shown to be 
mildly stabilising of the i-motif at acidic pH (ΔTm 7 – 10°C with 10 eq. of ligand) with 
binding affinities of 4 – 8 µM.122 However they have stronger affinity for G-
quadruplexes (Kd = 1.6 – 2.5 µM) and slightly weaker affinity for double stranded DNA 
(Kd = 6.7 – 12 µM).  
 
 
 
 
 
 
 
Figure 1.19: The structures of the phenanthroline derivatives. 
 
The neomycin-perylene conjugate (figure 1.20) showed some degree of affinity for 
the i-motif in competition dialysis experiments, measuring a bound concentration of 
~1.2 µM which was stronger than other G-quadruplexes and duplex tested (~0.2 µM 
bound concentration) but weaker than for telomeric G-quadruplex (~4 µM bound 
concentration).123 However these experiments were all carried out at pH 7 where the 
i-motif is normally unfolded so it may be that the observed affinity is for the single 
strand rather than the i-motif structure itself. 
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Figure 1.20: The structure of the neomycin-perylene conjugate. 
 
Crystal violet (figure 1.21) has been investigated as an i-motif ligand by several groups 
due to its fluorescent properties upon binding to DNA secondary structures. While 
crystal violet had previously been shown to bind to G-quadruplex DNA and to favour 
G-quadruplex over double stranded and single stranded DNA,124 it had not been 
studied as a potential i-motif ligand until 2011 when Chung-Lang Leung and co-
workers developed a DNA-based OR logic gate.125 Using UV titrations they were able to 
measure relatively strong binding affinities for crystal violet with a model 29 base 
sequence d(C5T3)3C5 (Kd = 0.83 µM), a 21 base sequence d(C3T3)3C3 (Kd = 1.4 µM) and 
a 17 base sequence d(C2T3)3C2 (Kd = 1.3 µM). This shows a trend in affinity consistent 
with the trend in i-motif stability of the sequences however, all of these affinities are 
significantly stronger than the affinity of crystal violet for the comparable 28 base and 
21 base G-quadruplex sequences with Kd’s of 53 µM and 28 µM respectively. Using 
molecular docking experiments they suggest that crystal violet binds to the simplified 
intermolecular i-motif (ACCCT)4 via end stacking interactions with a binding energy of 
-38.44 kcal.mol-1.125 More recently, the binding of crystal violet to i-motif DNA and its 
subsequent increase in fluorescence has been utilised by Zhou et al. as a probe for a 
NOTIF logic gate, consisting of a G-quadruplex and i-motif within the same strand,126 
and by Zhang et al. as a probe for a surface based electrochemical pH-switch.127  
 
 
 
 
 
 
Figure 1.21: The structure of crystal violet, CV. 
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Complexes of terbium and ruthenium (figure 1.22), which are known G-quadruplex 
ligands, have been investigated as potential i-motif ligands. The amino acid complexes 
[Tb2(DL-Cys)4(H2O)8]Cl2 and [Tb2(DL-HVal)4(H2O)8]Cl6 were shown to bind to 
telomeric i-motif at pH 5.5 with comparable affinity (Kd = 22 µM and 30 µM 
respectively) to the telomeric G-quadruplex  at pH 7.1 (Kd = 26 µM and 23 µM 
respectively).128 However, neither complex was able to stabilise the structures, 
showing a small decrease in melting temperature for both the i-motif (ΔTm = -0.5°C and 
-4.0°C respectively) and the G-quadruplex (ΔTm = -4.0°C and -3.0°C respectively). The 
ruthenium complexes [Ru(bpy)2(dppz)]2+ and [Ru(phen)2(dppz)]2+ are slightly 
more promising as they have stronger affinities than the terbium complexes (Kd = 5.6 
µM and 1.5 µM respectively) and do not destabilise the i-motif structure.129,130 However 
they are still not specific. [Ru(bpy)2(dppz)]2+ has a stronger affinity for the G-
quadruplex (Kd = 0.7 µM vs. 5.6 µM) while [Ru(phen)2(dppz)]2+ has a comparable 
affinity for the G-quadruplex (Kd = 2.1 µM vs. 1.5 µM) all at pH 5.5. However their 
increase in fluorescence signal upon binding enable their potential use as a light switch 
for G-quadruplex and i-motif structures.130  
 
 
 
 
 
 
 
 
 
 
Figure 1.22: The structures of terbium and ruthenium complexes. 
 
Pyrene or pyrene derivatives may also have potential as i-motif ligands. So far they 
have not been investigated as free ligands but they have been examined as part of 
covalent modifications to the i-motif structure. Modification of a terminal adenine base 
with pyrene (figure 1.23a) for use as a switch off fluorescent probe for i-motif 
formation resulted in a stabilisation of the structure (ΔTm = +11.4°C).131 Further 
modification of a terminal adenine and a central loop adenine in a dimeric sequence, 
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resulting in incorporation of 4 pyrene units into the i-motif structure, gave an even 
greater stabilisation of +23.5°C at pH 5.0.132 However, incorporation of the pyrene 
modified adenine base, into the central loop of an intramolecular i-motif resulted in a 
destabilising effect (ΔTm = -8.9°C) indicating that stacking on the terminal end of the i-
motif is preferable to incorporation inside the small central loop of this sequence.133 
These results have been supported by investigations of other groups also showing 
stabilising effects of terminal modifications and destabilising effects of central loop 
modifications. For example, incorporation of the pyrene intercalator TINA (figure 
1.23b) at the 3 different positions of the central loop of the telomeric i-motif resulted 
in destabilisation of the structure at pH 5.2 (ΔTm = -4.5°C to -8°C) but very little change 
at pH 6.2 (ΔTm = 0°C to -1°C).134 Finally, a dual pyrene labelled c-Myc sequence (figure 
1.23 c) was both stabilised and destabilised depending on pH and whether an extra 
base was incorporated.135 For the sequence with an additional adenine base, the 
terminal pyrenes had a destabilising effect at lower pH (ΔTm = -6.5°C at pH 5.0) but a 
stabilising effect at higher pH (ΔTm = +25.8°C at pH 7.0). Whereas, without an 
additional base, the sequence was stabilised at both pHs (ΔTm = +1.4°C at pH 5.0 and 
+7.1°C at pH 7.0).135 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.23: The structures of a) pyrene modified adenosine, b) the pyrene intercalator 
TINA, c) the pyrene labelled c-Myc sequence. 
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1.6 Challenges in i-Motif Research 
 
In summary, the i-motif is an alternative DNA secondary structure which can form in 
vitro in sequences complimentary to the G-quadruplex, in telomeric regions and close 
to transcription start sites with a variety of different topologies depending on the 
length and composition of the sequence.16 However, due to the instability of the 
structure and its reliance on acidic pH to form in vitro, there is still a lot of doubt as to 
whether the structure is physiologically relevant and therefore the potential biological 
application of the i-motif has had very little investigation. Work by the groups of 
Xiaogang Qu59 and Laurence Hurley69 have begun to relate some biological effects of 
telomerase inhibition and control of gene expression to i-motif binding compounds, 
suggesting that, at least in these special cases, the i-motif is a potential drug target and 
it is worthy of further investigation. As described in section 1.5, there are relatively few 
i-motif ligands in the literature and most are not specific, unlike the G-quadruplex for 
which there have been many ligands identified.89 So, in order to study the i-motif in 
more detail, a better chemical toolbox of ligands is needed.  
 
As Laurence Hurley and co-workers have shown for Bcl-2,69 the i-motif may turn out 
to be quite a dynamic structure, in equilibrium with other structures and factors that 
may affect i-motif stability and this equilibrium, such as the presence of cations, also 
need to be investigated. As described in section 1.4 there are a variety of techniques 
available which have been used extensively in the G-quadruplex field and are now 
being used to study the i-motif. However, applying these techniques to the i-motif 
introduces its own challenges with factors such as fluorescence and solubility that are 
strongly affected by pH.  
 
1.7 Aims and Objectives 
 
The aim of this project is to investigate the effect of both small molecules and cations 
on the structure and stability of i-motif DNA. This is in order to identify new i-motif 
binding ligands which can stabilise the structure and to look at how different cationic 
conditions may affect i-motif formation. The overall objective is to discover a range of 
tools that could be used to investigate the chemical biology of i-motif structures.  
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This work will be carried out in 3 stages described in this thesis. First in chapter 2, the 
existing i-motif stabilising ligand, BisA,100 is examined in detail using a variety of 
biophysical techniques that have not previously been used to look at this compound’s 
interaction with the i-motif. This is in order for it to be used as a positive control when 
looking for new i-motif ligands. In chapter 3, a library of 960 compounds are screened 
using a FRET melting assay, for interaction with the i-motif based on their ability to 
stabilise or destabilise the DNA. The purpose of this screen is to discover new i-motif 
binding compounds. Because there are so few i-motif ligands in the literature, a very 
diverse library is used to include a wide variety of structure types and chemical 
properties. Finally in chapter 4, the same screening methodology is applied to look at 
the effect of different cations on i-motif forming sequences both at acidic and neutral 
pH to see what effect they have on the stability of the structure. Some small studies 
have been carried out previously50–52 but this is expanded in this thesis to include other 
physiologically relevant cations not previously investigated.
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2.1 Introduction  
 
2.1.1 BisA is a known DNA binding compound 
 
The bisacridine macrocycle BisA (figure 1.15) was first synthesised by Marie-Paule 
Teulade-Fichou in Jean-Marie Lehn’s group in 1995.136 The group were particularly 
interested in BisA for its fluorescence properties and developed the compound as a 
tool for the selective molecular recognition of nucleosides and nucleotides. The stacked 
planar structure of the molecule gave sufficient space between the two acridine units 
(7 Å,137) to allow it to intercalate with a nucleoside or nucleotide base resulting in a 
change in fluorescence and effectively forming a receptor for these molecules.  
 
Using fluorescence titrations, they showed that the fluorescence of BisA was 
significantly enhanced by 70 – 130% in the presence of pyrimidine bases, while in the 
presence of purine bases the fluorescence of BisA was quenched by 70 – 80%. This 
change in fluorescence was consistent with both adenine and guanine vs cytosine and 
uracil. They also tested the nucleoside as well as the nucleotide mono-, di- and tri- 
phosphates showing the same enhancement or quenching of the fluorescence in all 
cases.  
 
After this initial work, the group moved on to investigate the interaction of BisA with 
hairpin DNA structures.138,139 They showed that BisA had a high binding affinity for the 
hairpin sequence d(GCGAAACGC) and selectively stabilised the hairpin structure over 
the alternative bulged duplex structure. On comparing the fluorescence spectra of BisA 
bound to the hairpin with the spectra of BisA in the presence of single stranded 
adenine sequences (dA3 and dA20) as well as adenine monophosphate (AMP) they 
observed the same λmax (441 ±2 nm). They therefore concluded that the binding site of 
BisA was the central adenine loop region with the most central adenine likely to be 
intercalating between the two acridine units of the structure.138 Using polyacrylamide 
gel electrophoresis where the duplex and hairpin structures are clearly visible as 
separate bands, they were able to show that increasing amounts of BisA actively 
shifted the equilibrium from duplex to hairpin structures.139 However, they also 
showed that higher concentrations of BisA (>25 µM) did cause aggregation of the DNA. 
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This was seen in gel experiments where, at lower BisA concentrations, they observed 
a 1:1 DNA:BisA complex which moved freely through the gel, whereas at higher BisA 
concentrations, aggregation was indicated by bands not migrating from the well and a 
smearing effect of the bands that did migrate.139  
 
In 1998 Jean-Marie Lehn and co-workers, exploited the preference of BisA for single 
stranded DNA over double stranded DNA to show that BisA could be used for selective 
photocleavage of circular single stranded DNA in the presence of supercoiled circular 
double stranded DNA.140 Meanwhile, control experiments with MonoA (figure 2.1) 
showed equal cleavage of both single and double stranded DNA sequences. Soon after, 
the group showed that while BisA preferentially cleaved single stranded DNA over 
normal double stranded DNA, it could in fact be used to cleave duplex DNA containing 
abasic sites.141 They showed that BisA formed a 1:1 complex with an abasic site 
containing duplex and that BisA stabilised this sequence (ΔTm = +14°C). The binding 
site was confirmed by NMR studies showing that one acridine unit intercalated 
between the adjacent base pair, while the other acridine unit resided in the pocket 
created by the abasic site.142 BisA is also able to destabilise duplex DNA, promoting the 
disassociation of the DNA into separate strands. The strong binding affinity of BisA for 
single stranded DNA then enables BisA to effectively compete with single strand 
binding (SSB) proteins.143 
 
 
 
 
Figure 2.1: Structure of the monoacridine MonoA. 
 
Finally in their most recent work on BisA, Marie-Paule Teulade-Fichou and co-workers 
have investigated the interaction of BisA with mismatched base pairs in duplex 
DNA.137,144,145 BisA was tested with 17 base pair duplexes containing a central TT, TC 
or TG mismatch and compared to the matched TA containing duplex. As expected, the 
introduction of a mismatched base pair destabilised the duplex and the effect was more 
pronounced with TT and TC mis-pairs, compared to a TG mis-pair. Addition of up to 2 
equivalents of BisA stabilised the mismatched duplexes by up to 7.1°C, restoring the 
stability almost back to that of the matched sequence. Conversely BisA had no effect 
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on the stability of the matched duplex, indicating a selectivity for mismatch containing 
DNA. The mono-acridine control compound showed no such selectivity, imparting a 
slight stabilisation on both matched and mismatched duplexes (ΔTm = 0.6 – 2.1°C).144 
By looking at the effect of BisA on permanganate oxidation of thymine in the 
mismatched duplexes, they also suggested that binding of BisA to the mismatched base 
pair results in base flipping of the thymine base out of the double strand into an 
extrahelical position, where it is more readily oxidised. This mimicked the effect of base 
modifying enzymes such as glycosylases and methyltransferases.144 This was later 
confirmed by electrospray ionisation mass spectrometry studies (ESI-MS), which 
showed that BisA had a much higher affinity for mismatch sequences (Kd = 0.5, 0.55 
and 3.1 µM for TT, TC and TG respectively) over the matched sequence (Kd = 10 µM).137 
 
2.1.2 BisA stabilises i-motif and G-quadruplex structures 
 
In the course of their investigations on the DNA binding properties of BisA Jean-Marie 
Lehn and co-workers examined the interaction of BisA with G-quadruplex and i-motif 
DNA structures, assessing its potential as an inhibitor of telomerase.100 In collaboration 
with Jean-Louis Mergny, a pioneer in the use of FRET to study the i-motif,98 they were 
the first group  to identify an i-motif stabilising ligand using this technique. Initially 
they carried out FRET melting experiments with the human telomeric G-quadruplex 
sequence (F21GT: FAM-5'-d(GGGTTAGGGTTAGGGTTAGGG)-3'-TAMRA) and the 
complimentary human telomeric i-motif sequence (F21CT: FAM-
d(CCCTAACCCTAACCCTAACCC)-TAMRA). Comparing BisA and MonoA they measured 
significant stabilisation of both G-quadruplex and i-motif (ΔTm = +15°C and +33°C 
respectively) for BisA while MonoA showed no significant change in melting 
temperature for either structure.100 
 
UV absorbance spectra for BisA showed a hypochromic affect at 360 nm upon addition 
of 21G (24%) or 21C (13%) which they took as indication of a binding event. The 
spectrum of MonoA also showed some hypochromism suggesting that although 
MonoA did not stabilise either G-quadruplex or i-motif structures, it may still weakly 
bind. This was confirmed by fluorescence titrations of MonoA, which indicated a weak 
binding affinity lower than 106 M-1 but was not determined exactly due to weak signal 
variations. The affinity of BisA for i-motif or G-quadruplex was not determined. 
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Equilibrium dialysis experiments were carried out to show the specificity of BisA for i-
motif and G-quadruplex structures over other types of DNA and RNA structure. In this 
experiment, 19 different nucleic acid sequences/structures are placed in separate 
dialysis tubes inside a common ligand solution. This enables the ligand to move freely 
under the same buffer conditions and bind to multiple different structures. Once 
equilibrium has been reached after 24 hours, the concentration of bound ligand is 
measured by UV-Vis spectroscopy to give an idea of specificity.146 Alberti and co-
workers measured higher bound concentrations for BisA with 3 different G-
quadruplex sequences and the i-motif forming sequence poly d(C)4, in comparison to 
duplex DNA, Z-DNA, single stranded DNA, triplex DNA and triplex RNA. However, 
caution should be taken in interpreting these results as in order to have all structures 
present in the same conditions, the equilibrium dialysis experiments were carried out 
at pH 7.0. At this pH the i-motif is not expected to form so the measured bound 
concentration is almost certainly for the single strand rather than the i-motif structure. 
 
The effect of BisA on duplex formation, as described in section 2.1.1, has previously 
been investigated but for a different sequence.143 In this study the effect of BisA on the 
telomeric double stranded sequence was assessed. F21GT in its G-quadruplex 
structure was titrated with the complimentary sequence 21C and the increase in 
fluorescence of FAM upon G-quadruplex unfolding and strand hybridisation was 
monitored over time with and without BisA. These experiments showed that BisA is 
able to inhibit duplex formation by stabilising the G-quadruplex structure. Conversely, 
the control compound MonoA had no effect on duplex formation. Finally, the ability of 
BisA to inhibit telomerase was assessed in a modified TRAP assay.147 The telomeric 
repeat amplification protocol (TRAP) assesses the ability of the telomerase enzyme to 
synthesise telomeric DNA by using the polymerase chain reaction (PCR) to amplify the 
telomeric product sequence.148 Inhibition of telomerase can then be observed by a 
reduction in the PCR products however, the compound must also be assessed for 
inhibition of the Taq polymerase enzyme used in the PCR reaction as a control. Alberti 
and co-workers showed that BisA inhibited telomerase with an IC50 of 0.75 µM, whilst 
MonoA did not (IC50 >> 10 µM). BisA had a weaker inhibition of Taq polymerase (IC50 
= 2.6 µM) measured at four times the concentration of BisA needed for telomerase 
inhibition indicating that the observed result was not due to interaction with Taq 
polymerase.100  
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2.1.3 Aims and Objectives 
 
Despite the i-motif field now rapidly growing, there are still very few i-motif ligands in 
the literature and there is no obvious trend as to what constitutes a good i-motif ligand. 
There have also been no other compounds assessed as i-motif binding ligands with a 
similar type of structure to BisA. In this chapter, BisA is synthesised with the aim of 
fully characterising in detail the effect of BisA on the i-motif structure.In previous work 
on BisA, other experiments such as fluorescence emission spectroscopy and 
polyacrylamide gel electrophoresis have been used to study the compound’s 
interaction with hairpin DNA but not the i-motif, as they have been applied in this 
chapter. As a comparison the compound MonoA, which has been used as a control 
throughout the previous work on BisA, has been tested. This will indicate whether it is 
simply the acridine unit that has an effect or whether there is something in particular 
about the BisA structure that enables its interaction with i-motif DNA. 
 
2.2 Synthesis of BisA and MonoA 
 
As mentioned in section 2.1.1, BisA was first synthesised by Marie-Paule Teulade-
Fichou in 1995 (Scheme 2.1).136 This procedure was used as a starting point for the 
synthesis of BisA. 4,4’-Dimethyldiphenyl-2-carboxylic acid 3 was prepared from 2-
amino-5-methylbenzoic acid and para-bromotoluene which are both commercially 
available. In Teulade-Fichou’s procedure, this was then cyclised to 9-chloro-2,7-
dimethylacridine 4 and dechlorinated by hydrogenation to give 2,7-dimethylacridine 
5. However, attempts to follow this route failed at this stage as hydrogenation of 4 did 
not produce any product. This is because the cyclisation reaction did not give the 9-
chloro-2,7-dimethylacridine 4 but instead produced the 2,7-dimethylacridone 8. It has 
previously been shown that acridones are effectively reduced using borane-THF 
complex to give the acridane and then re-oxidised to provide the desired acridine.149 
Therefore, the 4,4’-dimethyldiphenyl-2-carboxylic acid 3 was cyclised by heating to 
reflux in concentrated sulfuric acid and the resultant novel 2,7-dimethylacridone 8 was 
reduced to the novel 2,7-dimethylacridane 9 and re-oxidised to the desired 2,7-
dimethylacridine 5 (scheme 2.2). The methyl groups were oxidised to aldehydes 6 and 
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the final product 1 was formed by reductive amination with the diethylenetriamine 
linker via the imine 7 following Teulade-Fichou’s procedure (scheme 2.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2.1: The synthesis of BisA outlined by Marie-Paule Teulade-Fichou.136  
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Scheme 2.2: Formation of acridines from acridones using borane-THF complex.149 
 
2.2.1 Synthesis of 4,4’-dimethyldiphenyl-2-carboxylic acid (3) 
 
The first step in the synthesis of BisA was carried out using a copper catalysed Ullmann 
condensation reaction to couple 2-amino-5-methylbenzoic acid to p-bromotoluene to 
produce 4,4’-dimethyldiphenyl-2-carboxylic acid 3.136 The starting materials were 
heated to reflux at 150°C in n-pentanol with 1 equivalent of potassium carbonate base 
and catalytic amounts of copper and copper iodide. The crude product was purified by 
crystallisation from ethanol giving 64% yield from 4 crops and characterised by 1H 
NMR. 
 
 
 
 
 
 
Scheme 2.3: The synthesis of 4,4’-dimethyldiphenyl-2-carboxylic acid (3). 
 
The 1H NMR was carried out in deuterated chloroform and showed a broad singlet at 
9.05 ppm corresponding to the NH proton. The seven aromatic protons were shown in 
2 multiplet peaks, the most downfield at 7.82 ppm representing one proton at position 
3, with the multiplet at 7.12 ppm representing the other 6 protons. The two methyl 
groups are represented by separate singlet peaks at 2.35 and 2.26 ppm. This 
corresponded satisfactorily with the published NMR data.136 
 
The exact mechanism of the Ullmann condensation reaction still has not been fully 
elucidated. In their review in 2010, Elena Sperotto and colleagues discuss the different 
proposals in the literature.150 Generally, it is thought that the reaction proceeds via one 
of two routes which differ in the order of when oxidative addition and transmetallation 
occur (illustrated in schemes 2.4 and 2.5). In the first pathway (scheme 2.4), oxidative 
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addition of the copper catalyst to the C-Br bond of p-bromotoluene occurs first. The 
amine group, is then able to substitute for the bromine at the copper catalyst, releasing 
hydrogen bromide. Finally a reductive elimination completes the coupling of the 
nitrogen to the adjacent ring and the free acid is obtained in aqueous work up. In the 
second pathway (scheme 2.5), the copper catalyst first reacts with the nucleophilic 
amine before oxidative addition occurs with p-bromotoluene and finally reductive 
elimination regenerates the catalyst. 
 
 
 
 
 
 
 
 
 
 
Scheme 2.4: The possible mechanism of the Ullmann condensation reaction used in the 
first step of the synthesis of BisA.150 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2.5: The alternative mechanism of the Ullmann condensation reaction for step 1. 
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Other mechanisms have also been proposed using Cu(O) that is oxidised to Cu(II), as well 
as mechanisms using σ-bond metathesis or π-complexation where the oxidation state 
of copper does not change. A radical mechanism was previously disfavoured as early 
“radical-clock” experiments did not give the expected product. However, recent 
computational studies by Buchwald and Houk have suggested that a single electron 
transfer mechanism may still occur.151  
 
2.2.2 Attempted synthesis of 9-chloro-2,7-dimethylacridine (4) and 2,7-
dimethylacridine (5). 
 
 
 
 
Scheme 2.6: The POCl3 synthesis of 9-chloro-2,7-dimethylacridine (4). 
 
According to Teulade-Fichou’s synthesis, 4,4’-dimethyldiphenyl-2-carboxylic acid 3 
was cyclised using phosphorous oxychloride to give the 9-chloro-2,7-dimethylacridine 
4 (Scheme 2.6). 4,4’-dimethyldiphenyl-2-carboxylic acid 3 was dissolved in neat 
phosphorous oxychloride and heated under reflux conditions for 3 hours before the 
reaction was concentrated in vacuo, washed with 15% ammonium hydroxide solution, 
extracted with DCM, washed with water and dried over MgSO4. The product was 
recrystallised from ethanol and characterised by 1H NMR in d6-DMSO. The 1H NMR 
spectrum showed peaks at 8.01 ppm, 7.55 ppm and 7.46 ppm representing the 
aromatic protons and the methyl protons were found at 2.41 ppm.  
 
The shifts of these peaks did not match the published example (8.09, 8.07, 7.71 and 
2.58 ppm), however there were the right number of peaks representing the correct 
number of protons with the same multiplicities. Therefore the product was taken 
forward to the next step of hydrogenation to give 2,7-dimethylacridine 5. This was 
done by stirring 4 with potassium hydroxide and raney nickel in ethanol under an 
atmosphere of hydrogen. After this, the catalyst was removed, the solution was heated 
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to 60 °C and FeCl3 was added before being allowed to cool. The crude mixture was 
washed with 15% ammonium hydroxide and the volume reduced to dryness in vacuo. 
1H NMR indicated that unfortunately no reaction had occurred as there was no new 
proton at position 9. In a second attempt to hydrogenate 4, Palladium on carbon was 
added as an alternative catalyst and the mixture was stirred under hydrogen overnight 
but this also showed no reaction by 1H NMR. 
 
 
 
 
 
 
 
 
 
Scheme 2.7: Attempted hydrogenations of 9-chloro-2,7-dimethylacridine (4). 
 
The mass spectrum of 4 after the attempted hydrogenation, gave a molecular ion peak 
at m/z = 224.0 which was indicative of the 2,7-dimethylacridone compound 8 rather 
than the desired product 5 (m/z = 208). The NMR of the synthesis of 4 using POCl3 was 
re-examined in comparison to compound 8, which showed that the 2,7-
dimethylacridone 8 was the actual product of the reaction. This may be as a result of 
the purification procedure as, after a second attempt to produce 4 by this method, the 
crude NMR matched that in the literature. However, the NMR after purification by 
crystallisation from ethanol matched that of compound 8. 
 
 
 
 
 
Figure 2.2: The structure of 2,7-dimethylacridone (8). 
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Scheme 2.8: The SOCl2 synthesis of 9-chloro-2,7-dimethylacridine (4). 
  
The 2,7-dimethylacridone 8 was successfully converted into 9-chloro-2,7-
dimethylacridine 4 using thionyl chloride as outlined by Atwell and co-workers 
(Scheme 2.8).152 The acridone 8 was dissolved in thionyl chloride with a catalytic 
amount of DMF and heated to reflux at 90°C for 1.5 hours. The excess thionyl chloride 
was removed by trituration with benzene and the crude product was purified by flash 
coloumn chromatography in DCM before being characterised by mass spectrometry 
and 1H NMR in deuterated chloroform. The mass spectrum gave a peak at m/z = 
242.0734, corresponding to the M + H+ ion for the 35Cl isotope and a corresponding 
peak with one third the intensity was observed at m/z = 244.0704 corresponding to 
the 37Cl isotope. The 1H NMR gave a doublet at 8.02 ppm corresponding to the protons 
at position 4 and 5, a singlet at 7.97 ppm corresponding to the protons at position 1 
and 8 and a doublet of doublets at 7.50 ppm corresponding to the protons at position 
3 and 6. These protons showed a reciprocated 3 bond coupling to the protons at 
position 4 and 5 (J = 8.8 Hz) and a long range coupling to the protons at position 1 and 
8 (J = 1.6 Hz). 
 
With 9-chloro-2,7-dimethylacridine to hand, it was subsequently submitted to 
hydrogenation conditions to convert it to 2,7-dimethylacridine 5. Unfortunately 
neither raney nickel nor palladium on carbon conditions succeeded as could be seen 
by a 13C NMR distortionless enhancement by polarisation transfer (DEPT) experiment, 
which reduces the 13C NMR spectrum to just carbons that are attached to protons.153 
This did not show the required number of carbon peaks for the desired product 5. The 
proton NMR did show some changes but did not show the presence of an additional 
proton for the 9 position. Further attempts to hydrogenate 4 were not made, as an 
alternative route to 5 was used that is described in sections 2.2.4 and 2.2.5. 
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2.2.3 Synthesis of 9-oxo-9,10-dihydro-2,7-dimethylacridone (8). 
 
 
 
 
 
 
 
Scheme 2.9: The synthesis of 9-oxo-9,10-dihydro-2,7-dimethylacridone (8). 
 
4,4’-dimethyldiphenyl-2-carboxylic acid 3 was cyclised to give 8 by heating at reflux in 
sulfuric acid for 1 hour (scheme 2.9).154 The solid precipitate was filtered and 
recrystallised from DMF to give 8 as a yellow solid. The product is a novel compound 
and was fully characterised by melting point analysis, Infra-Red spectroscopy, mass 
spectrometry, 1H and 13C NMR as well as 2D correlated spectroscopy (COSY) NMR. The 
mechanism begins with protonation of the carbonyl oxygen (scheme 2.10), which has 
the effect of making the carbonyl carbon more electrophilic. The adjacent π-system is 
able to attack the carbonyl driven by the conjugation of the nitrogen lone pair into the 
ring in an enamine type reaction. The resultant unstable acetal, loses water to give the 
enol, which then tautomerises to give the desired acridone. 
 
Scheme 2.10: Mechanism of the acid catalysed cyclisation to form the acridone. 
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The melting point of 8 was >355 °C similar to other acridones in the literature.152 The 
IR spectrum showed a peak for the carbonyl bond at 1636 cm-1 with peaks at 2784 and 
1479 cm-1 representing C-H and C=C respectively. NMR experiments were carried out 
in d6-DMSO, the most downfield peak at 11.59 ppm is a singlet representing the N-H 
proton. The six aromatic protons are represented by 3 peaks, an apparent singlet at 
8.02 ppm for the protons at position 1 and 8. A doublet of doublets at 7.55 ppm 
representing the protons at position 3 and 6. This shows a 3-bond coupling to the 
adjacent protons at position 4 and 5 of J = 8.5 Hz and a long range 4-bond ‘w-coupling’ 
between position 3 and 6 and 1 and 8 of J = 2.0 Hz. The 3rd aromatic peak at 7.44 ppm 
is a doublet for the protons at position 4 and 5, reciprocating the 3 bond coupling to 
those protons at 3 and 6 of J = 8.5 Hz. Finally the methyl groups appear as a singlet at 
2.42 ppm. The 13C NMR consisted of 8 peaks, the most downfield at 176.31 ppm 
representing the carbonyl carbon of the acridone. Due to the symmetry of the molecule, 
the 12 aromatic carbons were represented by 6 peaks between 110 and 140 ppm while 
the methyl carbons were represented by the most up-field peak at 20.56 ppm. An 
accurate mass was obtained using atmospheric-pressure chemical ionisation (APCI) 
and was found at m/z = 224.1067 corresponding to the M+H+ ion, calculated to be m/z 
= 224.1070. 
 
2.2.4 Synthesis of 9,10-dihydro-2,7-dimethylacridine (9) 
 
 
 
 
 
Scheme 2.11: The synthesis of 9,10-dihydro-2,7-dimethylacridine (9). 
 
The acridone 8 was reduced to 9,10-dihydro-2,7-dimethylacridine 9 by heating to 
reflux at 70°C with a slight excess of 1 M borane-THF complex in THF for 1 hour 30 
minutes, following a procedure outlined by Nicolas Desbois.149 The mechanism of the 
reduction is shown in scheme 2.12. The unstable crude product was purified by short 
flash column chromatography (DCM) and characterised by melting point, IR, 1H, 13C 
and 2D COSY NMR before being used in the next step. 
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Scheme 2.12: The mechanism of reduction of the acridone by borane-THF complex. 
 
The melting point was measured to be 218°C which is much lower than the acridone 
pre-cursor. This is consistent with the loss of electron density in the π-system from 
losing the carbonyl group which weakens the possible π-π stacking interactions. The 
IR spectrum showed peaks at 3400 cm-1 characteristic of the N-H stretch, the rest of 
the spectrum consisted of peaks at 2920 cm-1 and 1610 cm-1 for C-H and C=C 
respectively and the absence of a C=O peak. The compound was more soluble than the 
acridone precursor as the reduction of the carbonyl to a sp3 carbon diminishes the π-π 
stacking capability and the NMR spectra could be obtained in deuterated chloroform. 
The compound has a line of symmetry through the central carbon and nitrogen so the 
protons at positions 1, 3 and 4 are identical to the protons at positions 8, 6 and 5, as 
are the two methyl groups. The aromatic protons were shifted significantly up-field 
with the protons at position 1 and 8 appearing as a singlet at 6.91 ppm, the protons 
meta to the amine at position 3 and 6 appear as a doublet at 6.87 ppm and the protons 
ortho to the amine at position 4 and 5 appear as a doublet at 6.55 ppm. These two sets 
of doublets show coupling to one another (J = 7.9 Hz) but it was not possible to see the 
expected long range coupling between position 3 and 6 and 1 and 8 under the 
experimental conditions. There is a broad singlet at 5.79 ppm representing the NH 
proton, the new CH2 protons at position 9 appear as a singlet at 3.98 ppm and the two 
methyl groups appear as a singlet at 2.26 ppm. 
 
Due to the symmetry of the compound, the 13C NMR has 8 peaks, the 6 aromatic carbons 
appear between 110 and 140 ppm, the reduced carbon at position 9 appears at 31.38 
ppm and the methyl groups appear at 20.59 ppm. The accurate mass was measured 
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using APCI and found an m/z = 210.1277 which corresponds to M+H+. This 
corresponds to loss of oxygen and gain of 2 hydrogens consistent with the expected 
structure. 
 
2.2.5 Synthesis of 2,7-dimethylacridine (5). 
 
 
 
 
Scheme 2.13: The synthesis of 2,7-dimethylacridine (5). 
 
The acridane 9 synthesised in section 2.2.4 is unstable and readily loses a proton in the 
presence of a Lewis acid in order to form the more stable aromatic acridine. Therefore, 
following the procedure outlined by Desbois,149 the acridane was stirred with an excess 
of iron trichloride in a mixture of water and ethanol at 50°C for 1 hour. This afforded 
the acridine 5 in a 96% yield and was of sufficient purity to use directly in the next step. 
The acridine was characterised using 1H NMR. This showed a singlet at 8.55 ppm for 
the proton at position 9, the two protons ortho to the nitrogen group at position 4 and 
5 appear as a doublet at 8.11 ppm. The protons at position 1 and 8 appear as a singlet 
at 7.73 ppm and the protons at position 3 and 6, meta to the nitrogen, appear as a 
doublet of doublets at 7.59 ppm. Finally the methyl group protons appear as a singlet 
at 2.58 ppm. The protons at position 4 and 5 show a 3 bond coupling to those at position 
3 and 6 (J = 8.9 Hz) as well as a long range coupling to the protons at position 1 and 8 
(J = 1.9 Hz). This is in agreement with previously published spectra.136 
 
2.2.6 Synthesis of 2,7-acridinedicarboxaldehyde (6). 
 
 
 
 
 
Scheme 2.14: Synthesis of 2,7-acridinedicarboxaldehyde (6). 
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The 2,7-dimethylacridine 5 was converted to the dicarboxaldehyde 6 according to 
Teulade-Fichou’s procedure.136 The acridine was oxidised using selenium dioxide at 
200°C with molten naphthalene as solvent. The crude product was purified by washing 
with hexane and the remaining naphthalene was removed by sublimation. The product 
was characterised by 1H NMR. This showed a downfield peak at 10.27 ppm for the 
aldehyde protons, singlets at 9.17 ppm for the proton at position 9 and at 8.60 ppm for 
the two protons at position 1 and 8 and a multiplet at 8.35 ppm for the remaining 4 
aromatic protons. The presence of the aldehyde protons and the absence of a peak at 
2.58 ppm for the methyl protons clearly demonstrates the formation of the product. 
This is in agreement with the spectrum in the literature.136 
 
2.2.7 Synthesis of 2,5,8,21,24,27-Hexaaza[9,9](2,7)acridinophane (BisA) 
 
 
 
 
 
 
 
Scheme 2.15: The synthesis of 2,5,8,21,24,27-Hexaaza[9,9](2,7)acridinophane (BisA). 
 
The final product was synthesised via reductive amination with diethylenetriamine 
according to Teulade-Fichou’s procedure.136 Diethylenetriamine was added slowly 
drop-wise to the acridinedicarboxaldehyde 6 in DCM and methanol and stirred at room 
temperature for 2 days. The resulting imine 7 (scheme 2.1) was reduced to the amine 
(1) by careful addition of sodium borohydride at 0°C. The crude product was purified 
by repeated washes with different organic solvents and then acidified with 
hydrochloric acid to give the 8 × HCl salt in 28% yield. The pure product was 
characterised by 1H NMR in deuterated water. The most downfield peak at 9.60 ppm 
represents the aromatic proton at position 9. The protons at positions 1 and 8 appear 
as a singlet at 8.39 ppm, those at positions 3, 4, 5 and 6 appear as two doublets at 8.21 
and 8.09 ppm, showing a 3 bond coupling between them (J = 9.1 Hz). The 8 protons 
between the acridine units and the amine linker appear as a singlet at 4.49 ppm. Finally 
the protons for the diethylenetriamine linker appear as two doublets at 3.40 and 3.31 
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ppm, showing a 3 bond coupling between them (J = 6.0 Hz). This is in agreement with 
the published spectra.136  
 
2.2.8 Synthesis of 2,7-(Di-n-propylaminomethyl)acridine (MonoA) 
 
 
 
 
 
Scheme 2.16: The synthesis of 2,7-(Di-n-propylaminomethyl)acridine (MonoA). 
 
Similarly to BisA, the control compound MonoA was synthesised via reductive 
amination with n-propylamine according to Teulade-Fichou’s procedure.136 n-
Propylamine was added drop-wise to the acridinedicarboxaldehyde (6) and stirred at 
room temperature for 2 days before being heated to reflux for a further 2 days to push 
the reaction towards completion. The imine product was reduced by stirring with 
sodium borohydride at 0°C for 30 minutes and then at room temperature for a further 
hour. The crude product was prepared in the salt form by washing with 1 M HCl in 
methanol and then purified by dissolving in water and washing repeatedly with DCM, 
ether, ethylacetate and hexane before being neutralised with saturated sodium 
hydrogen carbonate and re-extracted with DCM to give the pure product which was re-
made into the salt with 1 M HCl in methanol in 28% yield. The pure product was 
characterised by 1H NMR in deuterated water. The aromatic protons were found 
between 9.6 and 8.1 ppm with the proton at the 9 position being most downfield at 
9.59 ppm. The protons at position 1 and 8 appear as a singlet at 8.42 ppm, the protons 
at position 4 and 5 appear as a doublet at 8.28 ppm, while the protons at position 3 and 
6 appear as a doublet of doublets at 8.12 ppm. These protons show a 3 bond coupling 
to the 4 and 5 position of J = 9.0 Hz and a long range coupling to the 1 and 8 position of 
J = 1.8 Hz. The methylene protons between the amine and acridine units appear as a 
singlet at 4.48 ppm. The n-propyl protons appear further up-field in order of their 
distance from the amine. NH2CH2CH2CH3 appears as a triplet (J = 7.8 Hz) at 3.07 ppm. 
NH2CH2CH2CH3 appears as a sextet (J = 7.7 Hz) at 1.69 ppm. NH2CH2CH2CH3 appears 
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as a triplet (J = 7.5 Hz) at 0.91 ppm. The characterisation data compares well with the 
published spectra.136 
 
2.3 Biophysical Characterisation of BisA with i-Motif DNA 
 
2.3.1 Buffer conditions and the effect of BisA on pH. 
 
As described in the introduction to this thesis, the reliance on hemiprotonated 
cytosine-cytosine+ base pairs to form the i-motif structure means that the stability of 
the structure is highly pH dependent. The most stable i-motifs are around the pKa of 
cytosine (4.6). Therefore, when assessing potential i-motif ligands it is important that 
the buffer is of a sufficient concentration to maintain the pH with addition of ligand. A 
decrease in pH could be misinterpreted as a ligand induced stabilisation while an 
increase in pH could be perceived as a ligand induced destabilisation. The biophysical 
characterisation of BisA was carried out in 3 different pHs: firstly, at pH 6.8, this is the 
pH at which Alberti and co-workers carried out their experiments but as this is only 
marginally acidic, the i-motif is not very stable. Secondly at pH 5.5 where the i-motif is 
more stable and finally at pH 7.4, physiological pH, where the telomeric i-motif is not 
normally able to form and exists as a single strand in a random coil structure. Sodium 
cacodylate is the preferred buffer as its pKa is independent of temperature within the 
temperature range of our experiments and has been used previously for i-motif 
melting studies.93,98 The change in pH of each buffer with the addition of 10 µM and 
100 µM BisA was measured (Table 2.1). As can be seen, the change in pH of each buffer 
is minimal and actually increases slightly in the case of 10 µM BisA at pH 7.4. Due to 
the potential for change in pH, the concentration of BisA did not exceed 100 µM in any 
experiment and was kept well below 100 µM for the majority of experiments. 
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Buffer 
ΔpH 
10 µM BisA 100 µM BisA 
pH 5.5 -0.02 0.07 
pH 6.8 0.01 0.09 
pH 7.4 -0.10 0.13 
 
Table 2.1: Change in pH upon addition of BisA to different pH buffers. pH 5.5 and pH 7.4 
buffer = 10 mM sodium cacodylate 100 mM NaCl, pH 6.8 buffer = 10 mM sodium 
cacodylate. Error = ± 0.01. 
 
The buffers used throughout the experiments contain 10 mM sodium cacodylate and 
different amounts of salt, normally 100 mM sodium chloride (NaCl) is added to 
replicate a more physiologically relevant ion concentration. However it was not 
entirely clear whether Alberti and co-workers used 100 mM NaCl in their FRET melting 
experiments at pH 6.8 and the addition of salt can have a destabilising effect upon the 
i-motif structure.51 As described in section 1.4.5 circular dichroism is an optical 
technique that gives a different spectrum dependent on the type of DNA structure 
present in solution.102 i-Motif DNA gives a characteristic spectrum with a positive peak 
at 288 nm and a negative peak at 255 nm this can be seen at pH 5.5 in figure 2.3. Single 
stranded DNA gives a positive peak at 275 nm and a negative peak at 250 nm (figure 
2.3 pH 7.4). As the i-motif is already less stable at pH 6.8, it can be seen in figure 2.3  
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: CD spectra of the human telomeric i-motif sequence in different buffer 
conditions. Buffer = 10 mM sodium cacodylate with 0 or 100 mM NaCl. 
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that at pH 6.8 with 100 mM NaCl the spectrum resembles that of ssDNA with peaks at 
275 and 250 nm showing that no i-motif was detected by CD. Whereas at pH 6.8 with 
0 mM NaCl there is a shift in the positive peak towards 288 nm, indicating a small 
amount of i-motif may be present. Therefore experiments at pH 6.8 were carried out in 
10 mM sodium cacodylate with no additional salt whilst experiments at pH 5.5 and 7.4 
still contained 100 mM NaCl. 
 
Although BisA was synthesised as the 8 times hydrochloride salt, the pKa’s of the 
nitrogens are different and therefore BisA will have a different charge depending on 
the buffer conditions. Marie-Paule Teulade-Fichou and colleagues estimated the pKa of 
the different nitrogens in BisA based on previous experiments on MonoA and a related 
naphthalene macrocycle.136 Their experiments suggest that the central amine of the 
linker has a lower pKa of 2.5-3, whereas the amines at the ends of the linkers have 
higher pKa’s of 7.4-10 (figure 2.4). The acridine nitrogen of MonoA has a pKa of 3.65 
and the acridine nitrogens of BisA are likely to be slightly lower due to the polycationic 
environment of the cyclic compound. This indicates that BisA is likely to have a +4 
charge in each of the 3 buffer conditions and MonoA will have a +2 charge. This is 
important because the positive charge can affect the compounds affinity for the i-motif 
through electrostatic interactions and many of the existing i-motif ligands discussed in 
section 1.5 carry a positive charge. 
 
 
 
 
 
 
 
 
Figure 2.4: Charges of BisA and MonoA in experimental buffer conditions. pKa’s of BisA 
estimated from a naphthalene analogue and pKa’s of MonoA calculated from pHmetric 
titration by Marie-Paule Teulade-Fichou and co-workers.136  
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2.3.2 FRET melting studies 
 
With BisA in hand, the FRET melting study of Teulade-Fichou and co-workers was first 
repeated, to see whether the conditions of the experiments gave similar results. BisA 
was tested at a concentration of 1 µM against a 200 nM solution of fluorescently 
labelled oligonucleotide from the human telomeric region which is able to form an i-
motif. (hTeloCFRET: 5'-FAM-d(TAACCCTAACCCTAACCCTAACCC)-TAMRA-3'). The 
samples were prepared in 10 mM sodium cacodylate buffer at pH 6.8 to be consistent 
with the previously published examples.136 In their initial experiments, an increase in 
Tm of +33°C was measured for BisA (1 µM) from normalised melting curves. The 
melting temperature is defined as the point at which half the sample is unfolded and 
half is folded.91 In this case, normalisation assumes that at the lowest fluorescence 
intensity the DNA is completely unfolded and at the maximum fluorescence intensity 
the DNA is completely folded. Therefore, the data is converted to a graph of fraction 
folded between 0 and 1 versus temperature and the melting temperature is taken at 
fraction folded = 0.5. On repeating this procedure an even larger stabilisation was 
observed of +53°C (figure 2.5). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5: Normalised FRET melting curves showing the fraction folded of human 
telomeric i-motif, with and without 1 µM BisA at pH 6.8. [DNA] = 200 nM, buffer = 10 
mM sodium cacodylate. 
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However, looking at the raw melting curves (figure 2.6) it can be seen that the addition 
of 1 µM BisA significantly quenches the fluorescence of FAM, only starting to increase 
towards 90°C and there is not a complete transition observed under the conditions of 
the experiment. This may be because BisA interacts and stabilises the structure to such 
an extent that the i-motif does not melt in this temperature range, alternatively this 
may be due to precipitation or aggregation of the DNA or quenching of the fluorescence 
due to an interaction between the ligand and the fluorophores. It can also be seen that 
the starting level of the fluorescence in the absence of BisA is quite high and increases 
immediately with temperature. This suggests that the DNA is not fully folded under 
these conditions, consistent with the low stability of the i-motif at pH 6.8. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6: Raw FRET melting curves for human telomeric i-motif, with and without 1 
µM BisA at pH 6.8. [DNA] = 200 nM, buffer = 10 mM sodium cacodylate. 
 
To investigate this further, a range of concentrations between 0 and 1 µM were tested 
(figure 2.7). Here it can be seen that with increasing concentration, there is an overall 
decrease in the fluorescence signal across the temperature range. As an alternative to 
normalising the spectra, the first derivative may be taken as a measure of the melting 
temperature. Here the minimum point in the curve corresponds to the inflection point 
of the melting curve (figure 2.8).91 This method can only be used for intramolecular 
systems and still may not equal the precise melting temperature. A third method of 
melting point determination may also be used called the “base line” method. Here lines 
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are drawn tangential to the low fluorescence baseline and the high fluorescence base 
line. A line is then draw bisecting the two and where this crosses the data is then taken 
as the melting temperature.91 However, this method is subjective and it is not a good 
choice for melting curves which are not sigmoidal such as in figure 2.7 because one or 
more of the baselines cannot be accurately determined. Using the first derivative 
method, it can be seen that with increasing concentration of BisA, the minimum point 
is actually shifting towards lower temperatures, suggesting that BisA may actually be 
destabilising the i-motif at this pH (table 2.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7: Raw FRET melting curves for human telomeric i-motif with 0 – 1 µM of BisA 
at pH 6.8. [DNA] = 200 nM, buffer = 10 mM sodium cacodylate. 
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Figure 2.8: First derivative of FRET melting curves for human telomeric i-motif with 0 – 
1 µM of BisA at pH 6.8. [DNA] = 200 nM, buffer = 10 mM sodium cacodylate. 
 
[BisA] (µM) 
ΔTm (°C) 
pH 6.8 pH 5.5 
0.2 -0.3 -0.3 
0.4 -2 -1 
0.6 -3 -1.3 
0.8 nd* -2.7 
1.0 nd* -5.7 
 
Table 2.2: Change in melting temperature with increasing [BisA] at pH 6.8 and pH 5.5.  
* nd = not determined as there is no clear inflection point but could be >95°C. Error = ± 
0.3°C. 
 
As discussed earlier, the human telomeric i-motif is not very stable at pH 6.8 (Tm = 
35°C) so BisA was further tested at pH 5.5 where the i-motif is much more stable (Tm 
= 45°C). The same range of concentrations between 0 and 1 µM were tested against 
hTeloCFRET in pH 5.5 buffer (figure 2.9). This gave similar results with decreasing 
fluorescence signal across the pH range and apparent decrease in melting temperature 
(figure 2.10), though the effects were not as pronounced as at pH 6.8 (table 2.2). 
 
 
25 30 35 40 45 50 55 60 65 70 75 80 85 90 95
-2.5
-2.0
-1.5
-1.0
-0.5
0.0
0.5
d
F
/
d
T
 (
A
.U
.)
Temperature (
o
C)
 200 nM hTeloC pH 6.8
 0.2 M
 0.4 M
 0.6 M
 0.8 M
 1.0 M
Chapter 2: Characterisation of the i-Motif Binding Compound BisA 
 
 
 63 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.9: Raw FRET melting curves for human telomeric i-motif with 0 – 1 µM of BisA 
at pH 5.5. [DNA] = 200 nM, buffer = 10 mM sodium cacodylate and 100 mM NaCl. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.10: First derivative of FRET melting curves for human telomeric i-motif 0 – 1 
µM of BisA at pH 5.5. [DNA] = 200 nM, buffer = 10 mM sodium cacodylate and 100 mM 
NaCl. 
 
The FRET melting results of BisA at pH 7.4 are also interesting (figure 2.11). At this pH 
the hTeloCFRET sequence is unfolded in a single strand and gives a high florescence 
signal across the temperature range. With increasing BisA concentration, the starting 
fluorescence at 25°C decreases. This indicates folding of the DNA and at [BisA] = 0.8 – 
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1 µM a melt curve is observed suggesting that addition of BisA has caused the 
formation of a folded structure which melts with increasing temperature. However, it 
is not possible to determine from these FRET melting results alone, whether the DNA 
is folding into an i-motif structure or an alternative structure. 
 
 
 
  
 
 
 
 
 
 
 
 
Figure 2.11: Raw FRET melting curves for human telomeric i-motif with 0 – 1 µM of 
BisA at pH 7.4. [DNA] = 200 nM, buffer = 10 mM sodium cacodylate and 100 mM NaCl. 
 
Control FRET melting experiments were performed with the monoacridine (MonoA) 
in order to see whether the observed effects are as a result of the acridine unit itself or 
more specific to BisA and hence confirming the results of Alberti and colleagues.100 At 
pH 6.8, MonoA showed little to no effect on the melting temperature or on the 
fluorescence up to a concentration of 1 µM (figure 2.12). At pH 5.5 where the i-motif is 
more stable, it can clearly be seen that MonoA had no effect on the fluorescence or 
melting temperature of the i-motif, even at the higher concentrations (figure 2.13). The 
diethylenetriamine linker was also tested at pH 5.5 and shown to have little or no effect, 
even at high concentrations (figure 2.14). 
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Figure 2.12: Raw FRET melting curves for human telomeric i-motif with and without     
1 µM of MonoA at pH 6.8. [DNA] = 200 nM, buffer = 10 mM sodium cacodylate. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.13: Raw FRET melting curves for human telomeric i-motif with 0 – 10 µM of 
MonoA at pH 5.5. [DNA] = 200 nM, buffer = 10 mM sodium cacodylate and 100 mM 
NaCl. 
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Figure 2.14: Raw FRET melting curves for human telomeric i-motif with 0 – 100 µM of 
Diethylenetriamine (DETA) at pH 5.5. [DNA] = 200 nM, buffer = 10 mM sodium 
cacodylate and 100 mM NaCl. 
 
In summary, repetition of the previously published FRET melting experiments where 
the data was normalised (figure 2.5),100 indicated that BisA significantly stabilised the 
i-motif structure (ΔTm = 53°C). However, looking at the raw data in detail (figure 2.5 
and 2.6) shows that the fluorescence decreases throughout the temperature range and 
does not show a melting transition within the temperature range of the experiment. 
This could be due to BisA stabilising the DNA so much that it doesn’t melt, it could be 
as a result of BisA interacting with fluorophores and quenching fluorescence or it could 
be as a result of aggregation of the DNA. In any of these cases, the melting temperature 
determined from normalising the data is not accurate. 
 
Using the first derivative of the data provides an alternative measure of the melting 
temperature. Here the data indicates that BisA actually destabilises the i-motif (figure 
2.8) and this effect is also observed at pH 5.5 (figure 2.10) where the i-motif is more 
stable than at pH 6.8. Conversely the FRET melting data at pH 7.4, starting with the 
hTeloC sequence in an unfolded random coil, indicates folding of the DNA with 
increasing concentration of BisA (figure 2.11). Control experiments with the 
diethylenetriamine linker (DETA) and the monoacridine (MonoA) show that these 
compounds do not significantly affect the i-motif until much higher concentrations are 
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used. This is in agreement with Alberti and co-workers who showed that MonoA did 
not stabilise the i-motif.100 
 
 It is clear from these results that BisA is having an effect upon i-motif DNA and 
therefore it must be binding to the DNA in some way. However, FRET melting alone 
can only tell us whether the DNA is folding or unfolding, i.e. are the fluorophores 
moving closer together or further apart. This doesn’t provide any information about 
how the structure of the DNA is changing and for this, further experiments are needed. 
 
2.3.3 Circular Dichroism Experiments 
 
In order to examine in more detail what effect BisA is having on the i-motif structure 
as observed in the FRET melting experiments, circular dichroism spectroscopy was 
employed. As discussed in section 1.4.5 and 2.3.1, circular dichroism is a very useful 
technique for studying DNA secondary structure and gives a characteristic spectrum 
depending on the type of structure present.102 Folded i-motif DNA gives a positive peak 
at 288 nm and a negative peak at 255 nm. The CD spectrum of hTeloC oligonucleotide 
(5'-d(TAACCC)4-3') was measured at a concentration of 10 µM at pH 5.5, 6.8 and 7.4 
(figures 2.15, 2.16 and 2.17) in 10 mM sodium cacodylate buffer (with 100 mM sodium 
chloride at pH 5.5 and 7.4). BisA was titrated into the sample in 1 equivalent aliquots 
(10 µM) up to 10 equivalents (100 µM).  
 
 
 
 
 
 
 
 
 
 
 
Figure 2.15: CD titration of human telomeric i-motif with increasing concentration of 
BisA at pH 6.8. [DNA] = 10 µM, buffer = 10 mM sodium cacodylate. 
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The CD spectrum at pH 6.8 (figure 2.15) in the absence of any ligand shows the 
presence of the i-motif structure with a negative peak at 253.5 nm and positive peaks 
at 285.5 and 220 nm. As BisA is titrated into the sample, the spectrum shows a 
decrease in molar ellipticity and a hypsochromic shift in the positive peak to 278 nm 
after addition of 4 equivalents of BisA. This could be indicative of unfolding of the DNA 
however, this change is not accompanied by a shift in the negative peak to 250 nm that 
is expected for single stranded DNA. In fact the negative peak shifts in the opposite 
direction to 260 nm indicating a different structural change. After addition of more 
than 4 equivalents of BisA the positive peak also begins to shift towards higher 
wavelengths indicating a further structural change. After addition of 9 and 10 
equivalents of BisA, precipitation can be observed with very low molar ellipticity 
across the spectrum and with less smooth curves. Other changes are also observed at 
lower wavelengths where there is a decrease in molar ellipticity at 220 nm and 
formation of a new positive peak at 245 nm. This new positive peak is in the same 
spectral region as where BisA absorbs (248 nm) and could be an induced CD signal for 
the BisA molecule upon its binding to the DNA. These changes in the CD spectrum, 
clearly show that BisA is interacting with the i-motif and causing some form of 
structural change. 
 
Whether or not the new peak at 245 nm is due to BisA or the DNA, the change in molar 
ellipticity shows that BisA binds to the DNA and can be fitted to obtain a measurement 
of the binding affinity. The change in molar ellipticity at 245 nm with increasing 
concentration of BisA was normalised to give the change in terms of fraction of BisA 
bound between 0 and 1 (figure 2.16). As can be seen, the data does not reach a plateau, 
this is because at concentrations above 80 µM, precipitation occurred, causing a large 
decrease in molar ellipticity. The data was fitted with a 2 to 1 binding model (equation 
2.1) as this gave the best fit of the data.155 
 
Equation 2.1:   𝜃 =  
𝐾1[𝐵𝑖𝑠𝐴]+2𝐾1𝐾2[𝐵𝑖𝑠𝐴]
2
1+𝐾1[𝐵𝑖𝑠𝐴]+𝐾1𝐾2[𝐵𝑖𝑠𝐴]2
 
 
Where K1 and K2 are the equilibrium association constants for the first and second 
binding sites. This gave rise to dissociation constants of KD1 = 59.3 µM and KD2 = 96.0 
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µM. This indicates that BisA has a moderate binding affinity for the i-motif with two 
possible binding sites. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.16: Graph to show the fraction bound with increasing concentration of BisA 
from the change in molar ellipticity at 245 nm at pH 6.8. Error bars show the standard 
deviation across two repeats. [DNA] = 10 µM, buffer = 10 mM sodium cacodylate. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.17: CD titration of human telomeric i-motif with increasing concentration of 
BisA at pH 5.5. [DNA] = 10 µM, buffer = 10 mM sodium cacodylate and 100 mM NaCl. 
 
The CD titration at pH 5.5 (figure 2.17), gave similar final results to the titration at pH 
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300 nm, a shift in the negative signal from 255 nm to 260 nm and the formation of an 
ICD peak, this time at 242 nm were all observed. However, unlike at pH 6.8, the positive 
peak moves smoothly towards the higher wavelength rather than first moving towards 
278 nm and then back to 300 nm as was seen in figure 2.15. These observations suggest 
that in both cases the same or a very similar overall change in structure occurs 
however, at the two different pH’s this occurs by different routes. This may be because 
of the lower stability of the i-motif at pH 6.8. Another difference between the two pH’s 
is that under the more acidic conditions, precipitation did not occur which is illustrated 
by the much smoother spectrum and the fact that the molar ellipticity did not 
dramatically drop at high BisA concentrations such as at pH 6.8. 
 
As before, the change in CD signal is indicative of BisA binding to the i-motif and by 
fitting the change in molar ellipticity a binding affinity can be measured. In this case 
the data did reach a plateau (figure 2.18) and was first fitted with the two binding site 
model in equation 2.1. This gave dissociation constants of KD1 = 30.8 µM and KD2 = 259 
µM suggesting a moderate binding affinity for the first binding site with a much weaker 
second binding site. However, compared to pH 6.8 the data does show a greater degree 
of sigmoidal character, which means it may be better fitted by the Hill equation. This 
fitting not only gives a measure of the binding affinity but also of the cooperativity of 
binding meaning that the initial binding of BisA affects the binding of subsequent BisA 
molecules. The data was fitted with equation 2.2 where K is the equilibrium 
dissociation constant, equal to the concentration at which half the binding sites are 
occupied.156 n is the Hill coefficient which gives a measure of cooperativity, if n = 1 there 
is no cooperativity, n > 1 indicates positive cooperativity and n < 1 shows negative 
cooperativity. 
 
Equation 2.2:   𝜃 =
[𝐵𝑖𝑠𝐴]𝑛
𝐾𝑛+[𝐵𝑖𝑠𝐴]𝑛
  
 
Fitting with equation 2.2 gave a better fit of the data and gave rise to a dissociation 
constant of KD = 2.5 µM with a Hill coefficient of n = 2.3. These results suggests that 
BisA may have a much higher affinity for the i-motif and that the binding of BisA may 
show positive cooperativity. 
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Figure 2.18: Graph to show the fraction bound with increasing concentration of BisA 
from the change in molar ellipticity at 242 nm at pH 5.5. Error bars show the standard 
deviation across two repeats. [DNA] = 10 µM, buffer = 10 mM sodium cacodylate and 
100 mM NaCl. 
 
At pH 7.4, the i-motif is not formed and the sequence takes a random coil structure. 
This gives a different CD spectrum to the i-motif with a positive peak at 275 nm and a 
negative peak at 250 nm. When BisA was titrated with hTeloC at pH 7.4, similar 
reductions in signal could be seen at both 275 nm and 250 nm with the formation of a 
smaller ICD at 248 nm also occurring (figure 2.19). This data provides supporting 
evidence that BisA is not simply destabilising and unfolding the i-motif structure 
because if that was the case, very little change would be expected when BisA is added 
to already unfolded DNA. Here it is apparent that some condensation of the DNA is 
occurring, in fact at pH 7.4 and 6.8, visible precipitate was observed at the higher 
concentrations of BisA (70 and 80 µM respectively). The presence of an ICD signal 
gives further evidence that a binding event is occurring and the compound must bind 
to the DNA if it is causing aggregation. 
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Figure 2.19: CD titration of human telomeric i-motif with increasing concentration of 
BisA at pH 7.4. [DNA] = 10 µM, buffer = 10 mM sodium cacodylate and 100 mM NaCl. 
 
To give an indication of whether the signals seen at 242-248 nm were indeed ICDs 
rather than a signal originating from BisA in the absence of DNA, the CD spectrum of 
BisA was measured at the top concentration (100 µM) in each pH buffer (figure 2.20). 
BisA is not chiral so no CD signal is expected however, in all three cases a very weak 
negative signal is observed between 240 and 260 nm. The ICD signals in the presence 
of the DNA are positive and of a higher magnitude. The presence of a small signal in 
this region in the absence of DNA suggests that the ICD seen in figures 2.15, 2.17 and 
2.19 could be from BisA rather than a conformational change in the DNA. 
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Figure 2.20: CD spectrum of BisA at pH 5.5, 6.8 and 7.4. [BisA] = 100 µM, buffer = 10 
mM sodium cacodylate and 100 mM NaCl pH 5.5 and 7.4, buffer = 10 mM sodium 
cacodylate pH 6.8. 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 2.21: CD titration of human telomeric i-motif with increasing concentration of 
MonoA at pH 5.5. [DNA] = 10 µM, buffer = 10 mM sodium cacodylate and 100 mM NaCl. 
 
Control experiments were carried out with MonoA which show no change in the CD 
spectrum of hTeloC at pH 5.5 (figure 2.21). Therefore, if MonoA is binding to the i-motif 
it is not having any effect on the structure at this pH. At pH 6.8 there is a decrease in 
signal and a shift in the positive peak from 288 nm to 275 nm suggesting that at this 
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pH, where the i-motif is less stable, MonoA causes some unfolding of the structure 
(figure 2.22). As MonoA appears to cause some unfolding of the DNA at pH 6.8 it may 
be binding to the DNA, however there were no observable induced CD signals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.22: CD titration of human telomeric i-motif with increasing concentration of 
MonoA at pH 6.8. [DNA] = 10 µM, buffer = 10 mM sodium cacodylate. 
 
Once again the change in molar ellipticity as a result of MonoA can be fitted to obtain 
a binding curve. Following the same method outlined above for BisA, the change in 
molar ellipticity at 285.5 nm was normalised to give a measure of the fraction of DNA 
that is unfolded (figure 2.23) and this was fitted with both equation 2.1 and 2.2. Using 
the 2 to 1 model gave equilibrium dissociation constants of KD1 = 35.5 µM and KD2 = 
194 µM suggesting a moderate affinity for one binding site and a weaker affinity for a 
second binding site. Using the Hill equation gave a better fit of the data at higher 
concentrations of MonoA and was within the error at the lower concentrations. This 
fit gave the MonoA concentration at which half the DNA is unfolded ([MonoA]50) as 
2.58 µM. This suggests a stronger affinity for the structure. The cooperativity was 
measured to be n = 2.5 suggesting a positive cooperativity. Alternatively, as no change 
is seen at pH 5.5, MonoA may not be binding to the i-motif at all and may just be 
increasing the ionic strength of the sample due to its positive charge and hence this 
may be the cause of unfolding at pH 6.8. 
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Figure 2.23: Average change in molar ellipticity with increasing concentration of 
MonoA at pH 6.8. Error bars show the standard deviation across two repeats. [DNA] = 
10 µM, buffer = 10 mM sodium cacodylate. 
 
The combined circular dichroism results show that both BisA and MonoA interact with 
the human telomeric i-motif but they have differing effects which are also dependent 
on pH. At pH 6.8 BisA causes a change in structure of the DNA which is indicated by the 
change in CD spectrum as the positive peak at 285 nm first undergoes a hypsochromic 
shift which is followed by a bathochromic shift as more equivalents of BisA are added. 
Finally resulting in precipitation after 9 to 10 equivalents. At pH 5.5, the positive peak 
of the spectrum undergoes a red shift but there is no precipitation. In both cases the 
negative peak shifts towards 260 nm and there is the formation of a new peak at 
around 242 to 245 nm. This suggests that at both pHs, the same overall structural 
change is occurring but at pH 6.8 there is a different change, perhaps unfolding, that 
occurs as part of the process. This may be because of the lower stability of the i-motif 
at this pH, making it much more susceptible to unfolding. The peaks at 245 and 242 nm 
may be due to the conformational change of the DNA but, as BisA absorbs in a similar 
UV region (248 nm) there is a good chance that this peak is an induced CD signal arising 
from BisA as it binds to the DNA. BisA itself only shows a very weak negative signal in 
this region in the absence of DNA. Unlike BisA, the CD titration of the i-motif with 
MonoA showed no change in the spectrum at pH 5.5 and at pH 6.8 the changes in the 
CD indicate unfolding. This suggests that MonoA may be binding to the i-motif and has 
a destabilising effect on the already unstable structure but it may also be the case that 
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MonoA is simply increasing the ionic strength of the sample due to its positive charge 
and that this is enough to cause unfolding at pH 6.8.  
 
2.3.4 Fluorescence Titration Experiments 
 
Fluorescence emission spectroscopy provides an alternative means to measure a 
binding affinity of BisA for the i-motif. In circular dichroism, the concentration of DNA 
is kept constant and the amount of BisA is varied but in the fluorescence titration, it is 
the amount of DNA that is varied with BisA constant. Depending on the properties of 
the ligand, fluorescence spectroscopy can be carried out at lower concentrations and 
can enable the assessment of higher DNA:ligand ratios. 1 µM samples of BisA were 
excited at 255 nm and the emission was observed between 290 and 490 nm with peaks 
at 326 and 426 nm (figure 2.24). The change in fluorescence was measured as 
increasing amounts of telomeric i-motif (hTeloC) were titrated into the sample. Upon 
addition of the DNA, the fluorescence of BisA can be seen to decrease, reaching a 
plateau at around 15 equivalents of hTeloC to BisA. This decrease in fluorescence is 
consistent with previous observations of BisA fluorescence as described earlier 
(section 2.1.1) showing that BisA fluorescence is decreased between 70-80% in the 
presence of purine bases.136 The average decrease in fluorescence shown in these 
experiments is 76%, consistent with Teulade-Fichou and co-worker’s findings.136 
While the sequence of hTeloC is predominantly rich in pyrimidine bases cytosine and 
thymine, each loop of the i-motif contains two adenine bases. It has previously been 
shown that BisA is able to bind to the adenine loops of hairpin DNA.138,139 This decrease 
in fluorescence may therefore be the result of BisA binding to the adenine bases in the 
loops of the i-motif. This decreasing fluorescence signal could also be the result of 
condensation or precipitation of the DNA and BisA. In the previous FRET and circular 
dichroism experiments which indicate possible precipitation there is an excess of BisA 
compared to DNA however, in this experiment there is an excess of DNA and this means 
that there is less likely to be a precipitation effect. 
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Figure 2.24: Fluorescence titration of BisA with increasing concentration of human 
telomeric i-motif at pH 5.5. [BisA] = 1 µM, buffer = 10 mM sodium cacodylate and 100 
mM NaCl. 
 
The change in fluorescence at 426 nm was normalised and fitted with a 2 to 1 binding 
model (equation 2.1, figure 2.25) where K1 and K2 are the equilibrium association 
constants for the first and second binding sites. This gave an average KD1 = 2.1 ± 0.1 µM 
and KD2 = 146 ± 10.2 µM. This indicates a relatively strong binding affinity for the 1st 
binding event with a much weaker 2nd binding interaction and compares well with the 
KD measured from the Hill fit of the CD titration (figure 2.18, KD = 2.5 µM). 
 
Equation 2.1:   𝜃 =  
𝐾1[𝐷𝑁𝐴]+2𝐾1𝐾2[𝐷𝑁𝐴]
2
1+𝐾1[𝐷𝑁𝐴]+𝐾1𝐾2[𝐷𝑁𝐴]2
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Figure 2.25: 2 to 1 Binding curve for the normalised change in fluorescence of BisA with 
increasing concentration of human telomeric i-motif at pH 5.5. Error bars show the 
standard deviation across three repeats. [BisA] = 1 µM, buffer = 10 mM sodium 
cacodylate and 100 mM NaCl. 
 
These results provide further evidence that BisA binds to the i-motif. The decrease in 
BisA florescence is consistent with previous examples of BisA DNA binding136 and may 
indicate that BisA binds to the adenine loop region of the i-motif.138,139 These results 
may also be showing condensation of the DNA but as there is an excess of DNA it is 
more likely that the decrease in fluorescence is a binding effect. The change in 
fluorescence was fitted with a 2 to 1 binding model giving equilibrium binding 
constants of KD1 = 2.1 µM and KD2 = 146 µM. This is in contrast to the binding constant 
determined by circular dichroism and suggests a stronger affinity for the first binding 
site. However, these different results are not directly comparable as circular dichroism 
is carried out at higher BisA concentrations and the two techniques monitor two 
different properties; change in fluorescence of the ligand versus change in optical 
activity of the DNA and ligand. The fluorescence titration is likely to give the more 
reliable result because the experiment should not be affected by precipitation at these 
ligand:DNA ratios.  
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2.3.5 FRET Titration Experiments 
 
In order to investigate further the structural changes observed in CD experiments, a 
FRET titration was carried out. The CD titration at pH 6.8 was unusual in that it showed 
an initial shift in the positive peak to the left and then back to the right, this might 
indicate an unfolding event followed by a different change in structure. As described in 
section 1.4, by exciting the FRET labelled DNA at 490 nm and taking the emission 
spectrum from 500 to 650 nm, the fluorescence of both FAM and TAMRA can be 
observed at 515 and 580 nm respectively. When the DNA is folded the emission of FAM 
is expected to be low, if it unfolds the emission should increase at 515 nm. At pH 6.8 
(figure 2.26) the fluorescence of FAM in the absence of BisA is already at an 
intermediate level (120 A.U.) compared to the fully folded DNA at pH 5.5 (figure 2.27) 
where the fluorescence of FAM is very low (5 A.U.) This suggests that the i-motif is not 
fully and compactly folded at this pH, as was seen by the incomplete melting curves in 
figure 2.7. If folding occurs, the fluorescence of FAM is expected to decrease but the 
fluorescence of TAMRA should not change. If the fluorescence of both fluorophores 
decreases then this is indicative of precipitation. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.26: Example FRET titration of hTeloC with increasing equivalents of BisA at pH 
6.8. [DNA] = 100 nM, buffer = 10 mM sodium cacodylate. 
 
At pH 6.8 (figure 2.26), it can be seen that upon addition of BisA, the fluorescence of 
FAM at 515 nm increases with a negligible change in the fluorescence of TAMRA at 580 
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nm. This is indicative of the DNA unfolding. However, after addition of 5 equivalents of 
BisA, further additions of the compound cause the fluorescence of both fluorophores 
to decrease, eventually reaching a base level after addition of 20 equivalents. This is 
consistent with a condensation or precipitation of the DNA. However, the decreasing 
ratio between FAM and TAMRA (2:1 at 8 eq BisA, 1.5:1 at 10 eq BisA) does suggest 
that folding may be occurring or that the fluorophores are coming into close proximity 
during condensation. 
 
At pH 5.5 (figure 2.27), it can be seen that the fluorescence of FAM is already very low 
showing that the DNA is completely folded at this pH. As BisA is titrated into the 
sample, there is no increase in the fluorescence of FAM showing that at this pH, the 
addition of BisA does not cause unfolding of the i-motif. This is consistent with the CD 
spectrum in figure 2.17 which, unlike at pH 6.8 (figure 2.15), does not show a shift in 
the positive peak towards 275 nm. In the FRET titration experiment, as the 
concentration of BisA is increased, there is a decrease in the fluorescence of both FAM 
and TAMRA indicating condensation of the DNA. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.27: FRET titration of hTeloC with increasing equivalents of BisA at pH 5.5. 
[DNA] = 100 nM, buffer = 10 mM sodium cacodylate and 100 mM NaCl. 
 
These results show that BisA causes condensation or precipitation of i-motif DNA at 
both pH 6.8 and pH 5.5. The titration at pH 6.8 is consistent with the CD observations 
showing that the DNA begins to unfold before condensation occurs whereas at pH 5.5, 
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condensation occurs immediately. With similar shaped CD spectra at the end of both 
titrrations it was already hypothesized that the same type of structure is forming at 
both pHs. As both FRET titrations seem to show condensation or precipitation of the 
DNA it would indicate that this is also what is being observed in the CD titrations.  
 
2.3.6 UV Titration Experiments 
 
To further show the interaction between BisA and the i-motif and to see if there were 
other signs of precipitation or condensation, the compound was tested with the DNA 
in a UV titration experiment. The absorbance of hTeloC i-motif was measured at a 
concentration of 2.5 µM at 260 nm (figure 2.28). BisA was titrated into the DNA sample 
in 1 equivalent aliquots and the sample was mixed. In the first titrations carried out, 
the absorbance could be seen to increase with a shift in wavelength towards 248 nm, 
consistent with an increasing concentration of BisA (figure 2.28). However, there was 
also a small but consistent increase in absorbance in the base line between 500 and 
800 nm, indicative of a scattering effect. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.28: Example UV titration of hTeloC with increasing concentration of BisA at pH 
5.5. [DNA] = 2.5 µM, buffer = 10 mM sodium cacodylate and 100 mM NaCl. 
 
To ensure that there was no dust particles in the sample causing scattering, the 
titration was repeated but the sample was mixed and centrifuged at 6000 rpm before 
measuring each new concentration (figure 2.29).  
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Figure 2.29: UV titration of human telomeric i-motif with increasing concentration of 
BisA at pH 5.5. [DNA] = 2.5 µM, buffer = 10 mM sodium cacodylate and 100 mM NaCl. 
 
At pH 5.5 (figure 2.29) there is a significant decrease in the absorbance of DNA at 260 
nm (figure 2.30). This would indicate the precipitation of DNA which is then separated 
from the sample during centrifugation. After addition of 7 equivalents of BisA a peak 
begins to appear at 248 nm which corresponds to the absorbance of BisA itself and 
suggests that the majority of the available BisA binding sites had been filled. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.30: Change in UV absorbance at 260 nm with increasing concentration of BisA 
at pH 5.5. [DNA] = 2.5 µM, buffer = 10 mM sodium cacodylate and 100 mM NaCl. 
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Figure 2.31: UV titration of human telomeric i-motif with increasing concentration of 
BisA at pH 6.8. [DNA] = 2.5 µM, buffer = 10 mM sodium cacodylate. 
 
At pH 6.8 (figure 2.31), there was an initial increase in absorbance at 260 nm which 
may be indicative of the i-motif unfolding or BisA binding, but is quickly followed by a 
similar decrease in absorbance as the concentration of BisA is increased, indicating the 
same condensation of the DNA (figure 2.32). This is consistent with the earlier CD and 
FRET titration experiments which also indicate initial unfolding of the DNA at this pH. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.32: Change in UV absorbance at 260 nm with increasing concentration of BisA 
at pH 6.8. [DNA] = 2.5 µM, buffer = 10 mM sodium cacodylate. 
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To see whether BisA was simply aggregating with itself an analogous titration was 
carried out with just BisA in buffer at both pH 5.5 and 6.8 to check that the absorbance 
remained linear according to the Beer-Lambert law (equation 2.3) (figure 2.33 & 2.35). 
Where A is the absorbance, ε is the molar extinction coefficient, c is the concentration 
and l is the path length of the sample which in this case was 1 cm. This equation shows 
that the absorbance of BisA should remain linear with increasing concentration. 
 
Equation 2.3:   𝐴 = 𝜀𝑐𝑙 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.33: UV titration of BisA in the absence of any DNA at pH 5.5. Buffer = 10 mM 
sodium cacodylate and 100 mM NaCl. 
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Figure 2.34: Change in absorbance of BisA at 248 nm in pH 5.5 buffer showing it is 
linear, obeying the Beer-Lambert law. Buffer = 10 mM sodium cacodylate and 100 mM 
NaCl. 
 
These results show that as BisA is titrated into the buffer, the absorbance at 248 nm 
increases as expected (figure 2.33). It also shows that the absorbance at 260 nm 
increases, therefore, it would be expected that addition of BisA to DNA would result in 
an increase in absorbance at 260 nm, contradictory to what was observed. By plotting 
the absorbance at 248 nm with concentration of BisA (figure 2.34) it can be seen that 
the data is linear and therefore obeys the Beer-Lambert law showing, that it does not 
aggregate with itself over this concentration range. 
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Figure 2.35: UV titration of BisA in the absence of DNA at pH 6.8. Buffer = 10 mM 
sodium cacodylate. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.36: Change in absorbance of BisA at 248 nm in pH 6.8 buffer showing it obeys 
the Beer-Lambert law. Buffer = 10 mM sodium cacodylate. 
 
The titration of BisA alone at pH 6.8 is very similar to that at pH 5.5 (figure 2.35). Again 
showing that the absorbance at 260 nm with DNA would be expected to increase and 
that the absorbance at 248 nm is linear showing that BisA does not aggregate with 
itself at this pH. 
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The combined UV titration results are consistent with the observations made in CD and 
FRET titrations at these pH values, even though each experiment was carried out at 
different DNA concentrations. The UV results indicate that addition of BisA at pH 6.8 
initially causes the DNA to unfold, after which precipitation or condensation occurs. At 
pH 5.5, there is no unfolding observed and the addition of BisA appears to cause 
immediate condensation. The UV titrations of BisA alone in buffer show that these 
observations are not as a result of BisA aggregating with itself. In combination with the 
experiments carried out in the previous sections, these results provide strong evidence 
that BisA causes the condensation of the DNA. To further support this working 
hypothesis, further experiments such as polyacrylamide gel electrophoresis and 
dynamic light scattering were used to look for evidence of a condensation effect. 
 
2.3.7 Polyacrylamide Gel Electrophoresis Experiments 
 
As described in section 1.4.7, gel electrophoresis experiments are a useful tool to show 
ligands interacting with DNA structures. As ligands bind to the DNA this increases the 
molecular weight of the resultant complex and if binding occurs through an 
electrostatic interaction, some charge neutralisation can occur. Both of these changes 
can result in the sample moving more slowly through the gel. Aggregation of the DNA 
would also be indicated in gel experiments as small single DNA structures are able to 
move through the gel much more easily than aggregates. 15% Polyacrylamide was 
used rather than agarose due to the small size of oligonucleotides used (18 – 24 bases), 
for which polyacrylamide can provide a better resolution. Native polyacrylamide gel 
electrophoresis experiments were performed with the labelled oligonucleotide 
hTeloCFRET so that the gels could be visualised by fluorescence imaging and an 18-base 
sequence of single stranded DNA was used as a marker (FAM-5'-
GTAAAACGACGGCCAGTG-3'). The gels were run in pH 5.5 10 mM sodium cacodylate, 
100 mM sodium chloride running buffer at 100 volts for 1 hour 15 minutes. The gels 
were carried out under these native conditions to reduce the possibility of denaturing 
the DNA and of breaking up any complexes formed. Denaturing gels typically include a 
component such as urea to disrupt the DNA secondary structure and are run at higher 
temperatures and voltages.157 
 
Chapter 2: Characterisation of the i-Motif Binding Compound BisA 
 
 
 88 
 
 
 
 
 
 
 
 
 
 
Figure 2.37: BisA titration gel. Lane: 1 = 18 base marker, 2 = 1 µM hTeloC, lanes 3 – 9 = 
1 µM hTeloC + 1, 5, 10, 15, 20, 25, 30 equivalents of BisA. [DNA] = 1 µM, buffer = 10 mM 
sodium cacodylate and 100 mM NaCl pH 5.5, Voltage = 100 V, Time = 1 hour 15 minutes. 
 
The effect of BisA on the mobility of the i-motif through the gel was tested by 
combining 1 µM hTeloCFRET with 0, 1, 5, 10, 15, 20, 25 and 30 equivalents of BisA in 
lanes 2 to 9. The 18 base marker was placed in lane 1 (figure 2.37). It can clearly be 
seen, that with increasing BisA concentration from left to right, the progress of the 
band through the gel is retarded and at higher BisA concentrations there is a smearing 
effect. This demonstrates that BisA is binding to the DNA and suggests that there is 
condensation of the DNA occurring as the smearing may be caused by different sized 
pieces of DNA moving through the gel at different rates. These results agree with 
earlier gel experiments carried out on BisA by Slama-Schwok and co-workers.139 As 
described in section 2.1.1, their gels also showed a retardation and a smearing of the 
bands at BisA concentrations above 25 µM. In their experiments, aggregation 
happened slowly over the course of a day. However, in these experiments, 
condensation was observed more quickly in the time it took to add BisA, mix the 
sample and run the experiment which only lasted for 1 hour 15 minutes. The 
condensation effect may have been accelerated by centrifugation as the samples were 
centrifuged at a slow speed (3000 rpm) for 30 seconds to enable easier loading onto 
the gel.  
 
Control gels were carried out with MonoA and the diethylenetriamine linker (DETA) 
(figure 2.38). 1 µM hTeloCFRET was combined with 0, 2, 10, 20, 30, 40, 50 and 60 
[BisA] 
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equivalents of either MonoA or DETA in lanes 2 to 9 and the 18 base marker was again 
placed in lane 1. Double the concentrations were used for the experiments with MonoA 
and DETA in order to match the equivalents of each compound present in BisA. Here 
it can clearly be seen that the bands are not retarded and there is no difference in the 
bands compared to hTeloC alone. This suggests that MonoA and DETA are not 
interacting with the DNA or if they are, they are not affecting the progress of the DNA 
through the gel. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.38: a) MonoA titration gel b) DETA titration gel. Lane: 1 = 18 base marker, 2 = 
1 µM hTeloC, lanes 3 – 9 = 1 µM hTeloC + 2, 10, 20, 30, 40, 50, 60 equivalents of MonoA 
or DETA respectively. [DNA] = 1 µM, buffer = 10 mM sodium cacodylate and 100 mM 
NaCl pH 5.5, Voltage = 100 V, Time = 1 hour 15 minutes. 
 
These results provide further evidence that BisA is binding to i-motif DNA but appears 
to indicate that higher concentrations of BisA cause condensation or aggregation of the 
DNA. The results of the gels in figure 2.38 show that neither MonoA nor DETA have 
this same condensation effect at equivalent concentrations to BisA. This implies that 
the observed effects are a particular characteristic of the BisA structure, rather than 
simply the presence of two acridine units or two DETA units. 
 
2.3.8 Dynamic Light Scattering experiments 
 
In order to characterise the possible condensation effect of BisA, dynamic light 
scattering was used to try and observe the presence of condensed particles. This 
[MonoA] 
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technique monitors the reflection of laser light from particles forming in the solution 
and uses this to measure the size of particles formed. This can indicate whether there 
is general aggregation occurring, forming a polydisperse mixture of different sized 
particles, or if there is more uniform condensation to a particular particle size.158 By 
measuring the difference in scattering intensity over time, the instrument generates a 
correlation function (figure 2.39). The change in scattering over time is related to the 
size of the particles formed via the diffusion coefficient. The larger the particles, the 
slower they diffuse, hence the change in scattering is slower. By fitting the correlation 
curves with an exponential function an intensity distribution is calculated which is 
centered on the average particle size (figure 2.40). Looking at the correlation graph 
itself can also give useful qualitative information; if no particles form, the data given 
has a very low y-intercept, whereas particle formation is shown by a higher y-intercept 
closer to 1 and a sigmoidal curve. The time at which the inflection point occurs is 
indicative of the size of the particles formed, bigger particles at longer times. Finally 
the gradient of the sigmoidal curve is indicative of how polydisperse the sample is, i.e. 
the spread in the distribution of particle sizes. How flat the baseline is of the sigmoidal 
curve is indicative of the quality of the data as larger dust particles create an uneven 
baseline.  
 
As outlined above for the UV absorbance experiments, the sample was centrifuged at a 
relatively slow speed (6000 rpm) before being tested and after each addition of BisA. 
For DLS experiments this is important as this process helps remove any much larger 
dust particles that may contaminate the sample and give an erroneous result. Dust 
contamination is also minimised by passing the sample through a 0.2 µm filter and by 
rinsing tubes and pipette tips with filtered buffer. A concentration of 2.5 µM hTeloC 
was tested at the same three pH’s (pH 5.5, 6.8 and 7.4) that have been used throughout 
the previous experiments. In all three cases, the DNA alone, both in i-motif form at 
acidic pH and as a single strand at neutral pH, showed no particle formation (figure 
2.39). However, addition of just 1 equivalent of BisA resulted in the formation of a 
polydisperse mixture of particles. This is indicated by the increase in the correlation 
function (figure 2.39) giving a sigmoidal curve. Interestingly at pH 5.5, the inflection 
point of the correlation curves occur at longer times (figure 2.39) indicating that larger 
particles are formed. This can be seen in the intensity plot (figure 2.40), where the 
distribution of particles is centered at different sizes depending on the pH. At lower pH 
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the size distribution of particles formed by DNA-BisA aggregation is centered on 600 
nm in diameter with a second smaller distribution of particles centered around 100 
nm. Whereas, at the higher pH’s the population distribution is centered on the smaller 
100 nm particles with fewer larger particles. This is most likely due to the extra charge 
neutralisation of the phosphate backbone that occurs at acidic pH. This enables the 
strands to come into close proximity with minimum repulsion whereas, at higher pH’s, 
the phosphate backbone is still negatively charged and will cause electrostatic 
repulsion between the strands. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.39: Intensity correlation function graph of hTeloC in the absence and presence 
of 1 equivalent of BisA at pH 5.5, 6.8 and 7.4. [DNA] = 2.5 µM, buffer = 10 mM sodium 
cacodylate and 100 mM NaCl at pH 5.5 and 7.4, buffer = 10 mM sodium cacodylate at 
pH 6.8. 
 
 
 
 
 
 
 
 
 
 
0.1 1 10 100 1000 10000 1000001000000 1E7 1E8 1E9
-0.1
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
 2.5 M hTeloC pH 5.5 r1
 2.5 M hTeloC pH 5.5 r2
 +1 eq BisA pH 5.5 r1
 +1 eq BisA pH 5.5 r2
 2.5 M hTeloC pH 6.8 r1
 2.5 M hTeloC pH 6.8 r3
 +1 eq BisA pH 6.8 r1
 +1 eq BisA pH 6.8 r3
 2.5 M hTeloC pH 7.4 r1
 2.5 M hTeloC pH 7.4 r2
 +1 eq BisA pH 7.4 r1
 +1 eq BisA pH 7.4 r2
g
(q
,t
)
time (s)
Chapter 2: Characterisation of the i-Motif Binding Compound BisA 
 
 
 92 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.40: Intensity distribution graph showing the size range of particles formed 
upon addition of 1 equivalent of BisA to human telomeric i-motif. [DNA] = 2.5 µM, buffer 
= 10 mM sodium cacodylate and 100 mM NaCl at pH 5.5 and 7.4, buffer = 10 mM sodium 
cacodylate at pH 6.8. 
 
In a titration experiment (figure 2.41) it can be seen that the size of particles formed 
increases when the concentration of BisA is increased up to 10 equivalents (25 µM) as 
is illustrated by the increase in time for the inflection point of the correlation curve.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.41: Intensity correlation graph of hTeloC showing formation of increasing 
particle size with increasing concentration of BisA. [DNA] = 2.5 µM, buffer = 10 mM 
sodium cacodylate and 100 mM NaCl at pH 5.5. 
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In analogous control experiments, addition of 1 equivalent of MonoA showed no 
particle formation (figure 2.42). This indicates that MonoA does not cause the DNA to 
condense into particles under the conditions of this experiment. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.42: Intensity correlation graph of hTeloC showing that 1 equivalent of MonoA 
does not enable particle formation. [DNA] = 2.5 µM, buffer = 10 mM sodium cacodylate 
and 100 mM NaCl at pH 5.5, buffer = 10 mM sodium cacodylate at pH 6.8. 
 
The results of the DLS experiments provide the strongest evidence of this investigation 
that BisA is causing condensation of the DNA. With these experiments it was possible 
to actually observe particle formation and to measure the size distribution of the 
particles. These results also demonstrate that on average, larger particles are formed 
at pH 5.5 compared to pH 6.8 and 7.4. This is likely to be due to the protonation of the 
phosphate backbone which will reduce electrostatic repulsion between strands. The 
fact that only 1 equivalent of BisA was required to cause a condensation effect suggests 
that BisA may not be a good ligand to study the potential chemical biology of the i-
motif as it is able to cause condensation at low concentrations making it difficult for 
biological observations to be made. 
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2.4 Is this effect specific for i-motif? 
 
Having seen that BisA may bind to the human telomeric i-motif but also appears to 
cause the DNA to condense, we next wanted to investigate whether this effect was 
specific for the i-motif or whether BisA would also cause condensation of telomeric G-
quadruplex or double stranded DNA. 
 
2.4.1 FRET Melting Studies 
 
Analogous FRET melting experiments to those shown in section 2.3.2 for the i-motif, 
were performed for a human telomeric G-quadruplex and a double stranded sequence 
(hTeloGFRET and DSFRET) at pH 5.5, 6.8 and 7.4. The sequences were tested with 0, 0.2, 
0.4, 0.6, 0.8 and 1.0 µM concentrations of BisA. In each case, it can be seen that the 
fluorescence does decrease with increasing BisA concentration but not to the same 
extreme as with the i-motif sequence shown in section 2.3.2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.43: FRET melting curves for duplex DNA with increasing concentration of BisA 
at pH 5.5. [DNA] = 200 nM, buffer = 10 mM sodium cacodylate and 100 mM NaCl. 
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Figure 2.44: FRET melting curves for duplex DNA with increasing concentration of BisA 
at pH 6.8. [DNA] = 200 nM, buffer = 10 mM sodium cacodylate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.45: FRET melting curves for duplex DNA with increasing concentration of BisA 
at pH 7.4. [DNA] = 200 nM, buffer = 10 mM sodium cacodylate and 100 mM NaCl. 
 
These results show that at pH 7.4 (figure 2.45), BisA has very little effect on the duplex 
stability (ΔTm = 1.7°C at 1 µM). However at pH 5.5 and 6.8 (figure 2.43 and 2.44), while 
there is little change in the temperature of the melting transition there is a decrease in 
fluorescence suggesting that the DNA does not fully melt within the temperature range 
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of the experiment. This may be due to stabilisation of a different or partially folded 
structure, but taking into account the previous experiments on BisA, it is more likely 
to be a condensation effect. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.46: FRET melting curves for human telomeric G-quadruplex with increasing 
concentration of BisA at pH 5.5. [DNA] = 200 nM, buffer = 10 mM sodium cacodylate 
and 100 mM NaCl. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.47: FRET melting curves for human telomeric G-quadruplex with increasing 
concentration of BisA at pH 6.8. [DNA] = 200 nM, buffer = 10 mM sodium cacodylate. 
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Figure 2.48: FRET melting curves for human telomeric G-quadruplex with increasing 
concentration of BisA at pH 7.4. [DNA] = 200 nM, buffer = 10 mM sodium cacodylate 
and 100 mM NaCl. 
 
A similar pattern is observed for the G-quadruplex, at pH 5.5 and pH 6.8 (figure 2.46 
and 2.47) there is a decrease in fluorescence at higher temperatures. However, at pH 
7.4 (figure 2.48), sigmoidal melt curves are observed showing the expected increase in 
fluorescence upon melting. BisA clearly causes an increase in melting temperature 
(ΔTm = +16°C at 1 µM), which is consistent with the results observed by Alberti and co-
workers (ΔTm = +15°C).100 These results suggest that BisA may have a similar 
condensation effect on the G-quadruplex and duplex sequences used in this study but 
only under acidic conditions, as at neutral pH, normal melt curves were observed. 
However, the G-quadruplex does not have good sigmoidal melting curves at acidic pH 
even in the absence of BisA so the structure maybe less stable or only partially formed. 
 
2.4.2 Polyacrylamide gel electrophoresis experiments 
 
To further understand the interaction between BisA, duplex and G-quadruplex DNA, a 
native polyacrylamide gel was used (figure 2.49). This enables a direct visual 
comparison of the effect of BisA on i-motif, G-quadruplex and double stranded DNA at 
pH 5.5. Although double stranded and G-quadruplex structures are normally examined 
under neutral pH conditions, this would result in the i-motif sequence unfolding so the 
gel needed to be carried out at acidic pH. This is also the pH at which evidence of 
25 30 35 40 45 50 55 60 65 70 75 80 85 90 95
0
1
2
3
4
5
6
7
8
9
10
11
12
F
lu
o
re
sc
e
n
ce
 I
n
te
n
si
ty
 (
A
.U
.)
Temperature (
o
C)
 200 nM G4 pH 7.4
 0.2 M
 0.4 M
 0.6 M
 0.8 M
 1.0 M
Chapter 2: Characterisation of the i-Motif Binding Compound BisA 
 
 
 98 
condensation has already been observed (figure 2.37). An 18 base marker was placed 
in lane 1, as before. Lanes 2-4 contained hTeloC i-motif, lanes 5-7 contained double 
stranded DNA and lanes 8-10 contained hTeloG G-quadruplex, each with 0, 1 and 30 
equivalents of BisA respectively. It can be seen that 1 equivalent of BisA has little to no 
effect on the movement of the band for each type of DNA, but at higher BisA 
concentrations, a retardation and smearing of the band can be seen for each type of 
DNA. In particular the band in lane 10 is very faint as a result. This suggests that the 
condensation caused by BisA is not specific to the i-motif.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.49: Combined i-motif, G-quadruplex and DS gel at pH 5.5. Lane 1 = 18 base 
marker. Lane 2 - 4 = 1 µM hTeloC +0 eq, 1 eq & 30 eq BisA. Lane 5 – 7 = 1 µM duplex +0 
eq, 1 eq & 30 eq BisA. Lane 8 – 10 = 1 µM hTeloG +0 eq, 1 eq & 30 eq BisA. [DNA] = 1 µM, 
buffer = 10 mM sodium cacodylate and 100 mM NaCl. 
 
The gel shown in figure 2.49 provides further evidence to compliment the FRET results 
that BisA binds and causes condensation of both G-quadruplex and duplex DNA at 
acidic pH. Like the i-motif, this is probably a result of the combination of a bis-
intercalator as well as the charge neutralisation provided by the acidic conditions. The 
bis-intercalation properties of BisA enable it to interact with two separate strands 
simultaneously and bring them into close proximity. The acidic conditions protonate 
the phosphate back bone which would otherwise cause electrostatic repulsion when 
the strands are brought together. 
  
           hTeloC            DS           hTeloG 
 
 
M     0    1    30    0   1    30   0    1   30 
[BisA] 
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2.5 Conclusions 
 
In this chapter, the previously identified ligand BisA was synthesised and its 
interaction with the i-motif has been investigated in detail with a much wider range of 
experiments than previously published.100 First the FRET melting experiments carried 
out by Alberti and co-workers were repeated and a high stabilisation potential (ΔTm = 
+55°C) was observed after normalisation of the data, greater than the published result 
(ΔTm = +33°C).100 However, the raw data suggested that BisA may actually destabilise 
rather than stabilise the i-motif as indicated by the first derivative where the minimum 
which corresponds to the melting temperature can be seen to decrease with increasing 
concentration of BisA. Higher concentrations indicated possible aggregation and 
precipitation with a base level fluorescent signal throughout the temperature range.  
 
Circular dichroism was used to look at the interaction in more detail. This gave further 
evidence of BisA binding to the DNA and showed that it caused a change in structure. 
At pH 6.8 this change in structure appeared to transition via a partial unfolding event 
whereas at pH 5.5 the change occurred without unfolding. In both cases a new peak 
appeared in the spectrum at 242 to 245 nm which could be due to the change in 
structure or as a result of an induced CD signal from BisA which absorbs in a similar 
region (248 nm). By fitting this change in CD binding constants could be obtained 
suggesting that BisA bound to the DNA with a moderate affinity in the low micromolar 
range. The observations made in the CD titrations were supported by FRET and UV 
titration experiments, both of which indicated that BisA caused condensation of the 
DNA but that at pH 6.8 the DNA began to unfold first. A fluorescence emission titration 
of BisA with i-motif DNA provided another measure of the binding affinity under 
conditions which were unlikely to favour condensation (excess DNA). This suggested 
that BisA bound to  the i-motif in a 2 to 1 model with a stronger first binding site (KD1 
= 2.1 µM) and a weaker second binding site (KD2 = 146 µM). Finally, further evidence 
that BisA caused condensation of the DNA was provided by polyacrylamide gel 
electrophoresis experiments and dynamic light scattering. This experiment enabled 
the particles formed to be measured, showing that larger particles (~600 nm) form at 
pH 5.5 while smaller particles (~100 nm) form at pH 6.8 and pH 7.4. Most likely due to 
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the protonation of the phosphate backbone reducing electrostatic repulsion as a 
barrier to condensation.  
 
The DNA condensation effect of BisA was not restricted to just the telomeric i-motif 
sequence. FRET melting studies and gel electrophoresis showed similar effects for 
BisA with double stranded and G-quadruplex DNA but to a lesser extent. At different 
stages in the study, the effects of BisA were compared to the monoacridine compound 
MonoA. These experiments showed that it had little to no effect on the i-motif with no 
change in melting temperature, and little effect on the structure by CD other than to 
cause unfolding at pH 6.8 when the i-motif is already unstable. MonoA also showed no 
aggregation effect in gel or DLS experiments. The diethylenetriamine linker DETA also 
had no effects when tested on its own in FRET melting and gel experiments. Conversely 
other bisacridine analogues that are linear rather than cyclic, do appear to cause some 
condensation or precipitation effects in FRET melting and CD experiments. The 
combination of these results suggests that it is not simply the charge of BisA 
(represented by DETA) that causes condensation and not simply the acridine unit itself 
but the combination of both these entities in the BisA structure. 
 
These initial investigations of the interaction of BisA with the i-motif highlight some of 
the potential pitfall of converting FRET melting data to fraction folded in order to 
measure the melting temperature as, unless the data gives a sigmoidal curve, this can 
cause effects such as condensation or precipitation to be misinterpreted as 
stabilisation of the structure. Whilst these results indicate that BisA is not a good 
choice of ligand for investigating the potential biological effects of i-motif DNA, the DNA 
condensation properties of this molecule could make it a very useful tool in order to 
try and obtain a crystal structure. Further work based on this chapter would be to try 
and use BisA to form a DNA-ligand crystal at acidic pH. This would show whether the 
DNA changed structure upon condensing or whether multiple i-motif structures 
condensed together. It would also show where the BisA molecule is bound to the DNA, 
enabling the identification of potential binding sites to aid the design of future i-motif 
ligands. 
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3.1 Introduction 
 
3.1.1 The need for new i-motif binding ligands. 
 
Currently, there are very few i-motif binding ligands published in the literature. As 
discussed in section 1.5, the majority of i-motif ligands that have been identified often 
have stronger binding affinities for duplex or G-quadruplex DNA and impart little 
stabilisation on the i-motif structure. Despite this, there have been some good ligands 
which have enabled an insight into the potential biological functions of the i-motif. In 
particular, carboxyl-modified single-walled carbon nanotubes have shown that 
inhibition of telomerase is possible through stabilisation of the telomeric i-motif.59 
Whilst Laurence Hurley and co-workers have identified a ligand specific for the Bcl-2 
i-motif which increases expression of the gene.69 These results provide strong evidence 
that the i-motif is worthy of investigation as a potential therapeutic target. However, 
the i-motif is inherently unstable due to the need for hemiprotonation of cytosine and 
in vitro, does not usually form at neutral pH. In order to fully understand the i-motif 
structure, new high affinity ligands are needed which are able to stabilise the structure 
sufficiently under physiological conditions. 
 
3.1.2 Aims and Objectives. 
 
In this chapter, a 960 compound library was screened against the human telomeric i-
motif via a medium throughput FRET melting assay with the aim of identifying new i-
motif interacting ligands based on their ability to stabilise or destabilise the structure. 
The library was a very diverse group of known drugs and biologically active 
compounds, with a wide range of structure types, molecular weights and chemical 
properties. Such a diverse set of compounds was deliberately chosen because there are 
so few existing ligands and as yet there is no obvious i-motif binding chemotype. 
Therefore, it was important to cover a wide range of options as possible i-motif ligands.  
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3.2 The initial screen 
 
3.2.1 Library and screening method 
 
The screen was carried out in collaboration with Camille Huguin using the Gen-Plus 
library from Microsource Discovery Systems Inc. consisting of 960 drug standards with 
approval in Europe, Japan or the USA supplied as 10 mM solutions in DMSO which were 
diluted to 1 mM in 96 well plates. The compounds were screened against the human 
telomeric i-motif (200 nM) in pH 5.5 buffer with 10 mM sodium cacodylate and 5 mM 
sodium chloride. These conditions were chosen as they are the same as previous FRET 
melting studies on the i-motif which have been demonstrated in the literature.98 
Sodium cacodylate is an ideal choice of buffer for melting experiments because its pKa 
remains constant within the temperature range of the experiment.93 pH 5.5 was chosen 
as it offers the best compromise to ensure formation of a stable i-motif structure, whilst 
not being so acidic as to completely quench the fluorescence of the fluorophore. A 
higher pH such as pH 7.4 was not chosen because at this pH the DNA is unfolded and 
although a decrease in fluorescence might be observed, which would indicate folding 
of the DNA, the FRET melting data itself does not give information about the type of 
structure that is formed. The primary aim of this study is to identify ligands which bind 
to the i-motif structure and therefore conditions were chosen in order to be certain 
that a stable i-motif is present in solution as a binding target.  
 
The compounds were screened at a relatively high concentration of 100 µM. This is 
because there are so few existing i-motif ligands in the literature that it is still not clear 
what particular structure types and characteristics favour i-motif binding. As the 
library chosen was a diverse library it was important to choose a high initial 
concentration in order to increase the chance of observing an interaction and to 
maximise the number of possible hits. These initial hits can then be further refined to 
find the best compounds through further experiments. After dilution in buffer, the 
samples still contain 10% DMSO, which has a destabilising effect on the i-motif. 
Therefore, changes in melting temperature (ΔTm) were calculated in relation to a 
control sample containing i-motif in the presence of 10% DMSO.  
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The potential draw-backs of this screening method are that compounds which bind to 
the i-motif but do not alter its melting temperature may be over looked. This screen 
also relies on measuring changes in fluorescence of the labelled DNA, therefore 
compounds which interact with the fluorophores rather than the i-motif may be 
incorrectly identified as hits. The FRET melting screen does however, offer several 
advantages. By using a fluorescently labelled oligonucleotide the screen can be carried 
out at much lower DNA concentrations (200 nM) than for example a UV based assay(>1 
µM). This is more cost effective and enables compounds to be tested at much higher 
ligand:DNA ratios easily.  Using this assay, the samples could also be tested in a medium 
throughput manner, enabling the compounds to be screened in a short period of time. 
  
3.2.2 Hit identification 
 
Normalisation of data is a technique where the raw data is transformed so that the 
lowest point is equal to zero and the highest point is equal to 1, this simplifies the 
interpretation of the data and makes it easier to compare different data sets. By 
assuming that the lowest fluorescence corresponds to completely folded DNA and the 
highest corresponds to completely unfolded DNA, the normalisation of FRET melting 
data gives a graph representing the fraction of folded DNA. The melting temperature is 
defined as the point of mid transition and on this basis the melting temperature (T1/2) 
is measured at the point where the fraction folded = 0.5, the point at which 50% of the 
DNA is folded and 50% is unfolded. As described in section 2.3.2, it is not always 
appropriate to assume that the DNA is completely folded or unfolded and using this 
method can lead to falsely identified changes in melting temperature if the data is not 
a sigmoidal curve. Particularly if the data gives a low fluorescence signal across the 
whole temperature range. Therefore, as well as measuring the T1/2, the data from the 
screen was analysed by taking the first derivative. As discussed in section 2.3.2, the 
minimum in this graph represents a point of inflection in the melting curve which 
should represent the point of mid transition and hence the melting temperature (Tm).91 
This method is only valid for intramolecular systems and still may not represent the 
precise melting temperature. However, this method avoids the possible errors that 
normalisation of the data can introduce. The third method for determining the melting 
temperature, the “base line” method, is not suited to the analysis of melting curves 
where one or both baselines cannot be accurately determined.  
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The melting temperature derived from the first derivative method was assessed in 
combination with the raw melt curves to see that the melting point chosen made sense 
and did indeed reflect a transition in the melt curve. As the compounds were tested at 
quite a high concentration, this resulted in a number of them giving a base level 
fluorescence signal across the whole temperature range and not showing a melting 
transition at all. As has been illustrated by the previous chapter, this may be the result 
of condensation or precipitation of the DNA, however this may also be due to a highly 
stabilising effect of the ligand or an interaction with the fluorophore and cannot be 
verified without further experiments. Therefore for the purpose of hit identification, 
ligands which gave a base level fluorescence signal were assumed to have a Tm > 95 °C 
and were included as a hit. Initially 34 hits were identified which gave any degree of 
change in melting temperature. The hit compounds gave a wide spread in ΔTm values 
from -13.7 to +47 °C (table 3.1) and included a wide variety of different structures 
(figure 3.1). The only trends that were observed between their stabilisation potential 
(ΔTm) and any structural or chemical properties was that positive charge and a higher 
number of hydrogen bond donors tended to favour stabilisation. This is most likely due 
to the fact that the i-motif structure has two very narrow grooves where the phosphate 
backbones come into close proximity, the sugar phosphate backbone has a large 
number of oxygens which can act as hydrogen bond acceptors so molecules with a 
larger number of hydrogen bond donors will have more opportunity to form 
favourable binding interactions with the structure. 
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Compound ΔT1/2 (°C)a ΔTm (°C)b 
P2C5 Cetylpyridinium chloride 49 47 
P9C11 Alexidine hydrochloride 35 40 
P1A3 Chlorhexidine 31 38 
P9G8 Methylbenzethonium Chloride 26 25.7 
P3A4 Tyrothricin 24 24 
P9F11 Pararosaniline Pamoate 19 24.7 
P12B3 Amiodarone hydrochloride 19 7.7 
P12A6 Astemizole 18 -7.6, 19c 
P4B6 Tamoxifen Citrate 16 12.3 
P7D5 Bromocriptine mesylate 15 17.3 
P4E9 Hexetidine 14 11.3 
P11H11 Tilorone 13 12.3 
P10B5 Benzalkonium chloride 12 8 
P12C5 Flunarizine hydrochloride 11 13.3 
P9H8 Mitoxantrone 9 41.3 
P10C8 Clopidogrel sulfate 9 5.3 
P8F9 Fosfosal 7 5.3 
P2A6 Roxarsone 6 6 
P12F6 Pyrvinium 6 5.3 
P6H5 Halazone 5 3.7 
P8G9 Cefamandole sodium 5 4.7 
P1G6 Nicotine ditartrate 3 5 
P12G3 Geneticin 3 7 
P1C9 Sisomicin sulfate 1 4 
P8F8 Diacerin -3 -7.3 
P11F5 Sertraline hydrochloride -6 -9.3, 27.3c 
P3A2 Neriifolin -6 -2.3 
P5E4 Oxacillin sodium -7 -10, 4.7c 
P3A5 1,4-Naphthoquinone -7 -6.7 
P3A3 Diazoxide -8 -7 
P3A8 Rosolic acid -9 -7 
P6H7 Hexachlorophen -9 -9 
P6H6 Haloperidol -11 -11.3 
P6G6 Gallamine -14 -13.7 
Table 3.1: Melting temperatures of initial 34 hit compounds. a T1/2 = melting 
temperature from the normalised data at fraction folded = 0.5, error = ± 1°C. b Tm = 
melting temperature from the minimum of the first derivative, error = ± 0.3°C.  c A 
bimodal melting curve was observed so both melting temperatures were recorded.  
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Figure 3.1: Structures of the 34 hit compounds.* Tyrothricin is a peptide mixture. 
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Figure 3.1: Structures of the 34 hit compounds.* Tyrothricin is a peptide mixture. 
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3.2.3 Potential False Positives and Negatives 
 
As well as the 34 hits, a number of false positives were also identified (figure 3.2). 
Although these compounds gave base level fluorescence across the temperature range 
which could be due to a high degree of stabilisation, looking at the structures they are 
known DNA cross-linking agents and were therefore discounted as the high 
stabilisation is likely to be as a result of cross-linking159. Cadmium acetate also gave a 
base level fluorescence signal but is not a small molecule so was also discounted. 
 
 
 
 
 
 
Figure 3.2: Structures of false positives Cisplatin and Carboplatin, known DNA cross-
linking agents, as well as cadmium acetate. 
 
There were also a range of compounds which gave a maximal fluorescence across the 
whole temperature range. Looking at their structures (figure 3.3) it is likely that these 
compounds are able to interact with the fluorophores of the labelled oligonucleotide 
or in the case of P3A6 may fluoresce themselves under the same excitation conditions 
of this experiment due to its similar core structure to FAM. The increase in fluorescence 
observed is greater than that observed in other experiments for simple unfolding of 
the DNA, giving further support to a possible interaction with the fluorophores. This 
means it is not possible, under these experimental conditions, to tell whether they are 
interacting with the i-motif at all or what effect they are having and hence are potential 
false negatives. To investigate these compounds further, a non-fluorescence based 
assay would need to be used. 
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Figure 3.3: Structures of potential false negative compounds which gave high 
fluorescence signals. 
 
3.2.4 Repeat Testing of Initial Hits 
 
Next, the 34 hit compounds were tested again in 100 mM sodium chloride and 5 mM 
sodium chloride buffers to confirm the results of the initial screen. Both salt 
concentrations were tested because the i-motif is more stable with lower salt 
concentration but the higher salt concentration can reduce the effect of more non-
specific electrostatic interactions. Many compounds showed a smaller effect on repeat 
screening (table 3.2). This may be as a result of regression toward the mean, a common 
occurrence in high throughput screens.160 This effect occurs because initial screen data 
may contain more error as a result of testing a large number of compounds. The repeat 
results are likely to have less error as a smaller number of compounds have been 
tested.161 
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Compound 
Initial  
screen 
100 mM 
5 mM 
repeat 
ΔTm (°C) ΔTm (°C) ΔTm (°C) 
P2C5 Cetylpyridinium chloride 47 Tm >95 Tm >95 
P9C11 Alexidine hydrochloride 40 Tm >95 Tm >95 
P1A3 Chlorhexidine 38 3, 25a Tm >95 
P9G8 Methylbenzethonium Chloride 25.7 -1, 31.7a 38 
P3A4 Tyrothricin 24 22.3 41 
P9F11 Pararosaniline Pamoate 24.7 0.7 Tm >95 
P12B3 Amiodarone hydrochloride 7.7 0.3, 10a 7.3 
P12A6 Astemizole -7.6, 19a -0.7 0.3 
P4B6 Tamoxifen Citrate 12.3 1 21.7 
P7D5 Bromocriptine mesylate 17.3 -1 Tm >95 
P4E9 Hexetidine 11.3 1 14.3 
P11H11 Tilorone 12.3 0 50 
P10B5 Benzalkonium chloride 8 -1.7, 28a 38 
P12C5 Flunarizine hydrochloride 13.3 0 0.7 
P9H8 Mitoxantrone 41.3 33.3 Tm >95 
P10C8 Clopidogrel sulfate 5.3 2.7 1.7 
P8F9 Fosfosal 5.3 1.3 1 
P2A6 Roxarsone 6 1.3 5 
P12F6 Pyrvinium 5.3 -0.3 1 
P6H5 Halazone 3.7 2 1 
P8G9 Cefamandole sodium 4.7 0 0.7 
P1G6 Nicotine ditartrate 5 2 1.3 
P12G3 Geneticin 7 0.3 6.3 
P1C9 Sisomicin sulfate 4 0 6.3 
P8F8 Diacerin -7.3 0.7 0.3 
P11F5 Sertraline hydrochloride -9.3, 27.3a 0 -0.3 
P3A2 Neriifolin -2.3 0.3 0.3 
P5E4 Oxacillin sodium -10, 4.7a 0 0.3 
P3A5 1,4-Naphthoquinone -6.7 -0.3 0.3 
P3A3 Diazoxide -7 0.3 0 
P3A8 Rosolic acid -7 0.3 0.3 
P6H7 Hexachlorophen -9 -0.3 0.7 
P6H6 Haloperidol -11.3 -1.7 -0.3 
P6G6 Gallamine -13.7 0 -3.7 
Table 3.2: Melting temperatures of 34 hit compounds when in 100 mM and 5 mM NaCl, 
10 mM sodium cacodylate buffers at pH 5.5. a A bimodal melting curve was observed so 
both Tm’s were recorded. Error = ± 0.3°C. 
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3.2.5 Results 
 
As the compounds had initially been screened at a relatively high ligand concentration 
in order to give the best chance of seeing an effect, a minimum change in melting 
temperature criteria of ±5 °C was set in order to narrow down the hits to ones with a 
significant effect. This reduced the initial 34 hits to 13 lead compounds (figure 3.4). 
Here it can be seen that some of the compounds are only stabilising in 5 mM sodium 
chloride buffer, while others are highly stabilising in both salt concentrations. The 
structures of the hits are shown in figure 3.5, there are a variety of different structure 
types with a range of different sizes and properties.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: Comparison of the ΔTm’s of the 13 hit compounds in both 100 mM and 5 mM 
sodium chloride buffer. DNA = 200 nM hTeloC, buffer = 10 mM sodium cacodylate and 
100 mM or 5 mM NaCl at pH5.5. 
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Figure 3.5: Structures of the 13 lead hit compounds.* Tyrothricin is a peptide mixture. 
 
It should be noted that hit tyrothricin, is actually a mixture of two different classes of 
peptides called gramicidins and tyrocidines. The gramicidins are linear and make up 
approximately 37% of the mixture while the tyrocidines are cyclic and make up 62% 
of the mixture.162 Gramicidin was tested separately as part of the screen and did not 
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come out as a hit so it is likely that the resultant stabilisation of the i-motif is due to the 
tyrocidine component but tyrothricin will continue to be tested as a mixture here for 
the purposes of hit validation. 
 
3.3 Dose Response Studies 
 
3.3.1 Dose response versus telomeric i-motif with 100 mM NaCl 
 
To investigate the stabilisation potential of the hit compounds further, a range of 
concentrations between 0 and 100 µM were tested for each potential ligand (figure 3.7 
– 3.12 and appendix section A.1). Care had to be taken in interpreting the raw data as 
the different concentrations are prepared in buffer via serial dilution from stock 
solutions in DMSO and hence each concentration has a different percentage DMSO 
content. Therefore analogous dose response studies of just DMSO in buffer were 
carried out and the change in melting temperature for each ligand at each 
concentration was calculated in reference to the respective DMSO control (table 3.3). 
An example DMSO dose response showing the destabilising effect of DMSO is shown in 
figure 3.6. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6: Example FRET melting curves for human telomeric i-motif with increasing 
percentage of DMSO. [DNA] = 200 nM hTeloC, buffer = 10 mM sodium cacodylate and 
100 mM NaCl at pH 5.5. 
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Hit 
ΔTm (°C) 
100 µM 80 µM 60 µM 40 µM 20 µM 10 µM 5 µM 1 µM 
Chlorhexidine 3.2 5.2 4.0 2.5 0.5 0.5 -0.2 0.2 
Cetylpyridinium 
chloride 
Tm >95 Tm >95 Tm >95 Tm >95 Tm >95 0.0 -0.2 0.2 
tyrothricin 
0.0, 
17.2a 
-0.2 0.3 0.0 -0.2 0.2 0.0 0.2 
Tamoxifen citrate 3.0 3.3 2.3 0.8 0.0 0.0 -0.2 0.2 
Hexetidine 0.5 0.2 0.7 0.5 -0.3 0.0 -0.2 0.2 
Bromocriptine 
mesylate 
0.5 -0.3 0.0 0.3 -0.2 0.2 0.0 -0.2 
Alexidine 
hydrochloride 
31.7 27.3 22.0 18.0 3.0 1.5 -0.2 -0.2 
Pararosaniline 
pamoate 
0.5 0.2 0.5 0.2 -0.2 -0.2 0.0 -0.2 
Methylbenzethonium 
chloride 
35.8 
-1.7, 
18.8a 
-0.8, 
17.3a 
0.2, 
15.0a 
0.2, 
14.0a 
0.2 0.0 -0.2 
Mitoxantrone 
hydrochloride 
31.0 30.0 27.2 21.2 12.5 0.5 -0.3 -0.2 
Benzalkonium 
chloride 
-1.0, 
18.3a 
-1.2, 
17.3a 
-0.3, 
18.0a 
0.2, 
15.2a 
0.3 0.3 -0.2 0.0 
Tilorone 1.0 0.7 1.0 0.5 0.5 0.3 -0.2 0.0 
Aiodarone 
hydrochloride 
3.2 1.5 0.3 0.7 -0.2 0.2 0.0 -0.2 
Table 3.3: Average change in melting temperature with change in concentration of hit 
compounds. a A bimodal melting curve was observed so both melting temperatures were 
recorded. Error = ± 0.3°C. 
 
Example FRET melting curves for compounds with the most significant effects are 
shown in figure 3.7 to 3.12. Example FRET melting curves for the remaining 
compounds are shown in the appendix (section A.1). Hexetidine (P4E9) and 
Aiodarone hydrochloride (P12B3) showed no significant change in melting 
temperature at any concentration and had little effect at 5 mM salt concentration so 
they were no longer considered as hits and were discounted from further experiments. 
However, chlorhexidine (P1A3), tamoxifen citrate (P4B6), bromocriptine 
mesylate (P7D5), pararosanilone pamoate (P9F11) and tilorone (P11H11), which 
also did not show significant stabilisation, were taken forward due to their high 
stabilisation in 5 mM salt conditions. 
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Figure 3.7: Example FRET melting curves for human telomeric i-motif with increasing 
concentration of cetylpyridinium chloride. [DNA] = 200 nM hTeloC, buffer = 10 mM 
sodium cacodylate and 100 mM NaCl at pH 5.5. 
 
The results for cetylpyridinium chloride (figure 3.7) show that at concentrations 
above 10 µM, the DNA does not melt within the temperature range of the experiment 
as the fluorescence signal stays at a minimum from 25 to 90°C, only starting to increase 
slightly at 95°C. This may mean that the ligand has a highly stabilising affect on the i-
motif and that if the experiment could continue to higher temperatures, a normal 
melting transition would be observed. Alternatively the very low fluorescence signal 
may be as a result of precipitation of the sample as discussed in chapter 2. This makes 
it very difficult to measure a melting temperature and it is not possible to determine 
which of these two effects are being observed without using an alternative experiment 
such as circular dichroism that can give information about the actual structure of the 
DNA. For the purposes of comparing this compound to the other hits therefore, the 
melting temperature is assumed to be ≥95°C. 
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Figure 3.8: Example FRET melting curves for human telomeric i-motif with increasing 
concentration of alexidine hydrochloride. [DNA] = 200 nM hTeloC, buffer = 10 mM 
sodium cacodylate and 100 mM NaCl at pH 5.5. 
 
Unlike the previous example, alexidine hydrochloride (figure 3.8) does show small 
increases in fluorescence and it is at this point where the melting point has been 
measured. However, after these small increases, the fluorescence begins to decrease 
again and remains at a low intensity showing that the fluorophores are still in close 
proximity to one another. This suggests that the DNA may be only partially unfolding 
and then re-forming into an alternative conformation or that some ligand induced 
precipitation occurs but not until the DNA has begun to unfold. This means that the 
melting temperature determined from this data may not be an accurate representation 
of the complete melting of the DNA but instead indicates at what temperature the DNA 
is beginning to unfold. 
 
The data in figure 3.9 for mitoxantrone indicates that this is a very good example of a 
stabilising ligand which does not appear to cause any precipitation within the 
conditions of the experiment as the fluorescence still increases to high intensity levels 
close to that of the control sample in the absence of ligand (black line). The temperature 
of the transition point of the curves can clearly be seen to increase as the concentration 
of mitoxantrone increases and the gradient of the transition also appears to become 
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Figure 3.9: Example FRET melting curves for human telomeric i-motif with increasing 
concentration of mitoxantrone. [DNA] = 200 nM hTeloC, buffer = 10 mM sodium 
cacodylate and 100 mM NaCl at pH 5.5. 
 
shallower. This indicates that the DNA also melts more slowly and over a wider 
temperature range than in the absence of any ligand. The curves only show one 
transition point suggesting that only one DNA conformation is present in the sample. 
 
From these results it can be seen that cetylpyridinium chloride, alexidine 
hydrochloride and mitoxantrone are the most strongly stabilising hits as these cause 
the biggest increase in Tm with concentration of ligand (e.g. ΔTm = +50.7, +18.0 and + 
21.2°C respectively at 40 µM). However mitoxantrone is the most promising of the 
three as it gives the clearest melting transitions with no observable precipitation. The 
other two compounds may be highly stabilising but the data suggests that they may 
also cause some precipitation or change in conformation. These two compounds do not 
give a clear dose response and instead provide sudden changes in melting temperature. 
CD spectroscopy will be used in section 3.4 to examine the effect of these compounds 
on the i-motif structure in more detail.  
 
The compounds that show the next highest changes in melting temperature are 
tyrothricin (ΔTm = +17.2°C at 100 µM), methylbenzethonium chloride (ΔTm = +15°C 
at 40 µM) and benzalkonium chloride (ΔTm = +15.2°C at 40 µM). These compounds 
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are interesting as they show bimodal melting curves. Initially the fluorescence 
increases upon the first melting transition but then decreases again before the second 
melting transition. This suggests that in the presence of these compounds, there is 
more than one conformation of DNA in solution with different stabilities under the 
conditions of the experiment. The fact that the fluorescence increases and then 
decreases again before the second melt implies that one conformation of the DNA may 
be partially or completely unfolding before the sequence then refolds into a different 
structural form with a higher melting temperature stabilised by the ligands. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10: Example FRET melting curves for human telomeric i-motif with increasing 
concentration of tyrothricin. [DNA] = 200 nM hTeloC, buffer = 10 mM sodium 
cacodylate and 100 mM NaCl at pH 5.5. 
 
Tyrothricin only shows this bimodal melting curve clearly (figure 3.10) at a 
concentration of 100 µM but there is also a small fluctuation in the curve at 80 µM. At 
lower ligand concentrations there is no change in the melting curve at all suggesting 
that tyrothricin is only interacting with the i-motif to a significant extent at high 
concentrations. However, since tyrothricin is a mixture of peptides, it is likely that only 
one or a small number of the constituent peptides interacts with the i-motif and these 
will be at a much lower concentration than the mixture as a whole. Alternatively, the 
constituent peptides may each have a number of weak interactions that accumulate to 
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give the observed effect at higher concentrations. The first melting transition is almost 
the same as the i-motif in the absence of the ligand, suggesting that this transition is for 
the i-motif structure, whereas the second transition is for an alternative structure with 
a higher melting temperature that is stabilised by or forms as a result of the peptide 
binding. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11: Example FRET melting curves for human telomeric i-motif with increasing 
concentration of methylbenzethonium chloride. [DNA] = 200 nM hTeloC, buffer = 10 
mM sodium cacodylate and 100 mM NaCl at pH 5.5. 
 
Methylbenzethonium chloride (figure 3.11) and benzalkonium chloride (figure 
3.12) show very similar effects to tyrothricin (figure 3.10) but the changes in the 
melting curves begin at a lower ligand concentration (40 µM). Again the first melting 
transition occurs at almost the same temperature as the i-motif alone and implies that 
this melting event is that of the i-motif structure without any stabilising effect from the 
ligand and that it is the second melting point that represents an alternative 
conformation. Interestingly, in both examples, the change in fluorescence for the first 
transition is reduced at higher concentrations to the point that at 80 to 100 µM there 
is almost no observable melting transition at all. This implies that the two structures 
may be in equilibrium and that increasing concentrations of ligand shift the 
equilibrium towards that of the alternative structure. This structure could be a 
different i-motif conformation, a partially folded structure or a hairpin. 
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Figure 3.12: Example FRET melting curves for human telomeric i-motif with increasing 
concentration of benzalkonium chloride. [DNA] = 200 nM hTeloC, buffer = 10 mM 
sodium cacodylate and 100 mM NaCl at pH 5.5. 
 
One factor that may have an effect is that methylbenzethonium chloride, 
benzalkonium chloride and cetylpyridinium chloride consist of quaternary 
ammonium cations attached to lipophilic hydrocarbon chains and hence have the 
ability to form micelles. This is where multiple compounds in a polar solution such as 
water, can group together to form a spherical structure where the lipophilic portion of 
the molecules align together in the centre of the sphere, leaving the hydrophilic part of 
the molecule on the surface where it interacts more favourably with the aqueous 
solution. These structures occur spontaneously at higher ligand concentrations as it is 
more favourable for the lipophilic groups to interact with one another, rather than the 
surrounding solution. The ligand concentration at which spontaneous micelle 
formation occurs is called the critical micelle concentration (cmc) and this can vary 
depending on the solution conditions such as buffer and salt concentration. The cmc 
for these compounds is unknown in these buffer conditions and therefore it is unclear 
whether these compounds will be forming micelles at the concentrations that are being 
tested. 
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3.3.2 Discounting the effect of citrate and pamoate counter ions. 
 
As tamoxifen and pararosaniline have been tested as citrate and pamoate salts 
respectively, it is important to ascertain that the observed stabilisation is as a result of 
the ligand rather than of the pamoic or citric acid. To do this, tamoxifen free base and 
Pararosaniline chloride were tested. As pamoic acid is an aromatic compound with 
the ability to π-stack, it is likely that it is able to bind to DNA so this was also tested 
separately (figure 3.13). From these results it can be seen that pamoic acid has no effect 
on the melting temperature of the i-motif, so the stabilisation effects observed for 
pararosaniline pamoate (P9F11) are due to the pararosaniline moiety.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13: Example FRET melting curves for human telomeric i-motif with increasing 
concentration of pamoic acid. [DNA] = 200 nM hTeloC, buffer = 10 mM sodium 
cacodylate and 5 mM NaCl at pH 5.5. 
 
For tamoxifen, in 100 mM salt conditions the free base (figure 3.14) was more 
stabilising of the i-motif than the citrate salt with a maximum average stabilisation 
potential (ΔTm) of 12.5°C compared to 3°C at a concentration of 100 µM. As tamoxifen 
citrate only contains one citrate molecule per tamoxifen, it can be assumed that 
tamoxifen is at the same concentration in both cases. This suggests that the citrate 
may have been having some effect to cause the lower magnitude of stabilisation. 
Therefore, from here on, the free base form of tamoxifen (P4B6fb) was tested rather 
than the citrate salt form. 
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Figure 3.14: Example FRET melting curves for human telomeric i-motif with increasing 
concentration of tamoxifen free base. [DNA] = 200 nM hTeloC, buffer = 10 mM sodium 
cacodylate and 100 mM NaCl at pH 5.5. 
 
3.3.3 Dose response versus telomeric i-motif with 5 mM NaCl 
 
Having narrowed down the list of hits from 13 to 11 by exclusion of hexetidine and 
aiodarone hydrochloride, dose response studies were also carried out against the 
human telomeric i-motif in 5 mM salt conditions for comparison (table 3.4). Although 
11 hits are under consideration, only 9 hits were tested as the structures of some of the 
compounds are so similar that it was assumed they would have similar effects. In 
Particular chlorhexidine and alexidine hydrochloride are both bisbiguanides. While 
cetylpyridinium chloride and benzalkonium chloride are both quaternary amine 
compounds with an aromatic head and a long aliphatic tail. Hence only alexidine 
hydrochloride and cetylpyridinium chloride were tested. 
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Table 3.4: Change in melting temperature with change in concentration of hit 
compounds.a A bimodal melting curve was observed so both melting temperatures were 
recorded. Error = ± 0.3°C. 
 
As was seen in section 3.2.5, most of the compounds are more stabilising in the 5 mM 
NaCl buffer compared to the 100 mM NaCl buffer. Pararosaniline and bromocriptine 
only give a small stabilisation at higher concentrations however tilorone, which had 
no significant stabilising effect in 100 mM salt conditions, is significantly more 
stabilising. This suggests that tilorone binds through more electrostatic interactions 
as a high cation concentration would reduce this effect. Methylbenzethonium 
chloride still gave rise to a bimodal melting curve but at a lower concentration than 
previously (10 µM). While tyrothricin only showed a very small change in 
fluorescence before the melting transition at 20 µM. This suggests that the alternative 
DNA conformations that these compounds may be stabilising are even more favoured 
under these conditions. 
 
 
 
Hit 
ΔTm (°C) 
100 µM 80 µM 60 µM 40 µM 20 µM 10 µM 5 µM 1 µM 
Cetylpyridinium 
chloride 
47.7 47.7 47.7 44 47.7 47.7 -0.3 0.0 
Tyrothricin Tm >95 Tm >95 Tm >95 40.7 18.7 0.0 0.0 0.0 
Tamoxifen free base 17.0 15.8 13.5 10.5 2.7 0.3 0.2 0.2 
Bromocriptine 
mesylate 
6.7 6.0 4.7 0.3 0.3 0.3 0.3 0.0 
Alexidine 
hydrochloride 
Tm >95 Tm >95 Tm >95 Tm >95 Tm >95 Tm >95 3.7 0.0 
Pararosaniline 
chloride 
4.7 4.0 4.0 4.7 0.3 0.0 0.3 0.3 
Methylbenzethonium 
chloride 
Tm >95 Tm >95 Tm >95 Tm >95 16.7 
-0.7 
14.0a 
-0.3 -0.3 
Mitoxantrone Tm >95 Tm >95 Tm >95 Tm >95 Tm >95 45.3 44.3 -1.3 
Tilorone Tm >95 Tm >95 Tm >95 Tm >95 -1.7 -0.7 
0.3, 
4.3a 
0.0 
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3.4 Effect of Hits on i-Motif Structure: Circular Dichroism 
 
In order to see what effect the hit compounds were having on the i-motif structure, 
circular dichroism was used. As discussed in chapters 1 and 2, circular dichroism is a 
very useful tool for looking at structural changes in DNA as different structures give 
characteristically different spectra.102 The human telomeric i-motif was tested at a 
concentration of 10 µM with increasing number of equivalents of ligand, up to 20 
equivalents (figure 3.15 – 3.23). However, if precipitation occurred before 20 
equivalents, further aliquots of ligand were not added. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.15: Example CD titration of human telomeric i-motif with increasing 
concentration of cetylpyridinium chloride. [DNA] = 10 µM hTeloC, buffer = 10 mM 
sodium cacodylate and 100 mM NaCl at pH 5.5. 
 
The CD spectrum of cetylpyridinium chloride with the i-motif (figure 3.15) shows a 
decrease in signal at both 255 nm and 288 nm suggesting a decrease in the amount of 
i-motif structure present in the sample but no unfolding is observed as there is no shift 
in the peak towards 275 nm. There was no indication of precipitation from observation 
of the sample and there were no scattering effects which would be demonstrated by 
the appearance of signals above 320 nm. However, these scattering effects were not 
always observed with BisA in chapter 2 which did cause condensation and it is likely 
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that the general decrease in molar ellipticity across the spectrum is indicative of 
precipitation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.16: Example CD titration of human telomeric i-motif with increasing 
concentration of tyrothricin. [DNA] = 10 µM hTeloC, buffer = 10 mM sodium cacodylate 
and 100 mM NaCl at pH 5.5. 
 
Although the CD spectrum of tyrothricin (figure 3.16) does not show such a large 
decrease in molar ellipticity as the previous example, precipitation was observed at a 
concentration of 100 µM (10 eq). The increasingly negative peak in the spectrum at 
220 nm is likely to be due to the compound itself as the tyrocidines, a major constituent 
of tyrothricin have been shown to give a negative CD signal between 210 and 220 
nm.162 
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Figure 3.17: Example CD titration of human telomeric i-motif with increasing 
concentration of tamoxifen. [DNA] = 10 µM hTeloC, buffer = 10 mM sodium cacodylate 
and 100 mM NaCl at pH 5.5. 
 
The CD spectrum of tamoxifen (figure 3.17) with the i-motif gives a very similar 
spectrum to tyrothricin with a decrease in molar ellipticity at 255 and 288 nm. In this 
case however, tamoxifen is not chiral and there is no peak forming at 220 nm. As with 
tyrothricin, precipitation could be observed by eye at higher concentrations and this 
may be represented in the CD spectrum by the small decrease in molar ellipticity. This 
suggests that tamoxifen does not have a significant effect on the i-motif structure up 
to 10 equivalents. 
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Figure 3.18: Example CD titration of human telomeric i-motif with increasing 
concentration of bromocriptine mesylate. [DNA] = 10 µM hTeloC, buffer = 10 mM 
sodium cacodylate and 100 mM NaCl at pH 5.5. 
 
The CD titration of hTeloC with bromocriptine mesylate (figure 3.18) showed very 
little change up to 10 equivalents (100 µM) but began to show precipitation at this 
point which can be seen by the presence of a signal at 380 to 400 nm. A DNA sample 
should not give any signal in this region and this signal is a result of scattering effects. 
Higher concentrations of bromocriptine were not tested as precipitation had already 
occurred. The fact that the compound does not change the signal at 288 nm suggests 
that it may not be binding to the i-motif at all under these conditions or that if it does 
so, then there is no perturbation of the structure to alter its conformation. In earlier 
FRET melting experiments (Table 3.2 and 3.3) bromocriptine had little to no effect in 
buffer conditions containing 100 mM NaCl but did cause a base line fluorescence signal 
in 5 mM NaCl conditions. This suggests that the higher salt concentration may prevent 
any potential binding. 
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Figure 3.19: Example CD titration of human telomeric i-motif with increasing 
concentration of alexidine hydrochloride. [DNA] = 10 µM hTeloC, buffer = 10 mM 
sodium cacodylate and 100 mM NaCl at pH 5.5. 
 
In figure 3.19, the CD spectrum shows significant changes upon addition of alexidine 
hydrochloride with not only a decrease in molar ellipticity but a shift in the peak 
towards 300 nm. This is similar to the CD spectra observed for the condensation effects 
of BisA in chapter 2 (figure 2.15) and was accompanied by visible precipitation. It may 
well be the case that for compounds such as bromocriptine, tamoxifen and 
tyrothricin, for which precipitation was observed but there is little change in the CD 
spectrum, the observed precipitation is merely the ligand itself precipitating from the 
buffer solution. Whereas, in the case of alexidine hydrochloride or other compounds 
where the precipitation is accompanied by dramatic changes in the CD spectrum, this 
suggests that the compound does alter the conformation of the DNA and the observed 
precipitate may be the complex of the DNA and ligand. 
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Figure 3.20: Example CD titration of human telomeric i-motif with increasing 
concentration of pararosaniline. [DNA] = 10 µM hTeloC, buffer = 10 mM sodium 
cacodylate and 100 mM NaCl at pH 5.5. 
 
Figure 3.20 shows a slight decrease in signal at 288 nm that is most likely a result of 
dilution and is not significant. This indicates that if pararosaniline is binding to the i-
motif, it does not have any effect on the structural conformation that is significant 
enough to be observed by CD. This implies that pararosaniline may not bind to the i-
motif at all or if it does, that it is through an electrostatic or stacking interaction on the 
outside of the structure. Any binding within the loops, grooves or the core of the i-motif 
is likely to cause at least a small disturbance to the structure. Like bromocriptine in 
figure 3.18, pararosaniline only showed significant effects in FRET experiments in 
buffer containing 5 mM NaCl. Therefore the combined FRET and CD experiments 
suggest that the higher salt concentrations are inhibiting any possible binding 
interactions from taking place. 
 
 
 
 
 
 
 
220 240 260 280 300 320
-6
-4
-2
0
2
4
6
8
10
M
o
la
r 
E
ll
ip
ti
ci
ty
 (
×
 1
0
5
 d
e
g
.c
m
2
.d
m
o
l-
1
)
Wavelength (nm)
 10 M hTeloC pH 5.5
 1 eq P9F11
 5 eq P9F11
 10 eq P9F11
 15 eq P9F11
 20 eq P9F11
Chapter 3: Identification of i-Motif Binding Compounds Using a FRET Melting Based 
Screen 
 
 
 131 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.21: Example CD titration of human telomeric i-motif with increasing 
concentration of methylbenzethonium chloride. [DNA] = 10 µM hTeloC, buffer = 10 
mM sodium cacodylate and 100 mM NaCl at pH 5.5. 
 
The CD spectrum of methylbenzethonium chloride with the i-motif (figure 3.21) is 
very similar to that of cetylpyridinium chloride which is perhaps unsurprising as 
they share some similarities in their structures and both contain quaternary 
ammonium cation centres. This common functionality may be key to the compounds 
interaction with the i-motif and like cetylpyridinium chloride (figure 3.15) no 
precipitation was observed despite a decrease in molar ellipticity that suggests there 
is less i-motif structure present in solution. As both these compounds are able to form 
micelles, it may be the case that under the conditions of the experiment, micelles are 
being formed which interact with the i-motif instead of the individual compound. 
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Figure 3.22: Example CD titration of human telomeric i-motif with increasing 
concentration of mitoxantrone. [DNA] = 10 µM hTeloC, buffer = 10 mM sodium 
cacodylate and 100 mM NaCl at pH 5.5. 
 
Although mitoxantrone did not appear to cause any precipitation in FRET melting 
studies, at the higher concentrations used for CD spectroscopy, precipitation was 
observed at 10 and 15 equivalents (figure 3.22). This was observable by the naked eye 
and is apparent in the CD spectrum where the signal at 288 nm decreases and shifts 
towards 300 nm. Like figure 3.18 for alexidine hydrochloride this indicates that 
mitoxantrone is binding to the i-motif and forming a complex which may have a 
different structure upon condensation and precipitation. There are also significant 
changes in the spectrum between 220 and 280 nm which may be as a result of 
scattering or due to structural changes. Mitoxantrone is still a promising compound 
to investigate however as it does not cause precipitation at lower concentrations (50 
µM). 
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Figure 3.23: Example CD titration of human telomeric i-motif with increasing 
concentration of tilorone. [DNA] = 10 µM hTeloC, buffer = 10 mM sodium cacodylate 
and 100 mM NaCl at pH 5.5. 
 
Finally the CD titration of tilorone with the i-motif (figure 3.23) does not show a 
significant decrease in the signal at 288 nm and no precipitation was observed. In fact 
there is an increase in signal at 270 nm showing the formation of an ICD with increasing 
concentration of tilorone. This indicates binding and can be used to measure a binding 
affinity. 
 
By fitting the change in molar ellipticity with increasing concentration of ligand, a 
binding affinity can be measured. The change in molar ellipticity at 270 nm was 
normalised, which transforms the data so that the lowest point is equal to zero and the 
highest is equal to one, this gives a measure of the fraction of ligand bound to the DNA. 
The data was then fitted with both 1 to 1 and 2 to 1 binding models (equation 3.1 and 
3.2). The two models gave very similar fits (figure 3.24) resulting in similar Kd’s for the 
first binding site (table 3.5) but the 2 to 1 model with a very weak affinity for the second 
binding site gave a slightly better fit. 
 
 
Equation 3.1: 𝜃 =
𝐾𝑎[𝐿𝑖𝑔𝑎𝑛𝑑]
1+𝐾𝑎[𝐿𝑖𝑔𝑎𝑛𝑑]
    1 to 1 binding model 
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Equation 3.2: 𝜃 =
𝐾1[𝐿𝑖𝑔𝑎𝑛𝑑]+2𝐾1𝐾2[𝐿𝑖𝑔𝑎𝑛𝑑]
2
1+𝐾1[𝐿𝑖𝑔𝑎𝑛𝑑]+𝐾1𝐾2[𝐿𝑖𝑔𝑎𝑛𝑑]2
 2 to 1 binding model 
 
Where Ka is the association constant, K1 and K2 are association constants for binding 
site 1 and 2 respectively. Kd is the reciprocal of Ka. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.24: Normalised average change in CD at 270 nm for tilorone with human 
telomeric i-motif, fitted with 1 to1 and 2 to 1 binding models. Error bars show the 
standard deviation across 2 repeats. [DNA] = 10 µM hTeloC, buffer = 10 mM sodium 
cacodylate and 100 mM NaCl at pH 5.5. 
 
Binding affinity (µM) 
1 to 1 Kd  14 ± 10 
2 to 1 
Kd1  17 ± 10 
Kd2 1478 ± 2077 
 
Table 3.5: Binding affinities of tilorone for telomeric i-motif from CD titrations. The 
error given is the maximum difference between the average and individual data. 
 
These results indicate that tilorone has a moderately strong affinity for the i-motif 
with dissociation constants (Kd) measured in the low micromolar range. Whilst the 2 
to 1 binding model may give a marginally better fit, the very high dissociation constant 
for the second binding site and the similarity of the Kd for the first binding site to the 
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one given by the 1 to 1 model suggests that there is only one significant binding site for 
tilorone with the human telomeric i-motif. This binding affinity is comparable to those 
identified for other existing i-motif ligands such as the terbium complexes discussed in 
section 1.5.4 (Kd = 22 µM and 30 µM) but is not as strong as the affinity tilorone has 
for double stranded DNA (1.05 µM for poly(dA-dT)), though this was measured under 
different conditions.163 As tilorone has not been shown to bind to the i-motif before 
this does still suggest that it is a good starting structure to develop analogues from. 
 
3.5 Variation in stabilisation potential 
 
After excluding alexidine hydrochloride for its precipitation effects as well as 
cetylpyridinium chloride and methylbenzethonium chloride, which may be 
forming micelles, the six remaining compounds were taken forward for further study. 
Dose response studies were carried out to assess whether there was any degree of 
selectivity in the hits stabilising effect compared to other DNA structures.  The dose 
response experiments were repeated with 3 different structures. Firstly the c-Myc i-
motif, as described in section 1.3.2, is an oncogene promoter i-motif sequence. 
Therefore this represents a different form of anticancer target to that of the telomeric 
i-motif. This i-motif has a different structure to hTeloC with larger loops and the 
sequence 5'-TCCCCACCTTCCCCACCCTCCCCACCCTCCCCA-3'. Secondly, the hits were 
tested against the human telomeric G-quadruplex sequence. This is the complementary 
strand to the i-motif forming the very different G-quadruplex structure. As discussed 
in section 1.1, telomeric G-quadruplexes have been shown to inhibit telomerase and 
being complimentary to the i-motif, it is not yet clear what the dynamics between the 
two structures are. The telomeric G-quadruplex sequence is 5'-
GGGTTAGGGTTAGGGTTAGGG-3'. Finally, the hits were tested against a double 
stranded sequence 5'-TATAGCTATA-HEG(18)-TATAGCTATA-3'. This sequence was 
chosen because it has been used previously in the literature by a variety of groups in 
comparison to the G-quadruplex.164,165 Ideally the hit compounds would have some 
degree of selectivity for the i-motif structure over other types of secondary structure 
and may also be selective between different types of i-motif.  
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In figure 3.25 to 3.30 the change in melting temperature with increasing concentration 
is plotted for each of the 6 potential ligands. This is to see whether there is any variation 
in the ability of the ligands to stabilise the different DNA structures at different 
concentrations. However, care should be taken when comparing the maximum change 
in melting temperatures that are reached at higher ligand concentrations as double 
stranded DNA has a higher melting point than either the i-motif or the G-quadruplex 
under these conditions. This means there is a narrower range of temperature between 
the melting point and the maximum scale of the experiment of 95°C so only a lower 
maximum ΔTm is possible (~ 30°C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.25: Change in melting temperature with increasing concentration of 
tyrothricin with human telomeric i-motif (hTeloC), c-Myc i-motif, human telomeric G-
quadruplex (hTeloG) and duplex DNA. Error bars show the standard deviation across 2 
repeats. DNA = 200 nM, buffer = 10 mM sodium cacodylate and 100 mM or 5 mM NaCl. 
Two points are shown where biphasic melting curves were observed. 
 
The combined FRET melting results for tyrothricin (figure 3.25) show that in 100 mM 
salt conditions, this cyclic peptide is not strongly stabilising of the telomeric i-motif 
except at a concentration of 100 µM where a biphasic melting curve was observed, 
hence there are two data points on the graph. Conversely in 5 mM salt conditions, 
tyrothricin is highly stabilising, reaching maximum possible stabilisation potentials 
just above 40 µM. What is interesting is that for the c-Myc i-motif, there was very little 
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difference in stabilisation under the two salt conditions with the structure being highly 
stabilised under both conditions. This suggests that the interaction with the telomeric 
i-motif is perhaps more electrostatic because a higher salt concentration will disfavor 
this. Whereas the interaction with c-Myc may be less electrostatic with the larger loop 
sequences allowing easier access for π-π stacking between loop bases and aromatic 
residues in tyrothricin peptides. These results also indicate that tyrothricin is highly 
stabilising of the G-quadruplex and duplex DNA reaching maximum stabilisation 
potentials at higher concentrations (>80 µM). However, there is some degree of 
preference at concentrations of 20 µM, where tyrothricin is around 20 degrees more 
stabilising of i-motif and G-quadruplex sequences than of duplex. While at 40 µM, 
tyrothricin is a further 25 degrees more stabilising of the i-motif than of the G-
quadruplex. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.26: Change in melting temperature with increasing concentration of 
mitoxantrone with human telomeric i-motif (hTeloC), c-Myc i-motif, human telomeric 
G-quadruplex (hTeloG) and duplex DNA. Error bars show the standard deviation across 
2 repeats. DNA = 200 nM, buffer = 10 mM sodium cacodylate and 100 mM or 5 mM NaCl. 
 
The results for mitoxantrone (figure 3.26) again show that the compound is 
stabilising of all the DNA structures tested. This is not surprising however, as it is 
known to bind to duplex DNA as part of its inhibition of topoisomerase II166 and its flat 
planar  structure is similar to many other G-quadruplex ligands.89 The data suggests 
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that even at higher concentrations, mitoxantrone is more stabilising of hTeloC i-motif 
in 5 mM salt conditions compared to 100 mM salt conditions but is highly stabilising of 
c-Myc i-motif under both conditions. Again this may be as a result of the larger loops 
enabling better access for the compound to interact with the bases in the structure. 
Some degree of preference can be observed at low concentrations up to 5 µM where 
mitoxantrone stabilises c-Myc and hTeloC i-motifs in 5 mM salt conditions far more 
than the other structures. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.27: Change in melting temperature with increasing concentration of tilorone 
with human telomeric i-motif (hTeloC), c-Myc i-motif, human telomeric G-quadruplex 
(hTeloG) and duplex DNA. Error bars show the standard deviation across 2 repeats. 
DNA = 200 nM, buffer = 10 mM sodium cacodylate and 100 mM or 5 mM NaCl. Two 
points are shown where biphasic melting curves were observed. 
 
Although tilorone is known to bind to duplex DNA, only a small stabilisation of duplex 
DNA was observed (figure 3.27). The sequence used in this study is A-T rich and 
tilorone has a preference for A-T rich DNA,163 therefore, the compound is likely to still 
be binding to the DNA but without affecting the melting temperature significantly. In 
these results, it can be seen that tilorone has very little effect on either the telomeric 
or c-Myc i-motif structures in buffer containing 100 mM NaCl but is much more highly 
stabilising in buffer containing 5 mM NaCl. Tilorone does show some stabilisation of 
the c-Myc i-motif in 100 mM NaCl at 100 µM where biphasic melting curves were 
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observed but this is still not of the same magnitude as the stabilisation in 5 mM NaCl. 
Pleasingly, despite tilorone’s planar structure, the compound does not stabilise the G-
quadruplex to the same extent as the i-motif however this may again be due to the 
higher salt concentration. It is apparent from these results that tilorone is more 
stabilising of the i-motif than other structures at concentrations of 20 to 40 µM making 
it a worthwhile lead to follow, even if it is assumed the interaction is more electrostatic 
in nature. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.28: Change in melting temperature with increasing concentration of 
tamoxifen with human telomeric i-motif (hTeloC), c-Myc i-motif, human telomeric G-
quadruplex (hTeloG) and duplex DNA. Error bars show the standard deviation across 2 
repeats. DNA = 200 nM, buffer = 10 mM sodium cacodylate and 100 mM or 5 mM NaCl. 
 
Tamoxifen does not stabilise the i-motif to the same extent as the previous three 
compounds discussed (figure 3.28), however what is pleasing is that it shows no 
stabilisation of duplex DNA and even shows a small destabilisation of the G-quadruplex 
though this is likely to be within error of the experiment. Also, the observed 
stabilisation of the i-motif is less affected by the difference in salt concentration 
compared to some of the other hits. The reason for this specificity is most likely due to 
the three dimensional structure of tamoxifen. Although the structure of tamoxifen 
consists of three phenyl rings around a carbon-carbon double bond, the structure as a 
whole is not planar with a large extended π-system.167 This means it is less likely to 
stack on top of the G-quadruplex and is too large to be able to intercalate into duplex 
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DNA. However, the smaller phenyl rings are probably more able to slot into the loops 
of the i-motif to pick up π-stacking interactions with the loop bases. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.29: Change in melting temperature with increasing concentration of 
bromocriptine mesylate with human telomeric i-motif (hTeloC), c-Myc i-motif, human 
telomeric G-quadruplex (hTeloG) and duplex DNA. Error bars show the standard 
deviation across 2 repeats. DNA = 200 nM, buffer = 10 mM sodium cacodylate and 100 
mM or 5 mM NaCl. 
 
Bromocriptine mesylate shows only small stabilisation of the telomeric i-motif (6.7°C 
at 100 µM) in buffer containing 5 mM NaCl (figure 3.29). The compound shows almost 
no stabilisation of the other DNA structures with only a very weak stabilisation of 1.7°C 
for the c-Myc i-motif in 100 mM NaCl conditions. This suggests that bromocriptine 
does not interact strongly with the i-motif and most likely does so with a non-specific 
electrostatic interaction. This is why it shows much smaller effects in higher salt 
conditions as a higher concentration of sodium ions will disrupt the possible 
electrostatic interaction with the positive bromocriptine molecule and reduce its 
ability to bind to the DNA. 
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Figure 3.30: Change in melting temperature with increasing concentration of 
pararosaniline with human telomeric i-motif (hTeloC), c-Myc i-motif, human telomeric 
G-quadruplex (hTeloG) and duplex DNA. Error bars show the standard deviation across 
2 repeats. DNA = 200 nM, buffer = 10 mM sodium cacodylate and 100 mM or 5 mM NaCl. 
 
The results for pararosaniline (figure 3.30) show that it provides only a small 
stabilisation of the i-motif in low salt concentration buffer and gives a higher degree of 
stabilisation to the G-quadruplex. Although this is also still lower than other 
compounds such as mitoxantrone, tilorone and tyrothricin. In some ways this is 
surprising because pararosaniline has a very similar structure to crystal violet 
(figure 1.21) which is a known i-motif binding compound (Kd = 0.8 – 1.4 µM).125,127 
However the stabilisation potential of crystal violet was not assessed so, like 
pararosaniline, it may not stabilise the i-motif to a large extent. Equally, 
pararosaniline may still have a good binding affinity for the i-motif despite not 
causing a large increase in stability. This highlights a drawback to screening for i-motif 
ligands based on their ability to stabilise the structure as some compounds which bind 
to the i-motif but do not affect its stability may be overlooked.  
 
Unfortunately it is clear from these results that the most stabilising compounds 
tyrothricin, mitoxantrone and tilorone also seem to stabilise G-quadruplex and 
double stranded DNA. This isn’t particularly surprising from looking at their structures 
and as discussed, some of these compounds are already known to bind to double 
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stranded DNA. However, each of these three ligands do appear to impart a greater 
stabilisation on the i-motif than other structures at lower concentrations. The other 
compounds tamoxifen, bromocriptine and pararosaniline do not stabilise G-
quadruplex or double stranded DNA to the same extent but these compounds are also 
less strongly stabilising of the i-motif. From these results, mitoxantrone is the most 
promising ligand in terms of stabilisation potential as it imparts the greatest increase 
in melting temperature with concentration of ligand compared to the others. Tilorone 
and tamoxifen show the greatest degree of selectivity for the i-motif over G-
quadruplex and duplex, particularly tamoxifen, which does not stabilise duplex or G-
quadruplex at all. Pararosaniline and bromocriptine are the least stabilising of the 6 
ligands. The fact that bromocriptine only increases the melting temperature of the i-
motif in low salt conditions suggests that it interacts via a non-specific electrostatic 
interaction. However, the comparison of pararosaniline with crystal violet highlights 
that compounds may still bind to the i-motif even if they do not stabilise the structure 
and therefore these compounds will still be included in experiments to measure 
binding affinity. 
 
3.6 Measuring the Binding Affinity 
 
Having narrowed down the initial list of 34 compounds, which showed some effect on 
the melting temperature of the i-motif, to 6 lead compounds the next step in the 
investigation was to measure a binding affinity of the ligands for the i-motif. This can 
be done using a range of different methods as discussed in section 1.4, such as UV/Vis 
absorbance spectroscopy, fluorescence emission spectroscopy and surface plasmon 
resonance. Earlier in this chapter (section 3.4) the binding affinity of tilorone for the 
telomeric i-motif was measured using circular dichroism (figure 3.24). This gave a Kd 
of 14 µM, assuming a 1:1 binding model. In both UV and fluorescence titrations, the 
absorbance or emission of the compound is observed as increasing concentrations of 
DNA are added and the change in the spectrum is monitored. UV titrations generally 
only work well if the compound itself absorbs in a different part of the spectrum to the 
DNA, which absorbs in a range with a maximum around 260 nm. Otherwise it is difficult 
to deconvolute which changes are a result of binding and which are simply an increase 
in concentration of the UV active components. Fluorescence titrations do not have this 
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drawback because if it is unlabelled, the DNA is not fluorescent. However this does rely 
on the ligand having some degree of fluorescence. Surface plasmon resonance does not 
have these constraints as this experiment measures the effect of a binding event on the 
plasmons within a gold surface and therefore does not depend on any spectroscopic 
properties of either the target structure or the binding molecule. 
 
3.7 Surface Plasmon Resonance Studies on Tilorone and 
Mitoxantrone 
 
Having been unable to measure a binding constant for the hits by fluorescence 
emission or UV absorption titrations, surface plasmon resonance (SPR) was used to 
measure their binding affinities. This is a highly sensitive technique as described in 
section 1.4.5 that measures binding interactions of compounds with a target that is 
immobilised on the surface of a gold chip. A binding event results in a change of 
refractive index above the chip surface which affects the resonance of surface plasmons 
in the gold chip and is therefore measured as a binding response. Importantly, this 
means that the measurement of a binding response does not rely on any spectroscopic 
property of the target or the compound being tested. 
 
3.7.1  Preparation of the chip 
 
The chip used was a streptavidin coated sensor chip purchased from GE Healthcare. 
This chip was chosen because  biotinylated DNA can then be easily attached to the chip 
surface due to the extremely high affinity of biotin for streptavidin (Kd ~0.01 pM).168 
The chip surface is divided into four separate flow cells which are in series with one 
another, this enables the simultaneous testing of ligands against up to 3 different DNA 
targets. The first cell was left blank as a control to account for any non-specific binding 
to the chip surface. In this experiment, the human telomeric i-motif sequence (5'-
Biotin-d(TAACCCTAACCCTAACCCTAACCC)-3') was immobilised on flow cell 2 and the 
c-Myc oncogene promoter i-motif sequence (5'-Biotin-
d(CCTTCCCCACCCTCCCCACCCTCCCCA)-3') on flow cell 3 in order to compare the 
affinity of the hits for these two different i-motif structures. Finally, to look for 
specificity for i-motif over double stranded DNA a 22 base pair duplex sequence (5'-
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Biotin-d(GGCATAGTGCGTGGGCGTTAGC)-3' with its complement 5'-
d(GCTAACGCCCACGCACTATGCC)-3') was immobilised on flow cell 4, leaving flow cell 
1 blank as a control. 
 
3.7.2  Initial binding response tests 
 
Having prepared the chip surface, each compound was first tested at a concentration 
of 10 µM to see whether there was a binding response.  
 
a)                                                                                 b) 
 
 
 
 
 
 
 
Figure 3.31: Sensorgrams of initial binding response tests for a) mitoxantrone and b) 
tilorone with human telomeric i-motif. The sensorgrams are normalised with respect to 
a blank cell containing no DNA. Running buffer = 10 mM sodium cacodylate, 100 mM 
NaCl and 0.05% tween 20 at pH 5.5. 
 
Mitoxantrone (figure 3.31a) gave the clearest binding response. The response shows 
a sharp increase with a steep gradient after the ligand is injected which indicates a fast 
association rate (ka). The response levels off showing that equilibrium is reached and, 
after continuous flow of running buffer, the response decreases as the compound 
dissociates. The shallower gradient indicates a slower dissociation rate (kd) than the 
association. This is good because it indicates that the compound binds strongly as it 
does not become unbound as quickly. Tilorone (figure 3.31 b) gave a much lower 
magnitude binding response suggesting it has a weaker affinity for the i-motif. The 
response curve showed a sharp increase in the association phase and a sharp decrease 
in the dissociation phase indicating that the compound has fast association and 
dissociation rates. 
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a)                                                                                b) 
 
 
 
 
 
 
 
Figure 3.32: Sensorgrams of initial binding response tests for a) bromocriptine and b) 
pararosaniline with human telomeric i-motif. The sensorgrams are normalised with 
respect to a blank cell containing no DNA. Running buffer = 10 mM sodium cacodylate, 
100 mM NaCl and 0.05% tween 20 at pH 5.5. 
 
In contrast, the compounds bromocriptine and pararosaniline both showed almost 
no response at all (figure 3.32). This suggests that they do not bind to the i-motif with 
any significant degree of affinity. These compounds also showed very limited ability to 
stabilise the i-motif structure. The SPR studies were carried out in buffer containing 
100 mM NaCl so it may be that the compounds would show a greater binding response 
in the low salt conditions but this is likely to be a more non-specific electrostatic 
interaction. Because of this, these two compounds were not taken forward to try and 
measure their low binding affinities. 
 
a)         b) 
                                                                                  
 
 
 
 
 
 
Figure 3.33: Sensorgrams of initial binding response tests for a) tyrothricin and b) 
tamoxifen with human telomeric i-motif. The sensorgrams are normalised with respect 
to a blank cell containing no DNA. Running buffer = 10 mM sodium cacodylate, 100 mM 
NaCl and 0.05% tween 20 at pH 5.5. 
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Finally the compounds tyrothricin and tamoxifen showed some unusual and 
anomalous sensorgrams (figure 3.33). These effects are due to the DMSO content of the 
sample because of the low solubility of the compounds. DMSO is a more dense solvent 
than water and introduction of DMSO into the system creates a large bulk refractive 
index change when it moves across the surface of the chip, this is not an effect of DMSO 
binding to the chip or the DNA, but a change in the composition of the buffer mixture 
which results in an anomalous response measurement and it is not possible to clearly 
measure the binding response of the compounds. This can be accounted for by using 
DMSO in the running buffer and performing a solvent correction to calibrate the 
instrument to the presence of DMSO, however, no more than 10% DMSO can be used 
in the running buffer due to incompatibility with the plastic seals and tubing within the 
instrument. Despite 10% DMSO being used in the initial FRET screen it was found that 
tyrothricin precipitated at a concentration of 100 µM in the SPR running buffer with 
this percentage of DMSO. Although in FRET melting studies, tamoxifen appeared to 
stabilise the i-motif more than other structures, showing a greater degree of selectivity 
than the other compounds, it still shows only a weak response in the SPR experiment. 
Therefore it was not taken forward for further analysis. 
 
From these results, mitoxantrone and tilorone have been identified as the most 
promising i-motif binding compounds with the biggest binding responses. The fact that 
they are both water soluble also enables their binding affinity to be determined 
without the need to correct for DMSO. Therefore, these compounds were taken 
forward in order to try and measure binding affinities for the i-motif by SPR titrations. 
 
3.7.3  Determining the binding affinity of mitoxantrone for i-motif by SPR. 
 
After completing the initial binding response tests discussed in section 3.7.2, a titration 
was carried out over a wider range of concentrations in order to measure an accurate 
binding affinity. A large spread of concentrations between 0 and 100 µM was used in 
order to give the best chance of reaching a plateau and of having concentrations both 
above and below the KD as this gives the most reliable determination of affinity. The 
change in response over time as the compound was injected was plotted for each 
concentration to give a sensorgram (figure 3.34). The increase in response for each 
concentration plateaus out before finally decreasing again as the compound dissociates 
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and this point represents the equilibrium point. By measuring the change in response 
at the plateau with increasing hit concentration, the data can be fitted to obtain the 
equilibrium dissociation constant (KD).104 For each concentration, two curves are 
shown. These are repeat injections from the same sample and are used to show the 
reproducibility of the sensorgram.169 The software uses both sets of data when fitting 
to find the KD with a 1 to 1 binding model (equation 3.3). An example binding curve for 
mitoxantrone with human telomeric i-motif is shown in figure 3.35. Further examples 
are given in the appendix (section A.2). The data was double referenced by subtracting 
both the response from the blank flow cell and by subtracting a series of blank 
injections that do not contain any compound. This accounts for non-specific binding to 
the chip’s surface. 
Equation 3.3:  𝑅𝑒𝑞 =
𝐾𝐴[𝑴𝒊𝒕𝒐𝒙𝒂𝒏𝒕𝒓𝒐𝒏𝒆]𝑅𝑚𝑎𝑥
1+𝐾𝐴[𝑴𝒊𝒕𝒐𝒙𝒂𝒏𝒕𝒓𝒐𝒏𝒆]𝑛
 ,   
 
Where Req is the response at equilibrium, Rmax is the response at saturation, KA is the 
association constant and [Mitoxantrone] is the concentration of the compound. n is a 
constant to factor for steric interference and is set to 1 assuming a 1 to 1 binding model. 
The equilibrium dissociation constant 𝐾𝐷 =
1
𝐾𝐴
. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.34: Example sensorgram for mitoxantrone with human telomeric i-motif. The 
sensorgrams are double referenced by subtracting the response on the blank flow cell 
containing no DNA and by subtracting blank injections of just buffer. Running buffer = 
10 mM sodium cacodylate, 100 mM NaCl and 0.05% tween 20 at pH 5.5. 
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Figure 3.35: Example SPR binding curve for mitoxantrone with human telomeric i-
motif. Running buffer = 10 mM sodium cacodylate, 100 mM NaCl and 0.05% tween 20 at 
pH 5.5. 
 
Mitoxantrone Binding Affinity 
KD (µM) 
hTeloC 11.0 ± 4.3 
c-Myc 15.0 ± 6.5 
Duplex 19.8 ±3.0 
 
Table 3.6: Average binding affinities from 1:1 affinity fit. The error given is the 
maximum difference between the average and individual data. 
 
These results (table 3.6) show that mitoxantrone has a moderately strong affinity for 
the i-motif with dissociation constants in the low micromolar (KD = 11 and 15 µM for 
hTeloC and c-Myc) range and a similar though slightly better affinity for the i-motif 
structure over duplex DNA in this experiment. These affinities are of a similar 
magnitude to the affinities of existing i-motif ligands such as the phenanthrolines (4 to 
8 µM)122 and terbium complexes (22 to 30 µM).128 This offers a good starting point for 
further development of analogues with better affinity and specificity.  
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3.7.4  Determining the binding affinity of tilorone by SPR 
 
After measuring low micromolar KD’s for mitoxantrone, the binding affinity of 
tilorone was measured using the same procedure. This compound however has a 
weaker affinity for the i-motif and at the top concentrations, the sensorgrams do not 
plateau sufficiently suggesting that they have not reached equilibrium before 
dissociation occurs. An example sensorgram for the human telomeric i-motif is shown 
in figure 3.36. The result of this is that when the data is fitted, the curve does not 
plateau (figure 3.37) and this creates a greater error in the determination of the 
binding affinity as illustrated by the greater variance between the two repeats. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.36: Example sensorgram for tilorone with human telomeric i-motif. The 
sensorgrams are double referenced by subtracting the response on the blank flow cell 
containing no DNA and by subtracting blank injections of just buffer. Running buffer = 
10 mM sodium cacodylate, 100 mM NaCl and 0.05% tween 20 at pH 5.5. 
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Figure 3.37: Example binding curve for tilorone with human telomeric i-motif. Running 
buffer = 10 mM sodium cacodylate, 100 mM NaCl and 0.05% tween 20 at pH 5.5. 
 
Tilorone Binding Affinity 
KD (µM) 
hTeloC 157.9 ± 80.9 
c-Myc 862.4 ± 684.7 
Duplex 14.7 ± 4.3 
 
Table 3.7: Average binding affinities from 1:1 affinity fit. The error given is the 
maximum difference between the average and individual data. 
 
These results (table 3.7) show that tilorone has a much weaker affinity for i-motif than 
mitoxantrone (KD = 158 µM vs. 11 µM) and has a stronger preference for double 
stranded DNA (KD = 14.7 µM). This is unsurprising as tilorone is known to bind to 
double stranded DNA and the affinity that was measured in these experiments is 
actually slightly weaker than that measured previously in the literature by other 
methods (Kb = 1.05 µM for poly(dA-dT) and Kb = 7.30 µM for poly(dC-dG)).163 Despite 
this, neither tilorone nor mitoxantrone have previously been shown to bind to the i-
motif and they offer two new i-motif binding chemotypes which could be used as a 
starting point for development of analogues with improved binding to the i-motif and 
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could enable structure activity relationship studies to look at what features favour i-
motif binding. 
 
3.8 Discussion 
 
In this chapter, a library of 960 known biologically active compounds has been 
screened against the human telomeric i-motif using a FRET melting based assay. The 
initial screen identified 34 compounds which caused some change in the melting 
temperature of the DNA. This list of compounds were reduced to six lead compounds 
through a series of FRET and circular dichroism studies. These six compounds were 
tested by SPR and finally, binding affinities in the low micromolar range were 
measured for two of the compounds mitoxantrone (KD = 11 µM) and tilorone (KD = 
158 µM). Mitoxantrone is clearly the better of the two compounds in terms of affinity 
and is the primary hit from the screen. Although these two compounds are not novel 
structures themselves, they have never been identified as i-motif binding ligands 
before. Both mitoxantrone and tilorone are flat planar molecules with the ability to 
intercalate into DNA but it is this characteristic that enables them to stack on top of G-
quadruplex or i-motif structures also. In further work on this project, it may be possible 
to increase the selectivity of these compounds by adding different side chains to the 
core structure which are able to pick up more specific interactions within the loop 
region of the i-motif. The identification of two new i-motif binding ligands is of 
importance to the field of i-motif research as they provide two new structure types 
which may be used as starting points for development of novel ligands with improved 
affinity and selectivity for the structure. In the future, analogues of these ligands may 
then be used as tools to probe the potential biological functions of i-motif structures. 
 
These results have also highlighted that the FRET melting assay can be used to screen 
libraries of compounds for interaction with the i-motif. This method holds particular 
advantages for identifying compounds based on their ability to stabilise or destabilise 
the structure. The use of FRET also has advantages over UV melting for example, 
because lower concentrations of DNA and ligands are required and compounds which 
may absorb in the same UV region as DNA can still be examined. However, this study 
has highlighted several drawbacks. Some compounds may interact with the 
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fluorophores rather than the DNA or they may fluoresce themselves with the same 
excitation wavelength. For these compounds it is not possible to tell from the FRET 
assay whether they are interacting with the DNA or not. Another drawback is that for 
many compounds or for higher concentrations of most compounds, the results did not 
give sigmoidal melting curves making it difficult to accurately determine a melting 
temperature. Finally, by focusing on changes in melting temperature, this method may 
overlook compounds which bind to the i-motif but do not alter the melting 
temperature. More recently, an alternative FRET based screening method has been 
used by Laurence Hurley and co-workers to identify a compound interacting with the 
Bcl-2 i-motif.69 Their method did not look at the melting of the DNA but looked at the 
change in fluorescence at room temperature as an indication of whether the i-motif is 
favoured (low fluorescence) or disfavoured (high fluorescence). This may be a better 
screening method as it holds many of the advantages of FRET melting but does not 
overlook compounds which do not change the melting temperature. 
 
Although these compounds proved not to be selective for the i-motif, this is not a great 
surprise when screening a library of compounds with existing biological activity. For 
example mitoxantrone is a DNA intercalator used in chemotherapy for the treatment 
of a range of cancers including breast and lung cancer, melanoma, lymphoma, leukemia 
and prostate cancer. The drug’s mechanism of action is to inhibit the enzyme 
topoisomerase II.170 The function of this enzyme is to cleave the phosphate backbone 
and rejoin new DNA, relieving torsional stress in the process, mitoxantrone inhibits 
this process by intercalating at the cleavage site and trapping the complex.171 
Mitoxantrone has also been shown to inhibit telomerase with an IC50 of 2 µM.172 This 
is particularly interesting as inhibition of telomerase has also been demonstrated as a 
result of stabilising the telomeric i-motif.59 These results suggest the possibility that 
mitoxantrone may inhibit telomerase by binding to the i-motif as well as through 
binding to the G-quadruplex. However, further experiments would be required to 
demonstrate this. 
 
Tilorone is an antiviral agent that works by inducing the interferon response and has 
been shown to bind to AT rich double stranded DNA.163,173,174 While more recently, 
analogues of tilorone have been investigated for their anticancer activity.175,176 The 
interferon regulatory factor (IRF) genes code for transcription factors which activate 
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the transcription and production of interferon and their promoter regions are rich in 
cytosine.177 For example, the Sp1 binding site -393 to -362 bases from the start site of 
the IRF-1 gene has the sequence 5'-GATATACCTCCGCCCCCGCCCCGCCAGGAGG-3', 
while the Sp1 binding site -383 to -350 bases from the start site of the IRF-2 gene has 
the sequence 5'-GCGGCCTGCGCCCCCCGCCCCGGACCCCGACTC-3'.178 Although in these 
experiments, tilorone only showed weak binding affinity for the human telomeric and 
c-Myc i-motifs, the compound may well have a stronger affinity for different i-motif 
structures. As an example, this possibility has been demonstrated by Laurence Hurley’s 
group when they identified a Bcl-2 i-motif binding compound that is very specific and 
does not interact strongly with other i-motifs such as c-Myc.69 It has not yet been 
investigated whether there are any sequences capable of forming i-motifs within the 
IRF gene promoter regions but if there were, then the effect of tilorone on these 
structures could be investigated as a possible new mode of action. 
 
Further work should also be carried out to investigate the interaction of tyrothricin 
with the i-motif structure. Tyrothricin is a natural product produced by the gram-
positive bacteria Bacillus Brevis and is involved in the regulation of sporulation.179 As 
mentioned earlier, tyrothricin is a mixture of peptides called gramicidins and 
tyrocidines and has antibacterial properties due to its ability to lyse the cell 
membrane.162 Interestingly it has been shown that tyrocidine acts to reduce 
superhelical stress in plasmids and it was theorised that this is due to intercalation of 
the aromatic residues into the DNA.179,180 However, as mentioned in chapter 1, it has 
also been shown that formation of the i-motif can reduce superhelical stress.49 
Although it was not possible to accurately measure a binding affinity of tyrothricin by 
SPR, it is clear that there is some response which is masked by the effect of DMSO. 
Likewise, the fact that the compound gave rise to bimodal FRET melting curves with a 
higher melting temperature clearly shows that there is some interaction between 
tyrothricin and the i-motif that is worthy of investigation. A key aspect of this would 
be to separate tyrothricin into its constituent peptides and test them separately as it 
may be that only one of these is responsible for the effect, or that they may have a 
higher magnitude affect individually than as a mixture. The early investigations into 
tyrocidine by Bohg et. al.179,180 were published before the i-motif was identified so if a 
strong binding affinity for the i-motif was shown it would be worth investigating 
whether the effect of tyrocidine on superhelicity is linked to stabilisation of the i-motif. 
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4.1 Introduction 
 
4.1.1 The effect of cations on i-motif forming DNA sequences 
 
As discussed briefly in chapter 1, the effect of cations on i-motif DNA is an important 
consideration due to their abundance under physiological conditions. Despite this, 
there have been relatively few investigations in to the effects they may have on i-motif 
stability. Saxena and co-workers have investigated the effect of Na+, K+ and Mg2+ ions 
on the c-jun i-motif forming sequence.50 Their work showed no i-motif formation in the 
presence of 100 mM Na+ but the i-motif did form in the presence of K+ and Mg2+. This 
work supports an earlier study by Jean-Louis Mergny showing that even at pH 4.8 
(close to the pKa of cytosine, 4.6), the presence of 100 mM NaCl destabilised the i-
motif.51 However, they showed that increasing the sodium ion concentration further to 
300 mM did not further destabilise the structure. At pH 6.4 in the presence of 100 mM 
Na+, the addition of 5 mM Mg2+, Ca2+, Zn2+, Li+ or K+ also caused no additional 
destabilisation of the structure. This may be due to the already highly unstable nature 
of the i-motif at this pH and in the presence of a higher concentration of Na+ which 
could outweigh the effect of adding other cations. 
 
More recently, the effect of Li+ has been studied in more detail.52 Sung Eun Kim and 
colleagues have shown that Li+ ions do not prevent i-motif formation, but do promote 
unfolding of the structure at concentrations between 30 and 500 mM. In contradiction 
to the earlier studies, they showed using a single-molecule FRET experiment that 
analogous concentrations of Na+ and K+ ions did not destabilise the i-motif. However, 
their experiments were carried out between pH 6 and 6.4 where the i-motif is already 
less stable. They suggested that the reason Li+ destabilises the i-motif is due to its 
smaller size (0.7 Å) which enables it to fit in the centre of cytosine-cytosine+ base pairs 
that have an N3 to N3 distance of 1.8 Å,35 yet it is unable to support cytosine-cytosine 
base pairing because it does not have the low energy d-orbitals needed to coordinate 
to both cytosine nitrogens and cannot sufficiently replicate the effects of a proton. No 
other extensive investigations have been carried out into the effect of cations on i-motif 
DNA and, with the exception of Zn2+, these works have focused on group 1 and 2 cations 
and neglected transition metal and group 3 cations, several of which are of biological 
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relevance. Cations can interact with DNA in a variety of different ways, not just 
facilitating bonds between bases but also with the phosphate groups, with oxygens in 
the sugar moieties and between bases due to interactions with nitrogen lone pairs and 
the π-systems. All of these interactions can affect the stability of the DNA structure and 
could favour one structure over another. Therefore a wider screen of a variety of 
different cations would be an important step towards fully understanding the effect of 
cations on i-motif forming DNA sequences. 
 
4.1.2 Metallated DNA 
 
Metallated DNA is the incorporation of metal ions into DNA structure.181,182 It is a topic 
that has seen a surge in recent research due to its potential applications in electronics 
and nanotechnology. A range of different cations have been studied including zinc, 
copper, nickel, mercury and silver, mostly with the aim of incorporating a number of 
metal-mediated base pairs into double stranded DNA.183,184 This has enabled 
applications as molecular wires and sensors. Most of these applications have utilised 
non-natural “bases” to bind to the metal ion. For example the structure of a DNA duplex 
containing a sequence of consecutive imidazole-Ag+-imidazole base pairs has been 
solved by NMR.181 Non-natural substitutes for bases are also popular as they can 
include multi dentate ligands which bind much more strongly than the natural DNA 
bases.185  
 
Akira Ono and co-workers showed in 2007 that mercury ions bound specifically to T-
T mismatched bases forming a very stable T-Hg(II)-T pair which stabilised double 
stranded DNA (figure 4.1).186 They were able to observe 15N – 15N coupling across this 
bond using NMR and most recently obtained a crystal structure of duplex DNA 
containing two consecutive T-Hg(II)-T base pairs.182,187,188 Another group have also 
shown that mercury ions can facilitate T-T mispairing in a DNA polymerase reaction.189 
 
As well as T-T base pairs stabilised by mercury it has also been demonstrated that 
silver cations can stabilise C-C,190 C-A and C-T mismatches.191,192 Akira Ono and 
colleagues showed that both silver and mercury cations were able to stabilise a C-T 
mismatch in duplex DNA by around 4 °C and 7 °C respectively (figure 4.1).191 Later, it 
was shown that silver cations were able to stabilise a C-A mismatch, enabling the 
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formation of a full length replication product by a DNA polymerase using a template 
containing cytosine and dATP.192 In the absence of silver, the polymerase reaction was 
stopped at the cytosine position and if the system was inverted so that the template 
contained an adenine base, no incorporation of cytosine occurred even in the presence 
of silver. The group hypothesised that the C-A mispairing occurs by using the 
Hoogsteen face of adenine and that when adenine is incorporated into the primer it is 
unable to rotate sufficiently to enable this interaction (figure 4.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Proposed structures of mismatched base pairs stabilised by Mercury (II) and 
Silver (I) cations. 
 
Of these structures, only the T-Hg2+-T base pair has been structurally elucidated by 
NMR and X-ray crystallography.182,188 As Akira Ono and co-workers have been looking 
at these base pairs in the context of double stranded DNA, the structures they have 
proposed have the bases orientated in the same way as natural base pairs in an anti-
parallel duplex with both deoxyribose units on the same side. In the context of non-
duplex DNA structures, the strands may interact in a parallel direction such as in the 
structure of the i-motif.35 In this case the pairs form in the reverse orientation.191 
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4.1.3 Silver stabilises C-C base pairs 
 
As a follow up to their previous work on mercury mediated thymine-thymine base 
pairs in DNA, more specific research has been carried out by Akira Ono and colleagues 
who showed that silver (I) cations are able to bind specifically to C-C base pairs and 
stabilise a C-C mismatch containing duplex (figure 4.1).190 They then utilised this 
discovery to produce a DNA based sensor for silver cations where the presence of silver 
stabilises the formation of a DNA hairpin using C-C mismatched pairs. The hairpin 
sequence is labelled with two fluorophores which show FRET upon hairpin formation. 
This work has been applied by other groups to DNA based sensors for silver as well as 
the amino acid cysteine, a strong chelator of silver.193 Rather than a DNA hairpin, Wan 
Yi Xie et. al. used silver to promote formation of duplex DNA between two separate 
strands. One of the strands was labelled with a FAM fluorophore next to the cytosine 
base and upon formation of the cytosine-Ag+-cytosine base pair the fluorescence was 
quenched due to a photoinduced electron transfer (PET) effect. In the presence of 
cysteine, the silver is chelated and no longer facilitates the C-C mismatch base pair 
resulting in strand dissociation and an increase in FAM fluorescence.193 The same 
group went on to utilise this effect in the design of a DNA based logic gate.194  
 
Some investigations have already been published on the interaction between the i-
motif and silver but these have only looked at the formation of silver nanoclusters 
rather than stabilisation of the i-motif itself. Small nanoclusters of silver have strong 
fluorescent properties and are synthesised using oligonucleotide templates which 
enable the formation of clusters with different emission wavelengths.195 Bidisha 
Sengupta and colleagues used two different i-motif forming sequences (dTA2C4)4 and 
(dC4A2)3C4 to template the formation of silver nanoclusters with red or green 
fluorescence depending on experimental conditions. They showed that formation of 
clusters with red fluorescence were favoured at acidic pH when the i-motif is stable 
and that clusters with green fluorescence were favoured at basic pH when the i-motif 
sequence is expected to be unfolded. Interestingly, they show using size exclusion 
chromatography that the DNA forms a folded i-motif conformation at acidic pH, but 
that at higher pHs the strand-cluster conjugate appears to take the same type of 
structure.195 This is an early indication that silver cations may enable i-motif formation 
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and Sengupta et. al. postulate that an i-motif like structure may be forming as the DNA 
wraps around the silver clusters. 
 
Wei Li and co-workers have also completed a series of studies on the i-motif as a 
template for silver nanocluster formation, in comparison to other DNA secondary 
structures, namely single stranded DNA, G-quadruplex and duplex.196–198 Their results 
suggest that the i-motif is a better template than G-quadruplex and double stranded 
DNA, stabilising nanoclusters for a longer period of time.198 They used UV melting to 
measure a decrease in melting temperature of the dimeric i-motif d[C4A4C4] from Tm = 
43.5 °C to Tm = 34.4 °C upon addition of Ag+ which they suggest is due to the binding of 
Ag+ to the N3 of cytosine and disrupting the C-H+-C base pairing. At pH 7.0 they 
recorded CD spectra which suggests possible i-motif formation with a shift in the peak 
from 275 nm to 287 nm upon addition of Ag+ or Ag, which they explain is due to 
formation of C-Ag-C base pairs.196 With these hints and suggestions at i-motif formation 
in the presence of silver, a specific study into whether silver cations stabilise i-motif 
formation was necessary. 
 
4.1.4 Aims and Objectives 
 
As described in section 4.1.1, so far only a small number of investigations have been 
carried out to look at the effect of different cations on i-motif formation and these 
studies have only focused on a small selection of group 1 and group 2 cations. Akira 
Ono and co-workers have looked in more detail at metal-mediated base pairs showing 
that mercury (II) and silver (I) ions are able to stabilise T-T and C-C base pairs 
respectively. However, the focus of their work has been on duplex and hairpin DNA 
structures and no other secondary structures. The interaction between i-motif forming 
oligonucleotide sequences and silver (I) cations has been studied in the context of 
silver nanocluster formation (section 4.1.3), which has indicated the presence of folded 
structures at above neutral pH. Despite this, no detailed investigation has been carried 
out to look at i-motif formation in the presence of silver cations. This is the aim of the 
first part of this chapter. In the second part of the chapter, this work is extended to look 
at the effect of a wide range of other cations from across the periodic table, many of 
which are of biological relevance, rather than just group 1 and 2 cations which have 
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been studied previously. The objective of this research is to give a fuller understanding 
of the effect of different cationic conditions on i-motif formation. 
 
4.2 The Effect of Silver (I) Ions on i-Motif Forming DNA. 
 
4.2.1 FRET melting  
 
Using the established FRET melting experiment used in chapters 2 and 3, the human 
telomeric i-motif forming sequence (hTeloC) was tested in 10 mM sodium cacodylate, 
5 mM sodium chloride buffer to investigate the interaction between silver cations and 
i-motif forming DNA. A low salt concentration was used so that any effects of silver 
cations were not overwhelmed by the presence of a large amount of sodium ions. 
Previous FRET studies within the Waller group were carried out with up to 1 M AgNO3, 
which showed that even at an Ag+ concentration of 100 µM, the DNA did not melt. 
Therefore in these experiments, a range of concentrations of AgNO3 were tested 
between 0 and 100 µM. AgNO3 was used because this salt is very water soluble, 
whereas other  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2: FRET melting curves for human telomeric i-motif with increasing 
concentration of AgNO3 at pH 7.4. [DNA] = 200 nM, buffer = 10 mM sodium cacodylate 
and 5 mM NaCl. Figure adapted from Henry Day et. al.199 by permission of The Royal 
Society of Chemistry.  
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salts such as the halides have a much lower solubility. At pH 5.5 the hTeloC sequence 
forms a stable i-motif structure, while at pH 7.4 the oligonucleotide exists as a random 
coil. Therefore silver (I) cations were tested at both pHs to show any effects on an 
existing i-motif structure and to see whether silver could induce DNA folding. This 
would be apparent by a decrease in fluorescence signal as shown in figure 4.2. 
 
At pH 7.4, it can be seen that in the absence of any silver cations, there is a high 
fluorescence signal and no melting transition, consistent with the DNA taking a random 
coil conformation (Figure 4.2). During the experiment, as the concentration of silver 
ions is increased, there is a decrease in fluorescence signal, indicating that the 
fluorophores are coming into close proximity. This indicates that a folding event has 
occurred and at a AgNO3 concentration of 1µM a melting transition can be observed 
with Tm = 65 °C indicating that a stable folded structure has formed which then melts 
with increasing temperature. At 5 µM the folded DNA is strongly stabilised only 
beginning to melt at temperatures above 80 °C and at even higher concentrations, there 
is a low intensity fluorescence signal which does not show any sign of melting within  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3: Later work showing FRET melting curves for human telomeric i-motif with 
AgNO3 between 0 and 5 µM carried out by Zoë Waller. [DNA] = 200 nM, buffer = 10 mM 
sodium cacodylate and 5 mM NaCl. Figure adapted from Henry Day et. al.199 by 
permission of The Royal Society of Chemistry.  
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the temperature range of the experiment (Tm > 95°C). Later studies within the group 
examined the change in melting temperature at pH 7.4 between 0 and 5 µM silver 
nitrate (figure 4.3). These results showed a progressive increase in melting 
temperature with increasing silver nitrate concentration until at 4 and 5 µM, the folded 
DNA does not melt within the temperature range of the experiment. 
 
These results suggest that the presence of silver cations can induce the DNA to fold and 
that increasing concentrations of Ag+ increase the stability of the structure. It is not 
possible to tell from the FRET melting experiments alone, whether or not the folded 
structure is actually an i-motif. The low intensity fluorescence at 100 µM Ag+ may also 
be the result of precipitation as has been shown in the previous chapters. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4: FRET melting curves for human telomeric i-motif with increasing 
concentration of AgNO3 at pH 5.5. [DNA] = 200 nM, buffer = 10 mM sodium cacodylate 
and 5 mM NaCl. 
 
At pH 5.5, in the absence of silver (I) ions, the i-motif shows a single melting transition 
at Tm = 47 °C (figure 4.4). With the addition of silver nitrate, at low concentrations there 
was no change in melting temperature, but at concentrations of 5 µM and above, 
biphasic melting curves are observed with two melting temperatures, one lower than 
the i-motif alone (Tm = 43 °C) and one at a higher temperature (Tm = 65 °C) consistent 
with the decrease in melting temperature observed by Yan Fu and co-workers.196 
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Interestingly, the higher melting point is the same as that observed at neutral pH in 
figure 4.2, suggesting that the same structures or ones with similar stability are 
forming in both cases. The presence of biphasic melting curves indicates that two 
different conformations of DNA are present. The lower melting temperature could be 
an otherwise normal i-motif formed using cytosine-H+-cytosine base pairs that has 
simply been destabilised by the presence of a higher salt concentration. Whilst the 
higher melting temperature may represent an alternative structure such as an i-motif 
or hairpin stabilised by cytosine-Ag+-cytosine base pairs. Alternatively one or both 
melting temperatures may represent alternative structures stabilised by different 
mixtures of C-H+-C and C-Ag+-C base pairs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5: FRET melting curves for human telomeric i-motif with increasing 
concentration of NaNO3 at pH 7.4. [DNA] = 200 nM, buffer = 10 mM sodium cacodylate 
and 5 mM NaCl. Figure adapted from Henry Day et. al.199 by permission of The Royal 
Society of Chemistry. 
 
To account for any effects from the nitrate anion, sodium nitrate was tested at the same 
concentrations in both pH 7.4 and pH 5.5 buffers as a control (figure 4.5 and 4.6). From 
these tests it can be seen that the nitrate anion did not induce any folding of the i-motif 
sequence at pH 7.4 and had no effect on the stability of the i-motif structure at pH 5.5.  
This shows that the observed stabilisation of the i-motif sequence in figures 4.2 and 4.4 
is solely due to the presence of Ag+ cations. 
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Figure 4.6: FRET melting curves for human telomeric i-motif with increasing 
concentration of NaNO3 at pH 5.5. [DNA] = 200 nM, buffer = 10 mM sodium cacodylate 
and 5 mM NaCl. Figure adapted from Henry Day et. al.199 by permission of The Royal 
Society of Chemistry. 
 
In summary, the FRET melting data demonstrates that at pH 7.4, when the DNA starts 
in a random coil conformation, increasing the concentration of silver (I) ions causes 
the DNA to fold into an increasingly stable structure. At pH 5.5 where the i-motif 
structure is already stable, addition of increasing amounts of silver (I) ions leads to the 
appearance of biphasic melting curves, suggesting the presence of two different 
structures with different stabilities. As already described, these results are clearly due 
to the presence of the silver cations rather than the nitrate anion as control 
experiments with sodium nitrate showed it had no effect. These FRET melting results 
clearly show that silver (I) ions interact with the human telomeric i-motif forming 
sequence. To investigate this interaction in more detail, further experiments are 
required which are discussed in the next sections. 
 
4.2.2 Circular Dichroism 
 
As discussed in previous chapters, circular dichroism spectroscopy gives a specific 
signal dependent on the type of DNA secondary structure present in solution and 
therefore enables the monitoring of structural changes.102 The CD spectrum of single 
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stranded DNA has a positive peak at 275 nm and a negative peak at 250 nm. The CD 
spectrum of the i-motif is significantly different with a positive peak at 288 nm and a 
negative peak at 255 nm. The DNA was tested at a concentration of 10 µM in 10 mM 
sodium cacodylate 5 mM NaCl buffer at pH 7.4 (figure 4.7). These conditions were 
chosen so that any observed changes in structure could be related to the apparent 
folding effect that was seen in the FRET melting experiment in figure 4.2.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7: CD spectrum of human telomeric i-motif sequence with increasing 
concentration of AgNO3 at pH 7.4. [DNA] = 10 µM, buffer = 10 mM sodium cacodylate 
and 5 mM NaCl. 
 
In the absence of silver (I) ions, the DNA gave a spectrum with a positive peak at 275 
nm and a negative peak at 250 nm indicative of a random coil structure (figure 4.7). 
Silver nitrate was titrated into the sample in 1 equivalent portions up to a 
concentration of 10 equivalents (100 µM). With increasing concentrations of Ag+, the 
spectrum clearly shows a structural change with the positive peak undergoing a 
bathochromic shift from 275 nm to a broad peak at 288 nm while the negative peak 
also shifts from 250 nm to 260 nm (figure 4.7), this is indicative of formation of an i-
motif-like structure. As well as these changes, the molar ellipticity at 220 nm switches 
from positive to negative and there is the appearance of a new positive peak at 241 nm. 
Whilst the other peaks are characteristic of i-motif formation, it is unlikely that a silver 
stabilised i-motif structure would give an identical CD spectrum to an acid stabilised i-
motif due to the need to accommodate the Ag+ cation (figure 4.8). The distance between 
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cytosine base pairs in the i-motif is 1.8 Å,35 whereas the Ag+-N distance in Ag(NH3)2NO3 
has been shown to be 2.07 Å.200 This means the distance between cytosines in a C-Ag+-
C base pair could be more than double that of a normal i-motif, which would affect the 
glycosidic bond angles responsible for the optical activity observed in the CD 
experiment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8: Comparison of CD spectra for hTeloC in single stranded (pH 7.4) and i-motif 
(pH 5.5) conformations to the spectrum of the silver induced i-motif-like structure. 
[DNA] = 10µM, [AgNO3] = 100 µM, buffer = 10 mM sodium cacodylate and 5 mM NaCl at 
pH 7.4, buffer = 10 mM sodium cacodylate and 100 mM NaCl at pH 5.5.  
 
The observed CD spectrum of hTeloC in the presence of Ag+ at pH 7.4, is remarkably 
similar to that published by Jiangjiexing Wu and co-workers as part of a study on the 
growth of fluorescent silver clusters.197 Their spectrum of the i-motif with increasing 
concentration of silver also showed the formation of a new peak at 240 nm. Another 
investigation published by Yan Fu and colleagues looked at G-/C-rich DNA as a 
template for silver nanocluster formation, their CD data for the sequence C4A4C4 shows 
bimolecular i-motif formation at pH 5.0 with and without silver cations, while at pH 7.0 
the sequence G4T4G4-C4A4C4 shows a shift to 287 nm in the presence of Ag+ which could 
indicate i-motif formation in the C-rich strand.196 They also measure a CD spectrum of 
just C4A4C4 at pH 7.0 which shows a random coil conformation but the presence of Ag+ 
results in peaks at 287 nm, 260 nm and 240 nm consistent with the spectrum in figure 
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4.7. These observations support the suggestion that i-motif formation is occurring in 
the presence of silver cations at neutral pH. 
 
In order to measure the stoichiometry of the interaction with silver, the method of 
continuous variation binding analysis was used to create a Job plot (figure 4.9).201 A 
series of samples were prepared where the ratio of Ag+:DNA was varied between 0:1 
and 10:1 but the overall concentration of DNA + Ag+ was kept constant at 20 µM and 
the CD spectrum of each sample was measured. An analogous set of samples with the 
same DNA concentrations but in the absence of Ag+ were also tested this data was 
subtracted from the first set to give the change in molar ellipticity as a result of the 
silver (I) ions. Plotting the change in molar ellipticity at 275 nm against the molar ratio 
of DNA gives a graph with a change in gradient which corresponds to the stoichiometry 
of the interaction, this is known as a Job plot.201 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9: Job plot showing the stoichiometry of the interaction between silver and 
human telomeric i-motif DNA. Error bars show the standard deviation across 2 repeats 
[DNA] = 0 – 20 µM, [AgNO3] = 0 – 20 µM, buffer = 10 mM sodium cacodylate and 5 mM 
NaCl at pH 7.4. 
 
To calculate the stoichiometry the data was fitted with two linear lines of best fit which 
intersect. Solving the two linear equations simultaneously gives the molar ratio of DNA 
at the inflection point, which can then be converted into a stoichiometry. Analysis of 
these results led to an average stoichiometry of 4:1 Ag+:DNA. This is surprising as there 
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are 6 possible cytosine-cytosine pairs in the i-motif so it is reasonable to expect that 
the stoichiometry would be 6. However, the average stacking interval between 
cytosine pairs in a normal i-motif structure is 3.1 Å,35 but the distance between silver 
(I) ions in a duplex containing silver imidazole pairs was shown to be between 3.79 
and 4.51 Å.181 This suggests that incorporation of 6 cytosine-Ag+-cytosine base pairs 
would cause significant perturbation of the structure and may be unfavourable. This 
result suggests that not all the possible cytosine-Ag+-cytosine pairs need to form in 
order to stabilise an i-motif-like structure. That may be because only 4 cytosine-Ag+-
cytosine pairs, provide enough stability or it may suggest that the silver is stabilising 
the structure in a different way, perhaps by forming a nanocluster which the DNA then 
wraps around in an i-motif-like formation. 
 
4.2.3 Reversibility 
 
In previous published studies on the interaction of silver and cytosine it has been well 
documented that changes can be reversed by the use of cysteine to chelate the silver 
and remove it from the C-Ag+-C pair.194 For example, Wan Yi Xie and colleagues used a 
double stranded DNA probe as a sensor for silver based on the formation of C-Ag+-C 
base pairs which caused the quenching of a fluorescent label upon formation of the 
double stranded DNA but in the presence of cysteine, this change was reversed, 
restoring the fluorescence.193 They later applied this method to produce a DNA based 
logic gate for the detection of silver (I) ions and cysteine.194 Around the same time, 
Chun-Xia Tang and co-workers also developed a different double stranded DNA based 
electrochemiluminescent sensor for the recognition of silver and cysteine.202 
 
In order to examine whether L-cysteine could be used to reverse the apparent i-motif 
formation induced by silver ions, a CD titration was carried out on the human telomeric 
i-motif sequence in the presence of 10 equivalents of Ag+ with increasing 
concentrations of L-cysteine in 1 equivalent portions. It can be seen from the resultant 
spectrum (figure 4.10) that L-cysteine did effectively reverse the changes caused by 
silver with a shift in the positive peak back to 275 nm, the negative peak back to 250 
nm and a disappearance of the positive peak at 240 nm. After addition of 10 equivalents 
of L-cysteine shown in purple, the CD spectrum is almost identical to the starting 
spectrum of single stranded DNA, shown in grey. 
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Figure 4.10: CD spectrum of human telomeric i-motif sequence with 100 µM AgNO3 and 
increasing concentration of L-Cysteine at pH 7.4. DNA: 10 µM, buffer = 10 mM sodium 
cacodylate and 5 mM NaCl. Figure adapted from Henry Day et. al.199 by permission of 
The Royal Society of Chemistry. 
 
Having seen that equimolar amounts of cysteine can reverse the changes induced by 
silver and return the DNA to its single stranded form, further addition of silver was 
then able to return the DNA to the folded form. It was then shown that repeated 
addition of silver and cysteine could repeatedly fold and unfold the DNA. This could be 
seen in the CD spectrum itself and the molar ellipticity was measured at 250 nm and 
261 nm after sequential addition of 10 eq. Ag+ and 10 eq. cysteine showing repeated 
changes in the molar ellipticity (figure 4.11). This suggests the possibility that silver 
and cysteine could be used as an alternative switch mechanism for the controllable 
folding and unfolding of i-motif DNA rather than changing pH which is what has been 
used throughout other published examples.203 The recognition of silver and cysteine 
by the telomeric i-motif sequence could also be developed as a sensor for silver or 
cysteine similar to other examples involving hairpin or duplex DNA.190,193,194,202  
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Figure 4.11: Change in molar ellipticity of human telomeric i-motif sequence with repeat 
additions of 10 eq of AgNO3 and 10 eq of cysteine at pH 7.4. [DNA] = 10 µM, buffer = 10 
mM sodium cacodylate and 5 mM NaCl. Figure adapted from Henry Day et. al.199 by 
permission of The Royal Society of Chemistry.  
 
These results show that the apparent folding and change in structure of the telomeric 
sequence in the presence of silver (I) cations is reversible by addition of equal amounts 
of L-cysteine. Not only did the addition of cysteine return the CD spectrum to that 
previously shown for single stranded DNA but it was possible to repeatedly fold and 
unfold the DNA by successive additions of silver (I) ions and cysteine. This is important 
as the process needs to be reversible for it to find use in a nanotechnology application 
such as the sensing of silver or cysteine.193,194 
 
4.2.4 FRET Titration Experiments 
 
As described in section 1.4.4, another way in which the folding of the DNA can be 
monitored is by using the fluorescently labelled DNA in a FRET titration experiment. 
By exciting the FRET labelled human telomeric i-motif sequence at 490 nm and 
measuring the fluorescence emission from 500 to 650 nm, the fluorescence signal from 
both the FAM and TAMRA fluorophores can be monitored simultaneously at 515 nm 
and 580 nm respectively (figure 4.12). Unlike the FRET melting experiments, this 
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allows the observation of folding in real time. Upon addition of silver nitrate, the 
spectrum shows a decrease in fluorescence of FAM while the fluorescence of TAMRA 
does not change (figure 4.12). This indicates a folding event, bringing the fluorophores 
into close proximity so that Förster resonance energy transfer can occur. The fact that 
the fluorescence of TAMRA does not change provides further support that this is a 
conformational change rather than a precipitation event as this would result in a 
decrease in fluorescence of both FAM and TAMRA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.12: Fluorescence spectrum of hTeloC labelled with FAM and TAMRA at pH 7.4 
and in the presence of AgNO3 showing folding. [DNA] = 100 nM, [AgNO3] = 4 µM, buffer = 
10 mM sodium cacodylate and 5 mM NaCl. 
 
In previous work carried out in the Waller group by Camille Huguin a FRET titration 
was carried out to show the folding of hTeloC with increasing concentrations of silver 
nitrate at pH 7.4. From this experiment a positive cooperativity (n = 3.3) was 
determined and the concentration of silver (I) ions at which half the DNA was folded 
and half unfolded was also measured ([Ag+]50 = 1.9 µM). 
 
The reversibility of folding using cysteine was also seen in FRET titrations. The 
telomeric sequence was folded at pH 7.4 by addition of 4 µM AgNO3. The folded DNA 
was then titrated with increasing concentrations of L-cysteine. This caused an increase 
in the fluorescence of FAM at 515 nm indicating unfolding of the DNA (figure 4.13). As 
FAM 
TAMRA 
500 520 540 560 580 600 620 640 660
0
100
200
300
400
500
600
700
F
lu
o
re
sc
e
n
ce
 I
n
te
n
si
ty
 (
A
.U
.)
Wavelength (nm)
 100 nM hTeloC pH 7.4
 +4 M Ag+
Chapter 4: The Effect of Cations on i-Motif DNA 
 
 
 172 
can be seen, the fluorescence returned to starting levels after addition of 5 µM of L-
cysteine suggesting that the DNA was completely unfolded.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.13: FRET titration of hTeloC sequence folded with AgNO3, with increasing 
concentration of L-cysteine. [DNA] = 100 nM, [AgNO3] = 4 µM, buffer = 10 mM sodium 
cacodylate and 5 mM NaCl. 
 
The change in fluorescence can be used to give the FRET efficiency using equation 4.1. 
Where 𝐹𝐼𝑑  is the fluorescence intensity of the donor fluorophore FAM and 𝐹𝐼𝑑
0 is the 
fluorescence intensity of FAM in the absence of the acceptor fluorophore TAMRA which 
is taken as the fluorescence of FAM when the DNA is fully unfolded before any addition 
of Ag+. This gives a decreasing curve, indicating unfolding (figure 4.14). The FRET 
efficiency was fitted with equation 4.3 to obtain the [Cysteine]50 and the cooperativity 
of the interaction.  
 
Equation 4.1:   𝐸𝐹𝑅𝐸𝑇 = 1 − (
𝐹𝐼𝑑
𝐹𝐼𝑑
0) 
 
Equation 4.3:   𝜃 = 𝐴
[𝐶𝑦𝑠𝑡𝑒𝑖𝑛𝑒]𝑛
𝐾𝑛+[𝐶𝑦𝑠𝑡𝑒𝑖𝑛𝑒]𝑛
 
 
Where K is the ligand concentration at which half the DNA is unfolded ([Cysteine]50) 
and n is the Hill coefficient. A is a constant (A = start + (end-start) values). Using this 
method, [Cysteine]50 = 3.5 µM was measured and a very high positive cooperativity of 
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n = 9 was calculated. This indicates that an excess of L-cysteine is needed to unfold the 
structure. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.14: FRET efficiency showing unfolding of silver stabilised i-motif with 
increasing concentration of L-cysteine. Error bars show the standard deviation across 3 
repeats. [DNA] = 100 nM, [AgNO3] = 4 µM, buffer = 10 mM sodium cacodylate and 5 mM 
NaCl. Figure adapted from Henry Day et. al.199 by permission of The Royal Society of 
Chemistry. 
 
The repeat reversibility of folding which could enable switch functionality was also 
observed in the fluorescence at 515 nm with a slight decrease in fluorescence over time 
likely to be due to dilution (figure 4.15). The fluorescence of FAM was monitored at 
515 nm as sequential additions of 4 µM of AgNO3 and 4 µM of cysteine were added to 
the i-motif sequence. This resulted in a decrease in FAM fluorescence after addition of 
silver nitrate and an increase after addition of cysteine indicating folding and unfolding 
respectively. 
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Figure 4.15: Change in fluorescence intensity at 515 nm with repeated additions of 
AgNO3 and L-cysteine. [DNA] = 100 nM, buffer = 10 mM sodium cacodylate and 5 mM 
NaCl. Figure adapted from Henry Day et. al.199 by permission of The Royal Society of 
Chemistry. 
 
The FRET titration carried out previously in the Waller group indicates that the binding 
of silver (I) ions to the DNA is cooperative (n = 3.3) giving an [Ag+]50 = 1.9 µM. These 
results show that the addition of cysteine does unfold the DNA, giving further support 
for the observations made in circular dichroism experiments, and is also highly 
cooperative (n = 9). In this experiment, the concentration of cysteine at which half the 
silver structure was unfolded ([Cysteine]50) was determined to be 3.5 µM. This would 
suggest that slightly more cysteine than silver is required to unfold the structure. This 
may be because the first additions of cysteine will bind to the excess Ag+ ions in 
solution before binding to the Ag+ ions that are bound to cytosine. As described in 
section 4.2, these FRET experiments can only demonstrate that folding is occurring but 
cannot give information about the type of structure formed. The circular dichroism 
spectra in section 4.3 suggest that an i-motif-like structure is forming but also shows 
some differences in the spectra compared to a normal acid stabilised i-motif therefore 
more evidence is needed to support the hypothesis that an i-motif-like structure is 
forming. 
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4.2.5 UV Difference Spectroscopy 
 
To further investigate the type of structure formed, the change in UV absorbance of the 
DNA was measured with increasing concentrations of silver (I) ions. Whether folded 
or unfolded, DNA gives an absorbance peak at 260 nm. However, due to the difference 
in stacking interactions, the absorbance spectrum of folded and unfolded DNA is 
different. Whilst the absorbance at 260 nm changes very little, when folded, the 
absorbance of the i-motif is decreased between 220 and 260 nm and increased at 295 
nm. This can be observed in the spectra of the human telomeric i-motif forming 
sequence at low temperature (20°C) and at high temperature (90°C) shown in figure 
4.16. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.16: The UV absorbance spectra of the human telomeric i-motif sequence at 
20°C (folded) and 90°C (unfolded) at pH 5.5. [DNA] = 2.5 µM, buffer = 10 mM sodium 
cacodylate and 5 mM NaCl. 
 
The human telomeric sequence in its unfolded form at pH 7.4 was titrated with silver 
nitrate. This showed that with increasing concentrations of silver cations, the 
absorbance of the i-motif forming sequence increased at 260 nm with an isosbestic 
point at 255 nm (figure 4.17). This increase in absorbance does indicate a change in 
structure while the isosbestic point indicates that there are only two species involved 
in the absorbance, for example folded and unfolded DNA. The isosbestic point was 
maintained up until 6 equivalents of Ag+ were added, after which point the absorbance 
continued to increase with increasing silver concentration but the isosbestic point is 
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lost. This indicates that any structural change of the DNA is likely to be completed after 
addition of 6 equivalents of silver and that the further increases in absorbance seen 
with greater concentrations are due to the silver nitrate or scattering effects. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.17: The UV absorbance spectrum of human telomeric i-motif DNA with up to 6 
equivalents of AgNO3 at pH 7.4. [DNA] = 2.5 µM, Buffer = 10 mM sodium cacodylate and 
5 mM NaCl. 
 
As mentioned, the normal folding and unfolding of the i-motif does not show an 
increase in absorbance at 260 nm (figure 4.16) so on first appearance, the change in 
UV absorbance with silver may not be indicative of a folding event. However, after an 
analogous titration of silver nitrate alone in buffer is subtracted from the data, the 
resultant spectrum (figure 4.18), does show very little change at 260 nm as well as the 
decrease at 220 – 260 nm and the increase at 295 nm that is expected for a folding 
event. The subtraction is necessary to discount the absorbance effect of silver nitrate. 
 
 
 
 
 
 
 
 
220 230 240 250 260 270 280 290 300 310 320
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
A
b
so
rb
a
n
ce
 (
A
.U
.)
Wavelength (nm)
 2.5 M hTeloC pH 7.4
 0.2 eq Ag
+
 0.4 eq Ag
+
 0.6 eq Ag
+
 0.8 eq Ag
+
 1 eq Ag
+
 2 eq Ag
+
 3 eq Ag
+
 4 eq Ag
+
 5 eq Ag
+
 6 eq Ag
+
Chapter 4: The Effect of Cations on i-Motif DNA 
 
 
 177 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.18: The UV absorbance spectrum of human telomeric i-motif DNA with up to 6 
equivalents of AgNO3 at pH 7.4 after subtraction of an analogous titration of AgNO3 in 
buffer. [DNA] = 2.5 µM, Buffer = 10 mM sodium cacodylate and 5 mM NaCl. 
 
To look at the type of folded structure forming, the UV difference spectrum was 
measured.93 As described in chapter 1, in 2005 Jean-Louis Mergny and co-workers 
published an investigation showing that taking the difference between the UV spectra 
of folded and unfolded DNA gives a spectrum with a specific signal dependent on the 
type of DNA structure present in the solution. In Mergny et. al.’s work they used thermal 
melting in order to measure the spectra of both folded (low temperature) and unfolded 
(high temperature) structures.93 Here the DNA is being folded by the addition of silver 
cations, therefore the technique was adapted. To generate the difference spectrum, 
first a titration of AgNO3 alone in buffer was subtracted from the titration with DNA to 
discount any effects not due to binding. Then the spectrum of folded DNA (6 
equivalents of Ag+) was subtracted from the spectrum of unfolded DNA (0 equivalents 
of Ag+). This gave a “silver difference spectrum” (figure 4.19a) which can be used in a 
similar way to circular dichroism to indicate the type of DNA structure forming with 
addition of silver cations. 
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a) 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
Figure 4.19: a) “Silver difference” at pH 7.4 and thermal difference spectra at pH 5.5 of 
human telomeric i-motif. b) “Silver difference” spectra of human telomeric i-motif and a 
hairpin forming sequence at pH 7.4. [DNA] = 2.5 µM, [AgNO3] = 15 µM, buffer = 10 mM 
sodium cacodylate and 5 mM NaCl. Figure adapted from Henry Day et. al.199 by 
permission of The Royal Society of Chemistry. 
 
The silver difference spectrum has a positive peak at 245 nm and a negative peak at 
293 nm and is similar to the thermal difference spectrum of the acid stabilised i-motif 
which also has peaks in this region as illustrated by Mergny et al. for a variety of 
different i-motif sequences.93 This suggests that formation of an i-motif type folded 
structure is occurring. However, with the human telomeric sequence it is possible that 
the silver cations are only stabilising a hairpin folded structure rather than an i-motif 
like structure. To investigate this, a control UV difference experiment was carried out 
using the sequence 5'-d(CTCTCTTCTCTTCATTTTTCAACACAACACAC)-3'.190 This 
particular sequence was chosen because it is the same as the one used by Ono and 
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colleagues, which is known to form a hairpin in the presence of Ag+ ions and, the 
sequence does not have the necessary tracts of cytosine to enable i-motif formation. 
The control gave a significantly different spectrum (figure 4.19b) with a peak at 260 
nm and a much smaller negative peak at 295 nm. This UV difference resembles those 
of Hoogsteen duplexes in Mergny’s study,93 however, Mergny did not look at the 
thermal difference spectra of hairpin DNA and, as already discussed, this particular 
sequence is known to form a hairpin in the presence of silver.190 The difference 
between these spectra indicates that a structure other than a hairpin is formed by 
addition of silver (I) ions to the sequence. 
 
These results have again shown that the human telomeric i-motif forming sequence 
forms a folded structure in the presence of silver (I) ions at neutral pH. This supports 
the results of experiments in sections 4.2 to 4.5. The UV difference spectra for silver is 
an application of the thermal difference spectroscopy method outlined by Mergny and 
co-workers. These spectra demonstrate that the folded structure is not that of a simple 
hairpin and shows greater similarity to the thermal difference spectrum of the i-motif. 
This provides greater evidence in support of the CD spectra, suggesting that the folded 
DNA forms an i-motif-like structure in the presence of silver. 
 
4.2.6 Summary of effect of silver (I) ions on i-motif forming DNA. 
 
In summary, a number of investigations by Akira Ono have shown that Ag+ cations 
stabilise cytosine-cytosine base pairs by selectively binding to the N3 of cytosine. Here 
the hypothesis that this property could enable silver cations to stabilise i-motif 
formation at neutral pH has been tested with a range of biophysical experiments. The 
addition of silver (I) ions to the human telomeric i-motif forming sequence was shown 
to induce folding of the DNA in FRET melting experiments and FRET titration 
experiments with earlier work in the Waller group demonstrating a cooperative 
binding (n = 3.3) with an [Ag+]50 = 1.9 µM. Folding was also observed in circular 
dichroism experiments and UV titrations with the CD and UV difference spectra 
providing evidence of formation of an i-motif-like structure. UV difference 
spectroscopy was also used to rule out the formation of a simpler hairpin structure. 
The differences between the CD spectrum of the folded structure and that of a normal 
acid stabilised i-motif were not unexpected. This is because of the effect of 
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incorporating larger silver ions into the structure that will distort the conformation of 
glycosidic bonds. This is supported by the stoichiometry of 4:1 which was measured 
by CD indicating that less silver (I) ions are needed than the 6 cytosine pairs expected 
for a normal i-motif. This suggests that either only 4 cytosine-Ag+-cytosine pairs are 
required for the structure to form, or that the silver cations stabilise the structure in a 
different way, perhaps by resting between cytosine base pairs or by forming a 
nanocluster which the DNA can wrap around. Finally the reversibility of this structure 
formation was demonstrated using cysteine to chelate the silver (I) ions. This process 
was also shown to be cooperative (n = 9) with slightly more cysteine required to unfold 
the structure ([Cysteine]50 = 3.5 µM). 
 
The ability to reversibly fold and unfold i-motif forming sequences at neutral pH with 
addition of silver cations and cysteine could have a number of applications. The 
reversible folding of the i-motif due to changes in pH has been used in a range of 
nanotechnology applications and these results offer an alternative switch 
mechanism.203 As well as applications focusing on the folding of the DNA, these results 
also offer the potential for i-motif sequences to be used in cysteine sensing applications 
such as those previously published based on double stranded DNA.193,194 It is still not 
clear exactly where and how the silver ions are located within the structure and how 
the overall conformation of the DNA is different to that of an acid stabilised i-motif. 
Further work is needed using NMR or X-ray crystallography to get a clearer idea of 
what the silver induced structure looks like.  
 
4.3 Screening other cations 
 
As discussed in section 4.1.1, only a small number of mostly group 1 and 2 cations have 
been studied for their effect on the stability of i-motif DNA. After showing that silver 
cations are able to stabilise the formation of an i-motif like structure at neutral pH, the 
next stage in the investigation was to look at the effect of other cations on i-motif DNA. 
For this purpose, a selection of 26 different cations were screened using a FRET melting 
assay against the telomeric i-motif at pH 7.4 and pH 5.5 (table 4.1). The cations were 
from a variety of groups including 1, 2, and 3, the transition metals and the lanthanides 
and hence have a range of different charges and ionic radii. The selection also includes 
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cations of biological importance from the Irving-Williams series including Mn2+, Co2+, 
Ni2+, Cu2+ and Zn2+. This series describes the stability of complexes of the first row 
transition metals and is important in a biological context as it reflects the different 
binding affinities of proteins for these cations.204,205 Unfortunately Fe2+, which is also 
part of the series, could not be tested as the available salt, iron (II) chloride, was not 
soluble enough. However, iron (III) chloride was soluble enough to be tested.  
 
Salt Cation Group 
AlCl3 Al3+ 3 
BaCl2 Ba2+ 2 
CaCl2 Ca2+ 2 
CdCl2 Cd2+ TM 
CsCl Cs+ 1 
CoCl2 Co2+ TM 
CuCl2 Cu2+ TM 
Ga(NO3)3 Ga3+ 3 
HoCl3 Ho3+ L 
In(NO3)3 In3+ 3 
FeCl3 Fe3+ TM 
PbAc2 Pb2+ 4 
MgCl2 Mg2+ 2 
MnCl2 Mn2+ TM 
HgAc2 Hg2+ TM 
NiCl2 Ni2+ TM 
KCl K+ 1 
RbCl Rb+ 1 
RuCl3 Ru3+ TM 
SmCl3 Sm3+ L 
SrCl2 Sr2+ 2 
TlAc Tl+ 3 
TbCl3 Tb3+ L 
YbCl3 Yb3+ L 
YCl3 Y3+ TM 
ZnAc2 Zn2+ TM 
NaAc2 Acetate Control 
 
Table 4.1: Table of salts tested in the FRET melting screen. TM = Transition Metal, L = 
Lanthanide. 
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The cations were tested at concentrations of 100 mM, 1 mM, 100 µM and 10 µM in 10 
mM sodium cacodylate, 5 mM sodium chloride buffer the same as has been used 
previously in section 4.2. Most of the salts used were chlorides or nitrates with the 
exception of Pb2+, Hg2+, and Zn2+, for which the acetate salt was used. Nitrate has 
already been shown not to effect i-motif formation earlier in this chapter (figure 4.5 & 
4.6) and chloride is used throughout all our buffer conditions with no apparent effect 
on i-motif formation. However, the effect of the acetate anion has not been examined, 
therefore sodium acetate was also tested as a control. The cations were screened at pH 
7.4 in order to look for induced folding of the DNA at neutral pH, similar to that seen 
for silver. They were also screened at pH 5.5 as the i-motif is already formed under 
these conditions and this enables any stabilising or destabilising effects on the i-motif 
to be observed.  
 
After the initial screen, several hits were identified which seemed to cause folding at 
neutral pH. These were: AlCl3, CuCl2, Ga(NO3)3, HoCl3, SmCl3, TbCl3, YbCl3, YCl3, HgAc2 
and ZnAc2 (Table 4.2). These cations caused folding at concentrations between 0 and 
100 µM and most produced base level fluorescence signals, where the DNA does not 
melt, at 100 µM which may indicate strong stabilisation or precipitation. The cations 
all have a charge of +2 or +3, enabling them to effectively counteract the negative 
charge of the phosphate backbone. Of particular interest are copper, mercury and zinc, 
which have the same linear coordination geometry as silver, suggesting that they may 
be able to bind to cytosine base pairs. In fact, mercury has already been shown to 
stabilise T-T and T-C base pairs as described in section 4.1.2.191 
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Cation Concentration (µM) Tm (°C) 
Al3+ 100 65.8 
Cu2+ 10 57.2 
Ga3+ 100 72.5 
Ho3+ 10 81.8 
Sm3+ 10 63.8 
Tb3+ 10 78.8 
Yb3+ 10 >95 
Y3+ 10 92.5 
Hg2+ 10 61.5 
Zn2+ 100 76.5 
 
Table 4.2: Melting temperatures of folded DNA as a result of different cations. [DNA] = 
200 nM, buffer = 10 mM sodium cacodylate 5 mM sodium chloride. The error in the Tm 
values is ± 0.3 °C. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.20: FRET melting curves of human telomeric i-motif forming sequence at pH 
7.4 in the presence of cations which caused folding of the DNA. [DNA] = 200 nM, buffer = 
10 mM sodium cacodylate and 5 mM NaCl. 
 
Figure 4.20 shows the melting curves induced by the addition of the cations from table 
4.2 to the hTeloC sequence at pH 7.4. Some cations seemed to have more of an effect, 
causing folding at 10 µM while others only caused folding at 100 µM. As the DNA is 
normally unfolded at pH 7.4, it is not possible to measure a melting temperature in the 
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absence of the cations, however at acidic pH, the i-motif normally has a melting 
temperature of 46°C. These cations have significantly higher melting temperatures 
suggesting they form very stable structures. Full results from the cation screen can be 
found in the appendix (section A.3).  
 
The effect of the cations on the DNA was tested by circular dichroism in order to see 
what type of structure may be forming or if precipitation was occurring. Unfortunately, 
due to the higher concentration of DNA required for CD compared to FRET experiments 
(10 µM vs. 200 nM) testing the cations at the same concentrations as FRET (80 - 100 
µM) resulted in very little change in the CD spectrum, while testing at the same number 
of equivalents required much higher concentrations of cation (4 – 5 mM). At these 
concentrations, precipitation was apparent in the presence of Ho3+, Sm3+, Tb3+ and Yb3+ 
but the addition of Al3+, Ga3+ and Zn2+ did seem to induce i-motif formation. However, 
after testing the pH of the cations in the 10 mM sodium cacodylate buffer at this high 
concentration, the pH was not maintained when greater than 100 µM of ions were 
added. Therefore the observed change to i-motif structure is most likely a result of 
decreasing pH rather than stabilisation by the cations themselves and these were not 
investigated further. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.21: CD spectrum of human telomeric i-motif DNA at pH 7.4 with 0.5 mM YCl3. 
[DNA] = 10 µM, buffer = 10 mM sodium cacodylate and 5 mM NaCl. 
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More promisingly, Y3+ showed a small shift towards 280 nm in the CD spectrum at a 
concentration of 0.5 mM (figure 4.21) but the spectrum still indicated some 
precipitation. This concentration equated to 50 equivalents, the same number of 
equivalents at which a stabilisation effect was seen in FRET melting experiments, yet 
it was still below the concentration where changes in pH occurred. Cu2+ showed a small 
shift at 80 µM (figure 4.22). This is a comparable concentration to that used in FRET 
melting experiments where an effect was seen (100 µM) but represents fewer 
equivalents due to the higher DNA concentration in CD. YCl3 maintained a pH of 7 at 1 
mM and CuCl2 maintained a pH of 7.2 at 100 µM compared to pH 7.3 for the buffer 
initially, so these cations were taken forward for further study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.22: CD spectrum of human telomeric i-motif DNA at pH 7.4 with 80 µM CuCl2. 
[DNA] = 10 µM, buffer = 10 mM sodium cacodylate and 5 mM NaCl. 
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Figure 4.23: FRET melting curves for human telomeric i-motif at pH 7.4 with 100 µM 
YCl3 and CuCl2 at pH 7.4. [DNA] = 200 nM, buffer = 50 mM sodium cacodylate. 
 
In order to enable testing at higher cation concentrations without changing the pH, the 
concentration of sodium cacodylate in the buffer was increased from 10 to 50 mM. In 
these buffer conditions, the pH still showed a decrease but could be maintained at 
neutral or above at up to 4 mM CuCl2 (pH = 6.97) and 7 mM YCl3 (pH = 7.02). The 
drawback of this change is that the higher concentration of sodium ions could mask the 
effect of a lower concentration of another cation. To ensure that the cations still had a 
stabilising effect on the i-motif sequence in the new buffer concentrations, they were 
re-tested by FRET melting at 100 µM (figure 4.23). Here Y3+ no longer showed any 
folding effect on the DNA, whilst Cu2+ still showed a decrease in fluorescence indicating 
folding. 
 
In summary, after carrying out a FRET melting screen of 26 cations, 10 of them 
appeared to cause folding of the DNA at pH 7.4 (Al3+, Cu2+, Ga3+, Ho3+, Sm3+, Tb3+, Yb3+, 
Y3+, Hg2+ and Zn2+). Further testing of these hits by CD showed that several caused 
precipitation (Ho3+, Sm3+, Tb3+ and Yb3+), while others (Al3+, Ga3+ and Zn2+) did indicate 
i-motif formation but this was due to a decrease in pH. Unfortunately Hg2+ could not be 
tested due to the insolubility of the available salt leaving Y3+ and Cu2+ as the only 
cations which did show small shifts in the CD at concentrations that did not 
significantly alter the pH. In order to carry out further experiments at higher cation 
concentrations, the concentration of the buffer was increased to 50 mM in order to 
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maintain the pH above neutral. However, repeat FRET melting experiments on Y3+ and 
Cu2+ in the new buffer showed that only copper (II) ions still caused an apparent folding 
event. Therefore, only copper (II) ions have been taken forward for further 
investigation which is discussed in section 4.4. 
 
4.4 The Effect of Copper (II) Ions on i-Motif Forming 
Sequences. 
 
Having screened a range of different cations for stabilisation of the telomeric i-motif 
sequence at neutral pH, Cu2+ was the only cation from the screen that still appeared to 
stabilise a folded structure without reducing the pH below neutral. To investigate this 
further, preliminary experiments have been carried out using FRET melting, UV 
difference and circular dichroism spectroscopy. FRET melting alone can indicate 
folding, give information about the stability of the structure and the number of 
structures in equilibrium, but these other experiments are needed in order to give 
more detailed information about the type of structure that is being formed.  
 
 
4.4.1 FRET melting 
 
In section 4.3, the cations were screened at concentrations of 100 mM, 1 mM, 100 µM 
and 10 µM in 10 mM sodium cacodylate buffer with 5 mM NaCl, showing stabilisation 
between 0 and 100 µM. This result was confirmed in the new 50 mM sodium cacodylate 
buffer by repeating the experiment with 100 µM of Cu2+ and at this concentration the 
DNA did not melt within the temperature range of the experiment. Therefore a range 
of different concentrations of copper (II) cations were tested between 0 and 100 µM at 
pH 7.4 (figure 4.24) and pH 5.5 (figure 4.25) to examine whether the stabilisation 
shows a dose response. At pH 7.4, the data indicates the onset of folding with a decrease 
in fluorescence at a Cu2+ concentration of 10 µM. At 40 µM the DNA appears to be folded 
at 25°C and there is an apparent melting transition at Tm = 68°C which suggests the 
formation of a stable folded structure. At higher concentrations the fluorescence is 
quenched throughout the temperature range of the experiment. This could be due to 
high stabilisation or aggregation of the DNA. Conversely at pH 5.5, there appears to be 
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a slight decrease in melting temperature from 46.2°C to 45.5°C at [CuCl2] = 20 µM, 
however, as the concentration of CuCl2 is increased there is still a low fluorescence 
intensity. This could be as a result of stabilising an alternative structure or could again 
be due to precipitation. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.24: Example FRET melting data for the human telomeric i-motif sequence at 
pH 7.4 with increasing concentrations of CuCl2. [DNA] = 200 nM, buffer = 50 mM sodium 
cacodylate. 
 
 
 
 
 
 
 
 
 
 
Figure 4.25: Example FRET melting data for the human telomeric i-motif sequence at 
pH 5.5 with increasing concentrations of CuCl2. [DNA] = 200 nM, buffer = 50 mM sodium 
cacodylate. 
 
As described in section 4.2.4, further indication of folding can be seen in FRET titration 
experiments. As the DNA folds, the two fluorophores come into close proximity and the 
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fluorescence of FAM is quenched so it is expected that there will be a decrease in the 
fluorescence signal for FAM at 515 nm. However the fluorescence of TAMRA at 580 nm 
should not decrease. However, in figure 4.26, it can be seen that the signals of both FAM 
and TAMRA decrease. This would suggest a precipitation effect. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.26: FRET titration of human telomeric i-motif sequence with increasing 
concentration of CuCl2 at pH 7.4. [DNA] = 100 nM, buffer = 50 mM sodium cacodylate. 
 
The FRET melting results indicate that at pH 7.4, the addition of increasing 
concentrations of copper (II) ions leads to a decrease in the fluorescence signal 
suggesting the formation of a folded structure. At a Cu2+ concentration of 40 µM the 
folded structure shows a melting transition with a melting temperature (Tm) of 68°C 
which is much higher than an acid stabilised i-motif (Tm = 46°C) implying a more stable 
structure. A FRET titration at pH 7.4 also indicates folding of the DNA initially but, at 
higher concentrations of Cu2+ the fluorescence of both FAM and TAMRA decrease 
which indicates that precipitation is occurring. At pH 5.5, where the i-motif is already 
folded, the FRET melting experiments suggest that increasing concentrations of copper 
(II) ions destabilises the i-motif structure giving lower temperature melting transitions 
but the fluorescence remains low after this transition. There is not an obvious 2nd 
melting transition so it is not clear whether this effect is due to formation of another 
more stable structure as was seen with silver (I) ions. It is clear from these results that 
the copper (II) ions do interact with the i-motif structure and that they do induce 
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folding at neutral pH but further experiments such as UV difference and CD are 
required to give information about the type of structures forming. 
 
4.4.2 UV Difference 
 
Following the same procedure as described to show folding in the presence of silver 
cations (section 4.4), UV difference spectra were produced from UV titrations of 
different i-motif forming sequences in the presence of copper (II) ions. UV titrations 
were carried out with the human telomeric i-motif sequence as well as promoter region 
i-motif sequences from the c-Myc, HIF-1α and PDGF-A genes. These i-motif sequences 
are interesting because they are quite different to the telomeric i-motif. For example, 
the c-Myc i-motif (5'-CCCCACCTTCCCCACCCTCCCCACCCTCCCC-3') has longer loops 
(section 1.3.2), whereas the i-motifs formed from the HIF-1α (5'-
CGCGCTCCCGCCCCCTCTCCCCTCCCCGCGC-3') and PDGF-A (5'-
CCGCGCCCCTCCCCCGCCCCCGCCCCCGCCCCCCCCCCCCC-3') sequences have longer 
cytosine tracts, as described in section 1.3.2.41,62 As described in section 4.2.5, the UV 
difference spectra for each sequence (figure 4.27) was generated by subtracting the 
titration of just Cu2+ in buffer from the titration in DNA then subtracting the spectrum 
at the plateau (folded) from the starting spectrum (unfolded).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.27: Comparison of copper difference spectra of human telomeric, c-Myc, HIF-1α 
and PDGF-A i-motif sequences and the C-hairpin sequence at pH 7.4. [DNA] = 2.5 µM, 
[CuCl2] = 250 µM, buffer = 50 mM sodium cacodylate. 
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Figure 4.28: “Silver difference” and “copper difference” at pH 7.4 and thermal difference 
spectra at pH 5.5 of human telomeric i-motif and “silver difference” and “copper 
difference” of C-hairpin at pH 7.4. [DNA] = 2.5 µM, [AgNO3] = 15 µM, buffer = 10 mM 
sodium cacodylate and 5 mM NaCl, [CuCl2] = 250 µM, buffer = 50 mM sodium 
cacodylate. 
 
These “copper (II) ion difference spectra” show a great deal of similarity suggesting 
that a similar structure is being formed from each sequence. The spectra are 
significantly different from the thermal difference and “silver difference” spectrum of 
the i-motif shown in section 4.4 and closely resemble the “silver difference” spectrum 
of the C-hairpin sequence shown in figure 4.28.  As a further comparison, the “copper 
difference” of the C-hairpin forming sequence was measured which again showed 
significant similarity, sharing a peak at 260 nm. This suggests that rather than 
stabilising the i-motif, Cu2+ may in fact stabilise formation of a hairpin structure 
instead. To investigate this further, circular dichroism was used to give a more detailed 
view of the possible structural changes. 
 
4.4.3 Circular Dichroism 
 
Circular dichroism was used to look at the change in structure caused by addition of 
copper (II) cations. The copper (II) cations were titrated into a solution of 10 µM 
hTeloC both at pH 7.4, to give an indication of the folding effects observed in FRET 
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melting experiments, and at pH 5.5 to look for any evidence of a change in structure 
from the i-motif.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.29: CD spectrum of human telomeric i-motif sequence at pH 7.4 with increasing 
concentration of CuCl2. [DNA] = 10 µM, buffer = 50 mM sodium cacodylate. 
 
At pH 7.4, the high concentrations of Cu2+ required to replicate the same ratio as in the 
FRET melting experiments resulted in precipitation (figure 4.29). This can be seen by 
the decrease in molar ellipticity across the whole spectrum and by the fact that the 
curves themselves are less smooth, showing possible interference from precipitate. A 
small bathochromic shift in the positive peak is observed from 275 nm to 280 nm but 
the other peaks do not show any shift in wavelength. This small shift may again be due 
to precipitation as has been observed previously in the CD spectra of BisA in chapter 
2. 
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Figure 4.30: CD spectrum of human telomeric i-motif with increasing concentration of 
CuCl2 at pH 5.5. [DNA] = 10 µM, buffer = 50 mM sodium cacodylate. 
 
However, in contrast at pH 5.5 no precipitation occurred and the spectrum showed a 
gradual change with increasing copper concentration with the peak showing a 
hypsochromic shift from 288 nm to 276 nm (figure 4.30). The negative peak also 
showed a shift from 255 to 250 nm while the peaks at 220 and 200 nm showed a 
decrease and increase respectively. The spectrum also has multiple isodichroic points 
indicating that there are two structures in equilibrium with one another. After addition 
of 100 equivalents of Cu2+, the spectrum is very similar to that of single stranded DNA. 
However, the FRET melting data suggests that copper does not simply unfold the DNA 
as this would be indicated by an increase in the fluorescence intensity with increasing 
copper concentration and this is not observed in the CD experiment. 
 
By plotting the change in molar ellipticity at 288 nm with increasing concentration of 
CuCl2 at pH 5.5 (figure 4.31), the data can be fitted to obtain the [Cu2+]50 for the change 
and the cooperativity of the interaction using equation 4.3. Where K is the 
concentration at which half the structural change has occurred ([Cu2+]50) and n is the 
Hill coefficient. A is a constant (A = start + (end-start) values). Fitting this data gave a 
[Cu2+]50 = 378 µM and a Hill coefficient n = 2.8 showing positive cooperativity (n > 1). 
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Equation 4.3:   𝜃 = 𝐴
[𝐶𝑢2+]𝑛
𝐾𝑛+[𝐶𝑢2+]𝑛
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.31: Change in Molar ellipticity with increasing concentration of CuCl2 at pH 5.5. 
Error bars show the standard deviation across 3 repeats. [DNA] = 10 µM, buffer = 50 
mM sodium cacodylate. 
 
Comparing the CD spectra of the different structures (figure 4.32) shows that there is 
a slight difference between the spectrum of the single stranded i-motif sequence and 
that observed for the i-motif sequence with 100 equivalents of Cu2+. The largest 
positive peak only shows a slight difference in wavelength (280 nm) compared to the 
random coil (275 nm). However, what is striking is that this same small difference is 
also observed for the C-hairpin sequence under acidic conditions, which should form a 
hairpin. The rest of the spectrum has a lower molar ellipticity than the single strand 
and is similar to some CD spectra of hairpins published in the literature.206 Finally, 
there is an increase in molar ellipticity at 200 nm in both the C-hairpin sequence and 
in the presence of copper (II) ions, which is not observed in the spectra of either i-motif 
or single stranded DNA. This provides further evidence that copper cations may 
stabilise the formation of a hairpin structure in i-motif sequences. 
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Figure 4.32: CD spectra of different DNA structures i-motif, single stranded DNA and 
hairpin in comparison to hTeloC with 100 eq CuCl2 at pH 5.5. [DNA] = 10 µM, buffer = 50 
mM sodium cacodylate. 
 
These results provide further support for the results seen in sections 4.4.1 and 4.4.2. 
At pH 7.4 the CD titration indicates that copper (II) ions cause precipitation of the DNA 
but at pH 5.5 no precipitation occurs and it is clear that the addition of Cu2+ causes the 
i-motif to change to a different structure. This could explain the observed 
destabilisation in the FRET melting experiments at pH 5.5. The resultant CD spectrum 
after addition of 100 equivalents of copper (II) ions shows subtle differences to the 
spectrum of unfolded random coil structure and shares similarities with the spectrum 
of the C-hairpin sequence. This offers further evidence in support of the UV difference 
spectra suggesting that copper (II) ions are able to promote the formation of a hairpin 
structure within i-motif forming oligonucleotide sequences under acidic conditions 
where the i-motif would ordinarily be formed. 
  
4.4.4 Reversibility 
 
In order to see whether the changes induced by copper cations were reversible, the CD 
sample was titrated with equal equivalents of ethylenediaminetetraacetic acid (EDTA). 
This resulted in complete reversal of the spectral changes and a return to the spectra 
previously obtained for the i-motif or single stranded structures.  
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Figure 4.33: CD titration of human telomeric i-motif sequence with 100 eq CuCl2 and 
increasing concentration of EDTA at pH 7.4. [DNA] = 10 µM, buffer = 50 mM sodium 
cacodylate. 
 
At pH 7.4, it can be seen that there is an increase in molar ellipticity across the spectrum 
and there is a shift in the positive peak from 280 nm to 275 nm corresponding to the 
spectrum previously obtained for the random coil structure. The spectrum also 
becomes smoother. This indicates that addition of EDTA was able to re-dissolve the 
sample and afforded the single stranded DNA structure (figure 4.33).   
 
At pH 5.5, (figure 4.34) there is a decrease in molar ellipticity at 200 nm, an increase at 
220 nm, a decrease and a shift from 250 to 255 nm as well as an increase and shift from 
276 to 288 nm. These changes are the opposite to those seen for copper and return the 
spectrum to that previously obtained for the i-motif. This suggests that the addition of 
EDTA is able to reverse the change induced by copper and switch the structure back 
from a hairpin form to an i-motif form. 
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Figure 4.34: CD titration of human telomeric i-motif sequence with 100 eq CuCl2 and 
increasing concentration of EDTA at pH 5.5. [DNA] = 10 µM, buffer = 50 mM sodium 
cacodylate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.35: Change in molar ellipticity with increasing concentration of EDTA at pH 
5.5. Error bars show the standard deviation across 3 repeats. [DNA] = 10 µM, [CuCl2] = 
1000 µM, buffer = 50 mM sodium cacodylate.  
 
As with the data in figure 4.30, the change in molar ellipticity with increasing 
concentration of EDTA can be plotted to give a sigmoidal curve (figure 4.35). Fitting 
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this data with equation 4.3 gave a [EDTA]50 = 531 µM and a cooperativity of n = 5.2 
indicating that slightly more EDTA than Cu2+ is required for the reversal. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.36: CD spectrum of human telomeric i-motif with repeat additions of 100 eq 
CuCl2 and 100 eq EDTA at pH 5.5. [DNA] = 10 µM, buffer = 50 mM sodium cacodylate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.37: Change in molar ellipticity at 287 nm of human telomeric i-motif with 
repeat additions of 100 eq CuCl2 and 100 eq EDTA at pH 5.5. [DNA] = 10 µM, buffer = 50 
mM sodium cacodylate. 
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Figure 4.36 and 4.37 demonstrate that the DNA can be repeatedly switched from the i-
motif structure to the apparent hairpin structure at pH 5.5 with repeated additions of 
Cu2+ and EDTA. This is important as it offers a different kind of switchable motion to 
the normal folding and unfolding that could be used in nanomotor or logic gate 
applications.21,22 This result is also interesting as the dynamics between i-motif and 
hairpin formation have been shown to be important in the work of Laurence Hurley 
and co-workers on the Bcl-2 promoter region but has yet to be fully understood.69  
 
4.4.5 NMR studies on copper (II) ions with i-motif DNA 
 
Proton NMR studies were carried out in collaboration with Dr Colin MacDonald. The 
change in structure between a hairpin and an i-motif has previously been 
demonstrated using NMR by Laurence Hurley and co-workers investigating the 
structure dynamics within the Bcl-2 promoter region.69 The central imino protons 
which stabilise the cytosine-H+-cytosine base pairs in a normal i-motif structure give a 
characteristic peak in 1H NMR at around 15.5 ppm.35 In Hurley and colleague’s work, 
they showed that on moving from an i-motif to a hairpin structure, the imino proton 
peak is lost and a new peak forms at 12 – 13 ppm indicating the formation of a hairpin.  
 
In order to gain further evidence of a structural transformation in i-motif DNA on 
addition of copper (II) ions, a 1D 1H NMR experiment was carried out (Figure 4.38). 
The human telomeric sequence was prepared at a concentration of 10 µM in pH 5.5 50 
mM sodium cacodylate buffer with 5% D2O to enable the NMR instrument to obtain a 
solvent lock. The spectrum was obtained over 1 hour before 100 equivalents (1 mM) 
of CuCl2 was added and the spectrum taken again over 2 hours. Finally 100 equivalents 
(1 mM) of EDTA was added and the spectrum taken for a third time over 1 hour. 
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a) 
 
 
b) 
 
c) 
 
 
Figure 4.38: Proton NMR of the imino proton region of human telomeric i-motif at pH 
5.5. a) in the absence of Cu2+, b) in the presence of 1 mM Cu2+, c) in the presence of 1 mM 
Cu2+ and 1 mM EDTA. The spectra have been scaled for easier comparison. [DNA] = 10 
µM, buffer = 50 mM sodium cacodylate with 5% D2O. 
 
The spectrum in the absence of copper (II) ions (figure 4.38a) clearly shows a peak at 
15.5 ppm which corresponds to the central imino protons of the cytosine-H+-cytosine 
base pairs. The peaks at 9-10 ppm represent the other protons on the bases in the 
sequence. After addition of 100 equivalents of CuCl2 (figure 4.38) the spectrum has less 
resolution and the peaks become much broader. This is due to the presence of the Cu2+ 
ions which are paramagnetic. However, it can clearly be seen that there is an apparent 
reduction in the peak at 15.5 ppm corresponding to the i-motif, while there is the 
formation of a new peak at 12.5 ppm. This peak indicates a change in structure and 
may be representative of the protons in a DNA hairpin as suggested by Hurley et. al.69 
Taken on its own, it is not certain precisely which protons this peak represents, 
however, in conjunction with the UV difference and circular dichroism spectra, this 
spectrum provides further evidence to suggest the formation of a hairpin structure. 
Finally after addition of 100 equivalents of EDTA, the spectrum becomes clearer, the 
peak at 12.5 ppm disappears while the imino proton peak at 15.5 ppm remains, but 
with lower intensity (figure 4.38c). This suggests that EDTA is able to reverse the 
changes in the spectrum induced by copper. This provides further support for the 
reversibility of the changes that have been demonstrated by circular dichroism. 
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4.4.6 Summary of effect of copper (II) ions on i-motif forming DNA 
 
After it was initially identified as a hit from a screen of 26 different salts, copper (II) 
ions have been shown to interact with i-motif forming DNA sequences. At pH 7.4 where 
the DNA is unfolded, FRET melting experiments suggested that Cu2+ caused the DNA to 
fold and UV difference experiments indicated that the folded structure was not an i-
motif but may be a hairpin type structure as the “copper difference” spectrum shared 
similarities with the “silver difference” spectrum of a known silver DNA hairpin. 
However further FRET titration and circular dichroism experiments at this pH showed 
that the addition of copper (II) ions also resulted in precipitation. More interestingly, 
at pH 5.5 the addition of copper did not result in precipitation and, circular dichroism 
experiments also showed the formation of a possible hairpin structure. This was 
further supported by NMR experiments which showed a reduction in the imino proton 
peak at 15.5 ppm and the appearance of a new peak at 12.5 ppm which may be 
indicative of hairpin formation.69 In both CD and NMR experiments the structural 
changes were shown to be reversible upon addition of EDTA. 
 
These results are particularly exciting because the dynamics between hairpin and i-
motif structures have been shown to be important in the case of the Bcl-2 promoter 
region but have not been investigated fully.69 As well as this, most nanotechnology 
applications of i-motif DNA have relied on the structure changing from unfolded to 
folded, whether this be to create nanomechanical motion, or for sensing and logic gate 
applications.203 The ability to reversibly change from one folded structure to a different 
folded structure offers the possibility of a different switch system and a different type 
of “mechanical motion.” In combination with the existing ability of i-motif forming 
sequences to fold and unfold in response to changes in pH, or in response to silver and 
cysteine as shown in section 4.2, further work on this project could enable the 
development of switches or logic gates with multiple inputs and outputs using the same 
oligonucleotide sequence.  
 
 
 
 
Chapter 4: The Effect of Cations on i-Motif DNA 
 
 
 202 
4.5 Group 1 and 2 cations destabilise the i-motif 
 
As mentioned in the section 4.3, the cations were also tested at pH 5.5. Whilst the hits 
at pH 7.4 generally produced base level fluorescence signals, it was apparent that the 
cations from group 1 and group 2 had a destabilising effect on the i-motif (figure 4.39). 
Group 1 cations; potassium, rubidium and caesium as well as group 2 cations; 
magnesium, calcium, strontium and barium were tested as part of the screen in 10 mM 
sodium cacodylate buffer with 5 mM sodium chloride. At a cation concentration of 100 
mM they all showed a destabilising effect on the i-motif (table 4.3). In order to try and 
complete the set of group 1 cations and to compare the results to previously published 
examples, lithium and sodium were also tested. However, francium, beryllium and 
radium were not tested because they were not available and all three are highly toxic, 
particularly in the case of francium and radium which are radioactive. 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.39: Normalised FRET melting curves for human telomeric i-motif with 100 mM 
of group 1 and group 2 cations at pH 5.5. [DNA] = 200 nM, buffer = 10 mM sodium 
cacodylate and 5 mM NaCl. 
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[Salt] = 100 mM Tm (°C) ΔTm (°C) 
LiCl 45.8 -0.7 
NaCl 45.5 -1.0 
KCl 45.2 -1.0 
RbCl 44.2 -2.0 
CsCl 44.5 -1.7 
MgCl2 43.2 -3.0 
CaCl2 38.2 -8.0 
SrCl2 40.5 -6.0 
BaCl2 38.8 -7.3 
 
Table 4.3: Change in melting temperature of human telomeric i-motif with 100 mM of 
group 1 and group 2 salts. The error in the Tm values is ± 0.3 °C. 
 
These results give support to previous reports in the literature that Li+ ions destabilise 
the i-motif,52 as well as Na+, K+ and Mg2+ and shows that this is also the case for other 
group 1 and 2 cations.50,51 At pH 7.4 the group 1 cations have no effect on the unfolded 
DNA. The group 2 cations do cause a small decrease in fluorescence at 100 mM but this 
is not to base level suggesting it is not a folding event and there is no change with 
temperature. These results are only preliminary and are carried out at a pH where the 
i-motif is already stable. Further work could be carried out to see whether these cations 
promote unfolding of the i-motif using circular dichroism and FRET titrations at a pH 
closer to the transitional pH of the structure. This work offers important information 
to those working in the i-motif field about what factors affect i-motif stability 
particularly when choosing buffer conditions for example in the design of an i-motif 
screen or assay.  
 
4.6 Conclusions 
 
In the first part of this chapter, the interaction between silver cations and an i-motif 
forming sequence has been investigated, demonstrating that they are able to fold the 
DNA into an i-motif-like structure at neutral pH. This effect was observed using FRET 
melting and FRET titration experiments, circular dichroism and UV difference spectra 
summarised in section 4.2.6. Since these investigations were completed, the results 
have been supported by published results from other groups. Iryna Goncharova has 
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studied the effect of silver cations on the stability of C-C, G-G and C-G base pairs using 
electronic and vibrational circular dichroism.207 Her results showed that silver (I) ions 
enabled the stacking of cytosine base pairs at pH 10 that resembled the spectra of 
stacked cytosine-H+-cytosine base pairs in the i-motif. Matias Berdakin and co-workers 
took a different approach, comparing the structure of C-Ag+-C base pairs to C-H+-C base 
pairs in the gas phase using infrared-multiphoton dissociation spectroscopy.208,209 
Their results showed that the two types of base pair are both planar and share the same 
keto-amino structure with glycosidic bonds in the trans form. One difference they did 
observe is in the angle of the glycosidic bonds in the C-Ag+-C base pair compared to the 
hemiprotonated pair. This difference in glycosidic bond angle may be one contributing 
factor to the difference in CD spectra observed in section 4.2.2 as the optical activity 
that is responsible for the circular dichroism spectra of DNA are a result of changes in 
glycosidic bond orientation. In contrast to these published examples, Ting-Ting Zhao 
and colleagues have looked at the interaction between i-motif and silver in the 
formation of silver nanoclusters at acidic pH. Their CD data indicate that at acidic pH, 
silver disrupts the i-motif and favours the formation of an antiparallel 4 stranded 
structure.210 This may be supported by the FRET melting experiments carried out at 
pH 5.5 in section 4.2.1 (figure 4.4) which shows a small decrease in melting 
temperature for the first melting transition which is likely to be that of the i-motif, 
while there was a second, higher melting transition corresponding to a different 
structure. However, the CD spectrum they published does not resemble that observed 
at neutral pH in figure 4.7 as it does not have the positive peak at 240 nm and the 
strongly negative peak at 260 nm. 
  
The formation of an i-motif-like structure was also shown to be reversible using 
cysteine to chelate the silver. These results have a number of implications. The fact that 
silver enables the formation of an i-motif like structure at neutral pH could enable the 
study of the structure and investigation of compounds interacting with the structure 
at neutral rather than acidic pH. The reversibility of the folding with cysteine could be 
used as an alternative switch mechanism for i-motif nanotechnology applications such 
as motors and switches which have so far relied on changes in pH to create the required 
structural change.203 Since this work was carried out, the use of silver to form an i-
motif-like structure has already been applied to the design of a logic gate with OR and 
INHIBIT functionality that relies on both H+ and Ag+ as inputs to the system.211 When 
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combined with a fluorescent ligand that is selective for the i-motif, this work has been 
applied to the design of an i-motif based sensor for silver (I) ions with an estimated 
0.25 nM limit of detection.212 These results provide good evidence that addition of 
silver (I) ions results in a structure similar to the i-motif rather than a hairpin. Other 
applications in sensing of both silver and cysteine could be developed, particularly 
utilising the FRET effect of a dual labelled oligonucleotide, similar to examples that 
have already been published based on double stranded DNA.193,194 It is worthwhile to 
note that whilst the results strongly indicate the formation of an i-motif type structure, 
they also show some differences compared to a normal acid stabilised i-motif. It is 
therefore not clear exactly how the silver cations stabilise this structure – are they 
forming cytosine-Ag+-cytosine base pairs or are the silver ions sitting between base 
pairs or forming a nanocluster around which the DNA folds? To investigate this in more 
detail, structural studies will be required using NMR to build up a model of the 
structure or ideally a crystal structure would be obtained which could show precisely 
where the silver ions interact with the DNA. 
 
Having investigated the effect of silver cations on the formation of i-motif DNA, a wider 
investigation of the effect of different cations on i-motif DNA was undertaken. A 
selection of 26 different cations including those from groups 1, 2 and 3, the transition 
metals and the lanthanides, were screened by FRET melting at pH 5.5 and pH 7.4. 
Initially it could be seen that the group 1 and 2 cations: Li+, Na+, K+, Rb+, Cs+, Mg2+, Ca2+, 
Sr2+ and Ba2+ destabilised the i-motif at acidic pH with ΔTm’s between -0.7 and -8. This 
expands on previous work by Saxena,50 Mergny,51 and Kim.52 Further work could be 
carried out using circular dichroism or FRET titrations to see if these cations promote 
the unfolding of the i-motif, particularly at the transitional pH of the structure. These 
results have important implications as several of these cations are found in biological 
conditions and are routinely used in buffers to vary the ionic strength. This information 
could be important in choosing conditions for the design of experiments on i-motif 
DNA.  
 
The FRET screen at pH 7.4 identified 10 cations which seemed to show folding of the 
DNA. These were Al3+, Cu2+, Ga3+, Ho3+, Sm3+, Tb3+, Yb3+, Y3+, Hg2+ and Zn2+. Interestingly, 
Cu2+, Hg2+ and Zn2+ share the same linear coordination geometry as Ag+ which could 
enable them to facilitate C-C base pairs effectively. However when testing the cations 
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by CD, the majority caused precipitation of the DNA and lowered the pH at the high 
concentrations needed so they were not investigated further. Cu2+ was the only cation 
that was investigated in greater detail as it showed some signs of change in the CD at 
lower concentration and still caused folding of the DNA in a higher concentration buffer 
that maintained the pH. Hg2+ could not be tested due to the low solubility of the 
mercury salt used and would be worth investigating in the future with a more soluble 
salt such as Hg(ClO4)2  used by Ono and co-workers. 
 
In the second half of this chapter the effect of copper (II) ions on i-motif forming DNA 
was examined in more detail. By completing an analogous set of experiments to those 
used on the silver (I) interaction, the results suggest that copper (II) cations are able to 
initiate and stabilise a change in structure from an i-motif to a hairpin at acidic pH, 
summarised in section 4.4.6. The structural changes observed were also demonstrated 
to be reversible with the addition of EDTA enabling the structure to be repeatedly 
switched from i-motif to hairpin form. However, as with the silver (I) stabilised 
structure, it is not clear from these experiments exactly how the copper ions interact 
with the DNA. A high concentration of Cu2+ (1000 µM) is required to effect the changes, 
therefore it is unlikely that the Cu2+ is only simply stabilising C-C base pairs, as far more 
copper (II) ions are needed than the number of bases present. Again further work is 
required using NMR or X-ray crystallography to fully characterise the copper stabilised 
structure. For example, NMR experiments have been used previously to identify metal 
ion coordination sites in the loop regions of a DNA minihairpin.213 It is also not clear 
how the DNA rearranges itself when moving from the i-motif to a hairpin structure. 
Recently, molecular dynamics simulations have been used to model the unfolding of 
the i-motif,214 therefore similar experiments could be used to shed light on the way the 
structure changes during this transition.  
 
The dynamic equilibrium between hairpin and i-motif have already been shown to be 
important in a biological context. Laurence Hurley’s group, working on the i-motif 
formed within the Bcl-2 promoter sequence showed that stabilisation of the hairpin 
resulted in down regulation and stabilisation of the i-motif resulted in up regulation of 
gene expression.69  Therefore the effect of Cu2+ could be a useful tool to study this 
relationship as it could be used to design in vitro assays to assess the binding of ligands 
to both the i-motif and hairpin structures formed from the same oligonucleotide 
Chapter 4: The Effect of Cations on i-Motif DNA 
 
 
 207 
sequence. Without the use of copper to alter the structure, different sequences would 
be needed to form the two structures which may in itself affect the binding of potential 
ligands. Finally, the ability to reversibly alter the structure of DNA from the i-motif to a 
hairpin rather than just to and from unfolded DNA could provide useful applications in 
nanotechnology as it may offer a different kind of mechanical actuation. As has been 
described the ability of silver to form an i-motif-like structure has already been applied 
to the design of a logic gate.211 With the additional reversible effects of copper (II) ions, 
it may now be possible to design switches and logic gates which respond to multiple 
input signals of protons, silver (I) ions and copper (II) ions that give multiple outputs 
of single strand, i-motif and hairpin structures, all with the same oligonucleotide 
sequence. This will be of special interest to those working in the fast growing field of 
DNA based logic operations and nanotechnology.  
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5.1 Overall Conclusions 
 
This thesis has described investigations into the effect of small molecule ligands and 
cations on i-motif DNA. In chapter 1 the current research into the biological role of i-
motif structures has been reviewed highlighting the factors that show the i-motif is a 
promising target worthy of investigation while illustrating how little work has been 
done in comparison to more well established DNA structures such as the G-quadruplex. 
This provided the background for the work described in this thesis, which aimed to 
discover new chemical biological tools to interact with i-motif DNA structures. These 
could be used in the future to study the possible biological function of the i-motif in 
more detail.   
 
In chapter 2, an existing i-motif ligand BisA was investigated. This ligand was chosen 
in order to be used as a comparison when looking for new i-motif ligands. BisA was 
one of the first i-motif ligands to be identified using a FRET melting assay but no other 
data was shown to support this.100 Therefore, in this work a range of different 
biophysical techniques were used to look at the interaction between BisA and the i-
motif in more detail for the first time. First the FRET melting experiments on BisA were 
repeated at pH 6.8 and after normalising the data produced comparable results to 
those shown by Alberti and co-workers with an apparent stabilisation of ΔTm = 55°C. 
However, the raw FRET melting data showed a decrease in fluorescence signal across 
the temperature range of the experiment indicating that the DNA did not melt at up to 
95°C or that aggregation of the DNA had occurred. To look at this in more detail circular 
dichroism was used. This technique has not been used to look at the interaction 
between BisA and the i-motif before. Interestingly this showed an ICD signal for BisA 
which suggests a binding event and later a binding affinity was measured using 
fluorescence titrations (KD1 = 2.1 µM, KD2 = 145.9 µM). However, the rest of the CD 
spectrum showed a decrease in the i-motif signals indicating condensation of the DNA. 
This was further supported by UV titrations showing a decrease in absorbance at 260 
nm and by polyacrylamide gel electrophoresis which showed retardation and 
smearing of the bands associated with BisA binding. Finally dynamic light scattering 
was used to measure the formation of condensed particles, showing that bigger 
particles form at pH 5.5 compared to pH 6.8 and 7.4. The condensation effects were 
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also apparent with G-quadruplex and double stranded DNA. Control experiments were 
carried out with the mono-acridine (MonoA) and the linker molecule 
diethylenetriamine (DETA) and these did not show the same condensation effects. This 
indicates that it is the combination of two acridine units in the molecule, not just the 
positive charges, which causes this condensation effect. 
 
After identifying the problems with the known i-motif ligand BisA, it unfortunately was 
not suitable to be used as a comparison when looking for new i-motif ligands but did 
highlight the issue of condensation and how this can affect the biophysical techniques 
used to investigate i-motif-ligand interactions. With this in mind, in chapter 3 a diverse 
library of 960 known biologically active compounds was screened by FRET melting to 
identify new i-motif ligands based on the ability of the ligand to stabilise or destabilise 
the structure. This resulted in 34 hits which were narrowed down to 13 after setting a 
criteria of ΔTm = ±5°C. These hits were further reduced down after concentration 
dependence studies and circular dichroism experiments to 6 lead compounds. These 
were tested against different DNA structures by FRET melting and tested for binding 
by SPR. 
 
From this screen two new i-motif binding compounds were identified; tilorone and 
mitoxantrone (figure 5.1). Both are already known DNA binding compounds but have 
never before been shown to interact with i-motif DNA.163,171 The two compounds were 
shown to stabilise the DNA and binding affinities were measured by surface plasmon 
resonance in the low micromolar range (KD = 157.9 µM and 11.0 µM respectively). 
Since mitoxantrone has a much stronger binding affinity than tilorone it can be 
considered as the key hit from the screen. Whilst neither ligand showed any selectivity 
in their binding, mitoxantrone in particular provides a good starting point to develop 
novel analogues with better affinities and selectivities which are different to existing i-
motif ligands. 
 
In chapter 4, the focus moved on to the interaction of metal cations with i-motif DNA. 
It has previously been shown that silver cations stabilise cytosine-cytosine base pairs 
which lead to the hypothesis that silver may enable the formation of i-motif structure 
at neutral pH where the structure can be formed utilising cytosine-Ag+-cytosine base 
pairs instead of the cytosine-H+-cytosine base pairs which do not readily form at this 
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high pH. This hypothesis was tested using FRET melting which showed folding at 
neutral pH. CD titrations then showed formation of an i-motif like structure. FRET 
titrations showed the cooperativity of the interaction with an [Ag]50 = 1.9 µM. After 
this, the folding was shown to be reversible using cysteine to chelate the silver, thus 
providing an alternative switch mechanism for control of i-motif folding at neutral pH. 
 
Finally, the last part of chapter 4 extended the investigation of cations to screen 26 
different cations from groups 1, 2 and 3 as well as the transition metals and 
lanthanides. This screen showed that the group 1 and 2 cations destabilise the i-motif 
supporting work previously carried out on Lithium, sodium, potassium and 
magnesium and extending the study to include other group 1 and 2 cations not 
previously investigated.50–52 As well as this, copper (II) was identified for its ability to 
cause folding at neutral pH but as shown by CD experiments does not form an i-motif 
structure. In fact, it appears to favour formation of a different folded structure. A 
combination of UV difference, CD and NMR experiments all indicate that this structure 
is likely to be a hairpin. Like the effect of silver, the effect of copper was also reversible 
using EDTA and offers an alternative folding and unfolding mechanism which could be 
useful in nanotechnology applications. 
 
5.2 Future Work 
 
The most obvious priority for future work is to begin designing and testing analogues 
based on screen hit compounds in order to improve affinity and selectivity for the i-
motif over other secondary DNA structures. Both the ligands (figure 5.1) have a core 
planar structure with attached aliphatic chains. This provides the opportunity to vary 
the number and position of the chains, the length of the chains and how many hydrogen 
bond donors or acceptors are present. For example, adding another two aliphatic 
chains to mitoxantrone in the 5 and 8 positions may inhibit intercalation and 
disfavour duplex binding thus improving selectivity. Meanwhile, increasing the length 
of the chains at the 1 and 4 positions and increasing the number of hydrogen bond 
donors and acceptors within the side chains could enable a greater degree of 
interaction with loop regions in the i-motif and hence improve affinity. With the 
methods established in this thesis, analogues can quickly be tested by FRET melting to 
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look for stabilisation and compared to other structures such as the G-quadruplex or 
duplex. 
 
 
 
 
 
Figure 5.1: Structures of screen hits mitoxantrone and tilorone. 
 
Another hit from the screen worthy of investigation is tyrothricin. Although its 
binding affinity could not be measured by SPR, it is clear from the FRET melting 
experiments that tyrothricin has some effect on the i-motif structure. Tyrothricin 
itself is actually a mixture of different peptides called tyrocidines and gramicidins.162 
These need to be separated using HPLC or synthesised separately so that they can be 
tested individually. It may be that one of the compounds has a more significant effect 
than the mixture as a whole or the separate compounds may have opposing effects. 
Several reports by Hansjürgen Ristow and colleagues have looked at the interaction 
between tyrocidine and gramicidin and DNA suggesting that tyrocidine forms a tight 
complex with DNA which is disrupted by gramicidin.215,216 They have also shown that 
tyrocidine reduces torsional stress in DNA by forming a complex and altering DNA 
conformation with an effect on the regulation of sporulation which involves DNA 
replication.179,180 These investigations were carried out before the i-motif structure 
was proposed but suggest that tyrocidine does have an effect on DNA structure and 
could be of interest in the context of the i-motif. 
 
Aside from looking at analogues of the screen hit compounds, it is also important to 
look at different i-motifs. For example, tilorone showed only a weak affinity for the 
human telomeric i-motif however it may have a higher affinity for a different i-motif 
structure. Tilorone’s mode of action as an antiviral agent is to induce the interferon 
response but it is not clear precisely how it achieves this. The promoter regions of the 
interferon regulatory factor genes are rich in cytosine and may well contain a potential 
i-motif forming sequence. The interferon regulatory factors are transcription factors 
which control the expression of interferon, therefore the possibility of an i-motif in the 
IRF promoter region could be investigated as a possible mode of action for tilorone. As 
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well as this specific example, there is quite a lot of variety even between the relatively 
small numbers of i-motif structures that have been identified. In particular they vary 
in their loop length and sequence which could significantly affect the binding of a 
ligand. It is therefore important to test the hit compounds and any analogues against a 
range of different i-motif structures as some may have better affinities and specificities 
than others. For example IMC-48 identified by Laurence Hurley and colleagues was not 
only specific for i-motif but was specific for the Bcl-2 i-motif over other i-motifs such 
as VEGF and c-Myc.69 
 
The library screened in this work was quite small in comparison to other available 
libraries and whilst its diversity enabled the inclusion of a wide variety of different 
structure types it was difficult to see any trends in the types of ligands which may bind 
to the i-motif. Now, having established methods for screening libraries against the i-
motif, larger libraries could be screened to enable trends in i-motif binding compounds 
to be identified and more focused libraries of compounds analogous to the hit 
compounds could be screened to increase the number of chemical biological tools 
available to study the i-motif and look at structure activity relationships. Another 
drawback of this screen is that, despite initially identifying 34 interacting compounds, 
this resulted in only 2 main leads due to problems such as precipitation and possible 
micelle formation. Whilst this in itself is a reasonable hit rate from a comparatively 
small compound library, this could be improved by screening a library with better 
characteristics such as solubility. 
 
Throughout this thesis, the primary experiment for identifying an interaction with i-
motif DNA has been FRET melting, identifying compounds based on their ability to 
stabilise the DNA shown by an increase in melting temperature. However this 
precludes the possibility of compounds which bind to the i-motif but do not increase 
its melting temperature. A different screening method such as that used by Laurence 
Hurley and co-workers could be used to look at i-motif interaction by change in 
fluorescence.69 By testing at the transitional pH where the i-motif and the unfolded 
DNA are in equilibrium, a decrease in fluorescence would indicate a shift in the 
equilibrium towards i-motif formation whilst an increase would suggest the opposite. 
Re-screening the compound library by this alternative method may provide some 
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additional hit compounds which can shift the equilibrium towards i-motif but did not 
necessarily increase the melting temperature of an already stable i-motif structure. 
 
As described above, in chapter 4, the effect of different cations was investigated and it 
was shown that silver cations are able to stabilise the formation of an i-motif like 
structure at neutral pH. Further work in this area would be to apply this property for 
use as an alternative switch mechanism to fold the i-motif without the need for 
changing the pH. The rapid folding of the i-motif after decreasing pH has led to its use 
in a variety of nanotechnology applications which could now be extended to included 
Ag+ as a trigger.203 This has been illustrated recently with the design of OR and INHIBIT 
logic gates based on the i-motif structure using both H+ and Ag+ as inputs.211 Here 
Yunhua Shi and co-workers used a fluorescent probe to detect i-motif formation in the 
presence of H+ or Ag+ or both. As well as performing logic operations, the sensing of 
silver (I) ions has also been shown using an i-motif forming sequence combined with a 
fluorescent probe, enabling detection of silver ions at nanomolar concentrations.212 In 
the next part of the chapter, it was shown that unlike silver, copper cations stabilise 
the formation of a different type of structure within i-motif sequences which is likely 
to be a hairpin. This is exciting as it means that using the same oligonucleotide strand, 
three different structural conformations can be formed: single strand, hairpin and i-
motif depending on the different concentrations of H+, Ag+ or Cu2+. This is likely to be 
of interest to those working in the field of nanotechnology applications, enabling the 
design of logic gates or switches with multiple inputs and outputs.  
 
Another potential hit from the cation screen that is worthy of further investigation is 
mercury. This appeared to cause folding of the DNA in FRET melting experiments at pH 
7.4 with a melting temperature of 61.5°C (at [Hg2+] = 10 µM). Unfortunately this could 
not be investigated further because the salt HgAc2 was not sufficiently soluble. A more 
soluble salt such as Hg(ClO4)2 used by Akira Ono and co-workers,186 could enable the 
testing of Hg2+ with i-motif by CD and UV difference spectroscopy to further 
understand its effect on i-motif DNA. 
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6.1 General Experimental 
 
Chemical reagents were used as supplied unless otherwise stated and were of general 
purpose grade. Solvents were purchased from either Sigma-Aldrich or Fisher. 
 
NMR spectra were acquired on a Bruker Ultrashield Plus 400 MHz spectrometer and 
analysed using TopSpin 3.1. Deuterated solvents were used as indicated and at ambient 
probe temperature (300 K). The notation used for splitting patterns in 1H-NMR are: 
singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m) and broad (br). The signals 
are given as δ values in ppm with coupling constants (J), provided in Hertz. 
 
IR spectra were acquired as neat samples on a Perkin Elmer Spectrum BX FT-IR 
system with Spectrum v5.3.1 software. 
 
Mass spectra were obtained from the EPSRCs National Mass Spectrometry Service 
Centre at the University of Swansea using atmospheric-pressure chemical ionisation 
(APCI). 
 
TLC was carried out on Merck Kieselgel 60 F254 plates and spots were visualised under 
UV-light. 
 
Flash chromatography was carried out using Aldrich 60 silica gel at room 
temperature under a positive pressure of air.  
 
Melting Points were measured on an Electrothermal melting point apparatus using 
open capillary tubes. 
 
Oligonucleotides both labelled and unlabelled (table 6.1) were purchased from 
Eurogentec, purified by rpHPLC. Solid DNA samples were dissolved in MilliQ water to 
make stock solutions of 100 µM for labelled and 1 mM for unlabelled oligonucleotides. 
Using the extinction coefficients provided for each sequence, final concentrations were 
confirmed by UV absorbance at 260 nm with a Nanodrop ND-1000 spectrophotometer 
instrument. These stocks were then diluted in the appropriate buffers for further 
experiments. 
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Name Sequence 5'→3' 
hTeloC d(TAACCCTAACCCTAACCCTAACCC) 
hTeloG d(GGGTTAGGGTTAGGGTTAGGG) 
DSa d(TATAGCTATA-HEG(18)-TATAGCTATA) 
c-Myc d(TCCCCACCTTCCCCACCCTCCCCACCCTCCCCA) 
C-hairpin d(CTCTCTTCTCTTCATTTTTCAACACAACACAC) 
HIF-1α d(CGCGCTCCCGCCCCCTCTCCCCTCCCCGCGC) 
PDGFA d(CCGCGCCCCTCCCCCGCCCCCGCCCCCGCCCCCCCCCCCCC) 
hTeloCFRET FAM-d(TAACCCTAACCCTAACCCTAACCC)-TAMRA 
hTeloGFRET FAM-d(GGGTTAGGGTTAGGGTTAGGG)-TAMRA 
DSFRET FAM-d(TATAGCTATA-HEG(18)-TATAGCTATA)-TAMRA 
c-MycFRET FAM-d(TCCCCACCTTCCCCACCCTCCCCACCCTCCCCA)-TAMRA 
18 base marker FAM-d(GTAAAACGACGGCCAGTG) 
hTeloCBiotin Biotin-d(TAACCCTAACCCTAACCCTAACCC) 
c-MycBiotin Biotin-d(CCTTCCCCACCCTCCCCACCCTCCCCA) 
DSBiotin Biotin-d(GGCATAGTGCGTGGGCGTTAGC) 
DS compliment d(GCTAACGCCCACGCACTATGCC) 
 
Table 6.1: Sequences used throughout this research. a The double stranded sequence 
consists of two complimentary 10 base sequences linked by an 18 unit hexaethylene 
glycol (HEG) polymer. 
 
Annealing DNA. Where stated, samples were thermally annealed by heating to 95°C 
in a heat block before being allowed to cool to room temperature slowly over night. In 
general the sequences were annealed if forming duplex or G-quadruplex structures 
was required. The i-motif forming sequences were annealed at pH 6.8 but in general 
were not annealed at pH 5.5 because formation of the i-motif structure is rapid under 
the acidic conditionsand therefore was not necessary. The i-motif forming sequences 
were also not annealed when tested at pH 7.4 where the random coil structure was 
required. 
 
FRET melting experiments were carried out on a QIAgen Roto-gene Q PCR machine 
using QIAgen PCR tubes. The following fluorescently labelled oligonucleotide 
sequences were used hTeloCFRET, hTeloGFRET, DSFRET, c-MycFRET (table 6.1). In a typical 
experiment, 400 nM solutions of labelled oligonucleotide sequence were made up in 
the appropriate buffer. The donor fluorophore FAM was 6-carboxyfluorescein, the 
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acceptor fluorophore TAMRA was 6-carboxytetramethylrhodamine. Ligand stock 
solutions were made up in either water or DMSO and then diluted to the appropriate 
concentrations in buffer by serial dilution. Cation stock solutions were made up in 
water. 10 µL of DNA solution were combined with 10 µL of ligand or cation solution 
and the samples heated from 25 to 95°C at a rate of 1°C per minute. The samples were 
excited at 470 nm and the fluorescence of FAM was monitored at 510 nm using a green 
filter at 1°C intervals. The final data was analysed using QIAgen Roto-gene Q-series 
software, Microsoft Excel and Origin Pro 9.1. 
 
Fluorescence titrations were carried out on a Perkin Elmer LS55 fluorescence 
spectrometer using a quartz cuvette with a 10 mm path length. For FRET titrations, the 
appropriate FRET labelled oligonucleotide was diluted to 100 nM in either pH 5.5 or 
pH 7.4 buffer. The sample was excited at 490 nm and the fluorescence emission 
measured from 500 – 600 nm allowing the monitoring of emission peaks for both FAM 
(515 nm) and TAMRA (580 nm). Ligand or cation solutions were diluted in buffer and 
titrated into the sample in small aliquots using a Hamilton syringe or a pipette. The 
sample was mixed in the cuvette using a pipette and the fluorescence measured. The 
spectra measured are the average of 3 scans. For ligand fluorescence titrations, stock 
solutions of ligand were diluted in buffer and both the emission and excitation spectra 
were measured (200 – 800 nm) to find the most appropriate excitation and emission 
wavelengths. The concentration of ligand, slit width and scan speed were optimised to 
give the best spectrum for each ligand. Small aliquots of DNA were titrated into the 
sample using a Hamilton syringe or a pipette and the change in fluorescence of the 
ligand was measured. The data was analysed using Spekwin 32, Microsoft Excel and 
Origin Pro 9.1. 
 
Circular dichroism experiments were carried out on a JASCO J-810 
spectropolarimeter, under a constant flow of nitrogen using a quartz cuvette with a 1 
mm path length. In a typical experiment, hTeloC oligonucleotide was diluted in pH 5.5, 
pH 6.8 or pH 7.4 buffer to a concentration of 10 µM. Sample volumes were 200 µL. 
Aliquots of ligands or cations were added using a Hamilton syringe or a pipette and the 
samples were scanned from 400 nm to 200 nm using a data pitch of 0.5 nm, a scan 
speed of 200 nm.min-1, a response time of 1 s and a slit width of 2 nm. Each spectrum 
shown is the average of 3 scans. Each sample had a scan of the appropriate buffer 
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subtracted from it. The spectra were zero corrected at 320 nm and corrected for the 
effect of dilution. The data was analysed using Microsoft Excel and Origin Pro 9.1.  
 
UV Absorbance titrations were carried out on either a Hitachi U-3010 
spectrophotometer or an Agilent Technologies Cary 60 UV-Vis spectrometer as 
described, using a quartz cuvette with a 10 mm path length. UV melting experiments 
were carried out on an Agilent Technologies Cary 60 UV-Vis spectrometer with a 
Quantum Northwest TC 1 temperature controller. For UV absorption titrations, 
unlabelled oligonucleotide sequences were diluted in either pH 5.5, pH 6.8 or pH 7.4 
buffer and the absorbance measured from 200 to 400 nm or from 200 to 800 nm. Small 
aliquots of ligand or cation were titrated into the sample using a Hamilton syringe or a 
pipette and the change in absorbance monitored. An analogous titration of ligand or 
cation in just buffer was also carried out and subtracted from the titration with DNA. 
Data was baseline corrected by subtraction of the spectrum of just buffer and zero 
corrected at either 400 or 800 nm as described. The data was analysed using Microsoft 
Excel and Origin Pro 9.1.  
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6.2 Experimental for Chapter 2 
 
6.2.1 Synthesis of BisA and MonoA. 
 
These steps were carried out following literature procedures.136,149,154  
 
4,4’-dimethyldiphenylamine-2-carboxylic acid (3) 
 
 
 
 
 
 
 
2-amino-5-methylbenzoic acid (5.013 g, 33.2 mmol, 1.1 eq), p-bromotoluene (5.177 g, 
0.0302 mol, 1 eq), potassium carbonate (4.14 g, 30.2 mmol, 1 eq), copper iodide (95 
mg) and copper powder (94.8 mg) were dissolved in n-pentanol (dried over molecular 
sieves, 15 mL) and was heated to reflux at 150°C with vigorous stirring overnight. The 
hot reaction mixture was filtered through celite and then washed thoroughly with 
methanol. The dark filtrate was acidified with 6 M hydrochloric acid then left in the 
fridge overnight. Product crystals were collected by filtration and recrystallised from 
ethanol. The remaining dark filtrate was reduced to dryness, re-dissolved in DCM and 
filtered through a short silica column (100% DCM) until the fractions were clear. The 
yellow fractions were combined and reduced to give the crude product which was 
crystallised from ethanol to give 3 as a yellow solid (4.64 g, 64% from 4 crops) 
1H NMR (CDCl3) δH ppm: 9.05 (1H, NH, br s), 7.82 (1H, ArH, m), 7.12 (6H, ArH, m), 
2.35 (3H, CH3, s), 2.26 (3H, CH3, s). This is consistent with the literature.136 
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9-oxo-9,10-dihydro-2,7-dimethylacridone (8) 
 
 
 
 
 
4,4’-Dimethyldiphenylamine-2-carboxylic acid 3 (2.27 g, 9.42 mmol, 1 eq) was 
dissolved in concentrated sulfuric acid (25 mL) and heated to reflux at 100°C for 1 
hour.154 The reaction was then allowed to cool and poured over ice water (20 mL). The 
yellow precipitate was filtered and washed with water. The insoluble material was 
collected and recrystalised from DMF to give the pure product 8 as a yellow solid 
(0.814 g, 39% from 3 crops)  
m.p.: > 355oC, Rf: 0.29 (eluent: 100% DCM)  
1H NMR (DMSO) δH ppm: 11.59 (1H, NH, s), 8.02 (2H, ArH 1 and 8, ap s), 7.55 (2H, ArH 
3 and 6, dd, J1 = 8.5 Hz, J2 = 2.0 Hz), 7.44 (2H, ArH 4 and 5, d, J = 8.5 Hz), 2.42 (6H, CH3, 
s). Assignments were confirmed by 2D COSY NMR. 13C NMR (DMSO) δC ppm: 176.31 
(1C, CO 9), 138.87 (2C, ArC), 134.70 (2C, ArC 1 and 8), 129.77 (2C, ArC), 125.04 (2C, 
ArC 3 and 6), 120.21 (2C, ArC 2 and 7), 117.21 (2C, ArC 4 and 5), 20.56 (2C, CH3). IR: 
2785 cm-1 (C-H), 1637 cm-1 (C=0), 1480 cm-1 (C=C) HRMS (APCI): Calculated for 
C15H14O1N1 ([M+H+]): 224.1070. Found: 224.1071. 
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9-Chloro-2,7-dimethylyacridine (4) 
 
 
 
 
 
Acridone 8 (106.7 mg, 0.478 mmol) was dissolved in thionyl chloride (1 mL) with 1 
drop of DMF and heated to reflux at 90°C for 1.5 hours.152 After which, the mixture was 
reduced in vacuo, washed with benzene and reduced to dryness in vacuo to give a 
yellow solid. The crude product was purified by flash column chromatography (100% 
DCM) to give the yellow product as a solid (122.7 mg, impure due to remaining DCM). 
1H NMR (DMSO) δH ppm: 8.02 (2H, ArH 4 and 5, d, J = 8.8 Hz), 7.97 (2H, ArH 1 and 8, 
ap s), 7.50 (2H, ArH 3 and 6, dd, J1 = 8.8 Hz, J2 = 1.6 Hz), 2.50 (6H, CH3, s) (This 
corresponds with the literature,136). HRMS (APCI): Calculated for C15H13N1Cl1 
([M+H+]): 242.0731. Found: 242.0734. 
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9,10-dihydro-2,7-dimethylacridine (9) 
 
 
 
 
 
The acridone 8 (640 mg, 2.87 mmol, 1 eq) was suspended in anhydrous THF (11 mL) 
under nitrogen. 1 M Borane-THF complex (3.44 mL, 3.44 mmol, 1.2 eq) was added 
drop-wise and the reaction was heated to reflux under nitrogen overnight. 3 M aqueous 
hydrochloric acid solution (20.8 mL) was added before the mixture was basified with 
saturated sodium carbonate solution (88 mL). The mixture was extracted with DCM (3 
x 50 mL), dried over magnesium sulfate and reduced in vacuo. The unstable product 
was quickly purified on a short column (eluent: 100% DCM) and reduced in vacuo to 
give a white solid (376 mg, 63%).  
m.p.: 218oC, Rf: 0.78 (100% DCM) 
1H NMR (CDCl3) δH ppm: 6.91 (2H, ArH 1 and 8, s), 6.87 (2H, ArH 3 and 6, d, J = 7.9 
Hz), 6.55 (2H, ArH 4 and 5, d, J = 7.9 Hz), 5.79 (1H, NH, br s) 3.98 (2H, CH2 9, s), 2.26 
(6H, CH3, s). Assignments were confirmed by 2D COSY NMR. 13C NMR (CDCl3) δC ppm: 
138.03 (2C, ArC), 129.57 (2C, ArC), 129.12 (2C, ArC), 127.40 (2C, ArC), 119.86 (2C, 
ArC), 113.21 (2C, ArC), 31.38 (1C, CH2 9), 20.59 (2C, CH3). IR: 3400 cm-1 (N-H), 2920 
cm-1 (C-H), 1610 cm-1 (C=C), 1510 cm-1 (C=C). HRMS (APCI): Calculated for C15H16N1 
([M+H+]): 210.1277. Found: 210.1277.  
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2,7-dimethylacridine (5) 
 
 
 
 
 
The acridane 9 (376.2 mg, 1.8 mmol, 1 eq) was stirred in ethanol (47 mL) and water 
(9.5 mL) with iron trichloride (1.42 g) at 50°C for 1 hour. Saturated sodium bicarbonate 
solution (81.47 mL) was then added and the mixture extracted with DCM (3 x 50 mL), 
dried over magnesium sulfate and reduced in vacuo. This gave the yellow product 5 
(358.3 mg, 96%), which was used in the next step without purification.  
1H NMR (CDCl3) δH ppm: 8.55 (1H, ArH 9, s), 8.11 (2H, ArH 4 and 5 d, J = 8.9 Hz), 7.73 
(2H, ArH 1 and 8, ap s), 7.59 (2H, ArH 3 and 6, dd, J1 = 8.9 Hz, J2 = 1.92 Hz), 2.58 (6H, 
CH3, s). This is consistent with the literature which gave (CDCl3, 200 MHz): 8.56 (1H, 
s), 8.12 (2H, d, J = 9.0 Hz), 7.73 (2H, s), 7.61 (2H, d, J = 9.0 Hz), 2.58 (6H, s).136  
 
2,7-acridinedicarboxaldehyde (6) 
 
 
 
 
 
2,7-Dimethylacridine (337.4 mg, 1.63 mmol, 1 eq), selenium dioxide (397.9 mg, 3.59 
mmol, 2.2 eq) and naphthalene (1.627 g, 12.7 mmol, 7.8 eq) were heated slowly to 
200°C in a heat block and stirred. The reaction was monitored by TLC (100% DCM). 
When the starting material was exhausted (~5 hours), the mixture was dissolved in 
DCM and filtered through celite. The filtrate was reduced in vacuo, washed with hexane 
and reduced to dryness. Excess naphthalene was removed by sublimation at 200°C to 
give the pure yellow product 6 as an amorphous solid (319 mg, 83%). 
1H NMR (CDCl3) δH ppm: 10.27 (2H, CHO, s), 9.17 (1H, ArH 9, s), 8.60 (2H, ArH, s), 8.35 
(4H, ArH, m). This is consistent with the literature.136 
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2,5,8,21,24,27-Hexaaza[9,9](2,7)acridinophane (1 BisA) 
 
 
 
 
 
 
 
 
 
2,7-Acridinedicarboxaldehyde (100 mg, 0.426 mmol, 2 eq) was dissolved in a mixture 
of DCM and methanol (34.1 mL, 1:1 v/v) under nitrogen. Diethylenetriamine (45.9 μL, 
43.88 mg, 0.426 mmol, 2 eq) in DCM and methanol (3.41 mL, 1:1 v/v) was added drop-
wise and the reaction stirred at room temperature under nitrogen for 48 hours. The 
mixture was then reduced to dryness in vacuo at 25°C, washed with diethyl ether and 
redissolved in a solution of DCM and methanol (25.6 mL, 1:2 v/v). Sodium borohydride 
(48.3 mg, 1.278 mmol, 6 eq) was added to the solution at 0°C then stirred for 3 hours. 
The resultant mixture was reduced in vacuo and redissolved in water (7 mL) and 
extracted with a solution of DCM and methanol (4 × 10 mL 9:1 v/v). The combined 
organic extracts were dried and reduced. The residues were dissolved in water washed 
repeatedly with ether and DCM. 6 M hydrochloric acid (200 μL) was added and the 
solution reduced in vacuo to give the pure yellow green product as the 8 × HCl salt (53.1 
mg, 28%). 
1H NMR (D2O) δH ppm: 9.60 (2H, ArH, s), 8.39 (4H, ArH, s), 8.21 (4H, ArH, d, J = 9.09 
Hz), 8.09 (4H, ArH, d, J = 9.09 Hz), 4.49 (8H, NHCH2Ar, s), 3.40 (8H, NHCH2, t, J = 6 Hz), 
3.31 (8H, NHCH2, t, J = 6 Hz). This compares well with the literature which was carried 
out on a lower sensitivity instrument (D2O, 200 MHz): 9.84 (2H, s), 8.54 (4H, s), 8.24 
(8H, q), 4.57 (8H, s), 3.48 (16H, s).136 
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2,7-(Di-n-propylaminomethyl)acridine (2 MonoA) 
 
 
 
 
 
2,7-Acridinedicarboxaldehyde (48 mg, 0.20 mmol, 1 eq) was dissolved in a mixture of 
DCM and methanol (62.5 mL, 1:1 v/v) and added dropwise to a solution of n-
propylamine (0.62 g, 0.45 mL, 10.5 mmol) in methanol (6.2 mL) under argon and 
stirred at room temperature for 48 hours. The mixture was reduced in vacuo to give a 
yellow solid with some red/brown side products. The mixture was redissolved in 
methanol (100 mL), the yellow solid was soluble but the red/brown material was not 
soluble. Sodium borohydride (18.3 mg, 0.483 mmol, 2.3 eq) was added to the 
suspension at 0°C and the reaction stirred at 0°C for 30 minutes then for a further hour 
at room temperature until TLC showed the reaction to be complete. The mixture was 
reduced in vacuo to a yellow solid then re-dissolved in water (5 mL) and extracted with 
a mixture of DCM in methanol (40 mL 40:1 v/v). The organic extract was washed with 
water (3 × 5 mL) and the aqueous layer was extracted with DCM (3 × 15 mL). The 
combined organic extracts were dried over MgSO4 and reduced in vacuo. The crude 
product was again re-dissolved in methanol and centrifuged to remove insoluble red 
material. The methanol supernatant was reduced in vacuo to give a yellow/brown oil. 
The product was washed with 1 M hydrochloric acid in methanol (5 mL) then reduced 
in vacuo. Half the MonoA salt (26.2 mg) was dissolved in saturated NaHCO3 (2 mL) and 
extracted 8 times with equal volumes of DCM, dried over MgSO4 and reduced in vacuo 
to give the pure yellow green solid which was re-made into the salt form by dissolving 
in 1 M hydrochloric acid in methanol (2 mL) and reducing to dryness in vacuo (24 mg, 
0.056 mmol, 28%).  
1H NMR (D2O) δH ppm: 9.59 (1H, ArH 9, s), 8.42 (2H, ArH 1 and 8, ap s), 8.28 (2H, ArH 
4 and 5, d, J = 9.03 Hz), 8.12 (2H, ArH 3 and 6, dd, J1 = 9.03 Hz, J2 = 1.83 Hz), 4.48 (4H, 
NH2CH2ArH, s), 3.07 (4H, CH2CH2NH2, t, J = 7.78 Hz), 1.69 (4H, CH2CH2NH2, m), 0.91 
(6H, CH3CH2, t, J = 7.46 Hz). This compares well with the literature (D2O, 200 MHz): 
9.78 (2H, s), 8.46 (2H, s), 8.24 (4H, q), 4.47 (4H, s), 3.03 (4H, t), 1.65 (4H, m), 0.87 (6H, 
t).136 
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6.2.2 FRET Melting Experiments 
 
FRET melting experiments were carried out as described in section 6.1. hTeloCFRET 
oligonucleotide was used at  pH 5.5 and 7.4 without annealing but at pH 6.8 was 
thermally annealed, hTeloGFRET and DSFRET oligonucleotide sequences were thermally 
annealed, all at a concentration of 400 nM. A stock solution of BisA was made up in 
water at a concentration of 10 mM and then diluted to the appropriate concentration 
in buffer by serial dilution. 10 µL of DNA solution were combined with 10 µL of BisA 
solution giving final concentrations of [DNA] = 200 nM and [BisA] = 0, 0.2, 0.4, 0.6, 0.8 
and 1 µM. 
 
6.2.3 Circular Dichroism Experiments 
 
Circular dichroism experiments were carried out as described in section 6.1. 200 µL of 
10 µM unlabelled hTeloC oligonucleotide was thermally annealed in either 10 mM 
sodium cacodylate buffer (pH 6.8), or used immediately without annealing in 10 mM 
sodium cacodylate 100 mM sodium chloride buffer (pH 7.4 and 5.5). 1 equivalent 
aliquots of BisA were added, up to a concentration of 100 µM using a Hamilton syringe 
and the samples were mixed with a pipette before being scanned from 400 nm to 220 
nm.  
 
6.2.4 Fluorescence Titration Experiments 
 
Fluorescence titrations were carried out as described in section 6.1. BisA was diluted 
to a concentration of 1 µM in pH 5.5 buffer. The sample was excited at 255 nm and 
emission spectra taken from 265 to 500 nm with a slit width of 5 nm and a scan speed 
of 500 nm.min-1. Unlabelled hTeloC DNA was titrated into the sample in 1 equivalent 
portions using a Hamilton syringe, the sample was mixed with a pipette and the change 
in fluorescence at the emission wavelength of 426 nm was measured. 
 
6.2.5 FRET Titration Experiments 
 
FRET titrations were carried out following the procedure outlined in section 6.1. 
Fluorescently labelled oligonucleotide hTeloCFRET was diluted to 100 nM and annealed 
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in pH 6.8 buffer containing 10 mM sodium cacodylate or diluted in pH 5.5 buffer 
containing 10 mM sodium cacodylate and 100 mM sodium chloride and used 
immediately without annealing. BisA was titrated into the sample in small aliquots up 
to a concentration of 2 µM using a Hamilton syringe. The sample was excited at 490 nm 
and the emission spectrum taken from 500 to 660 nm. This enabled the monitoring of 
the change in fluorescence of both FAM (515 nm) and TAMRA (580 nm). 
 
6.2.6 UV Titration Experiments 
 
UV titrations were carried out on a Hitachi U-3010 spectrophotometer as described in 
section 6.1. A matched cuvette containing buffer was used as a reference sample. 
Unlabelled hTeloC i-motif was diluted in 10 mM sodium cacodylate 100 mM sodium 
chloride buffer (pH 5.5) or thermally annealed in 10 mM sodium cacodylate buffer (pH 
6.8) and diluted to a concentration of 2.5 µM and a volume of 200 µL. Aliquots of BisA 
were added with a Hamilton syringe and the sample mixed with a pipette. Initial 
titrations were carried out without centrifugation but in later titrations the sample was 
centrifuged at 6000 rpm before scanning to remove dust. The samples were scanned 
from 200 – 800 nm. The change in absorbance of DNA with increasing BisA 
concentration was plotted at 260 nm. An analogous titration of just BisA in buffer was 
carried out and the change in absorbance of BisA was plotted at 248 nm.  
 
6.2.7 Polyacrylamide Gel Electrophoresis Experiments 
 
hTeloCFRET labelled DNA was diluted to 1 µM in pH 5.5 10 mM sodium cacodylate 100 
mM NaCl buffer without annealing. For titration gels, samples of i-motif DNA were 
combined with 0, 1, 5, 10, 15, 20, 25 and 30 equivalents of BisA, in lanes 2 to 9. Control 
gels were carried out showing the effect of increasing concentrations of MonoA and 
DETA. For these gels, samples of i-motif DNA were combined with 0, 2, 10, 20, 30, 40, 
50 and 60 equivalents of MonoA or DETA in lanes 2 to 9.  A comparison gel was carried 
out to directly compare the effect of BisA on i-motif, G-quadruplex and duplex DNA 
structures. For this gel i-motif, double stranded and G-quadruplex DNA sequences 
were combined with 0, 1 and 30 equivalents of BisA in lanes 2 to 10 respectively. The 
samples were transferred to a native 15% polyacrylamide gel and run at 100 Volts for 
1 hour 15 minutes in pH 5.5 10 mM sodium cacodylate 100 mM sodium chloride buffer. 
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An 18 base single stranded sequence labelled with FAM was used as a marker in lane 
1 for all the gels (table 6.1). Gels were made by combining 30% acrylamide/bis solution 
(5 mL) with water (4.5 mL), 10 x TBE pH 8.0 buffer (0.5 mL) and 10% ammonium 
persulfate (100 µL) before addition of tetramethylethylenediamine (4 µL) and being 
allowed to set for approximately 1 hour. The gels were imaged on a FujiFilm LAS-3000 
dark box using 460 nm excitation and a Y515 filter with a ¼ second automatic 
exposure. 
 
6.2.8 Dynamic Light Scattering Experiments 
 
Dynamic light scattering measurements were carried out on a Malvern Zetasizer 
Nanoseries Nano-ZS instrument using a quartz cuvette with a 10 mm path length. For 
pH 5.5 experiments, unlabelled hTeloC DNA was diluted in pH 5.5 10 mM sodium 
cacodylate 100 mM NaCl buffer and used immediately. For pH 6.8 and pH 7.4 
experiments, unlabelled hTeloC DNA was diluted in pH 6.8 10 mM sodium cacodylate 
or pH 7.4 10 mM sodium cacodylate 100 mM NaCl buffer and thermally annealed. In all 
cases, the DNA was diluted to 2.5 µM and the buffers, BisA solution and final sample 
were filtered through 0.22 µm syringe filters to remove any particulate matter. 1 
equivalent aliquots of BisA were added with a Hamilton syringe and centrifuged at 
6000 rpm for 3 minutes again to remove dust then measured. The sample was 
irradiated at 633 nm and the scattering was measured at an angle of 173°. The 
presented results are the average of 3 scans. The data was analysed using Malvern 
Zetasizer Software v6.34, Microsoft excel and Origin Pro 9.1. 
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6.3 Experimental for Chapter 3 
 
6.3.1 Initial FRET melting screen 
 
The initial FRET melting screen was performed in collaboration with Camille Huguin. 
hTeloCFRET labelled oligonucleotide was diluted to 220 nM and annealed in 10 mM 
sodium cacodylate buffer at pH 5.5 with 100 mM sodium chloride. The 960 compound 
library was provided as individual 1 mM stock solutions of each compound in DMSO. 2 
µL of compound stock solution was combined with 18 µL of DNA to give a final 
concentration of [DNA] = 200 nM and [Ligand] = 100 µM. Control samples were 
prepared of just DNA in buffer and DMSO with DNA in buffer. The 960 compound 
library was tested 70 compounds at a time following the same procedure as described 
in section 6.1. The data was analysed using Roto-gene Q series software and Microsoft 
Excel. Initial Hits were repeated in 10 mM sodium cacodylate buffer at pH 5.5 with both 
100 mM and 5 mM sodium chloride concentrations following the procedure outlined 
above and in section 6.1. 
 
6.3.2 FRET dose response 
 
Hit compounds from the initial screen were repeated against hTeloCFRET and compared 
to c-MycFRET at pH 5.5, hTeloGFRET and DSFRET at pH 7.4 in 10 mM sodium cacodylate 
buffers with both 5 mM sodium chloride and 100 mM sodium chloride salt conditions. 
The experiments were carried out as previously described in section 6.1. Hit 
compounds were diluted in buffer by serial dilution and tested at concentrations of 1, 
5, 10, 20, 40, 60, 80 and 100 µM. For the initial dose response study with hTeloC in 100 
mM salt conditions, control samples were made with 0.1, 0.5, 1, 2, 4, 6, 8 and 10% 
DMSO. For later dose response studies a control of just 10% DMSO was used. The data 
was analysed using Roto-gene Q series software and Microsoft Excel.  
  
6.3.3 Circular Dichroism  
 
CD experiments were carried out as described in section 6.1. Unlabelled hTeloC 
oligonucleotide was diluted to a concentration of 10 µM in pH 5.5 10 mM sodium 
cacodylate 100 mM sodium chloride buffer. Hit compounds from the screen were 
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titrated into the sample using a Hamilton syringe, mixed with a pipette and were tested 
at concentrations of 10, 50, 100, 150 and 200 µM. If precipitation occurred at lower 
concentrations then higher concentrations were not tested. The samples were scanned 
from 220 to 400 nm. 
 
6.3.4 Surface Plasmon Resonance (SPR) Experiments 
 
SPR experiments were carried out on a Biacore T200 instrument from GE Healthcare 
using a series S streptavidin (SA) coated gold chip. Throughout all the SPR experiments 
a pH 5.5 running buffer was used containing 10 mM sodium cacodylate, 100 mM 
sodium chloride and 0.05% Tween 20, which was filtered and degassed before use. 
Biotinylated DNA hTeloCBiotin, c-MycBiotin sequences (Table 6.1) were diluted to 1 µM in 
running buffer. Biotinylated double stranded DNA was produced by combining a 
biotinylated oligonucleotide DSBiotin with its complimentary strand DScomp at 1 µM in 
pH 5.5 running buffer and thermally annealed. The chip was primed with running 
buffer and the detector was then normalised using the BIA normalising solution 
containing 70% (w/w) glycerol. The biotinylated oligonucleotides were bound to the 
streptavidin chip surface using the immobilisation wizard in the Biacore T200 
software. This includes a conditioning of the chip surface with three 60 s washes of 1 
M NaCl and 50 mM NaOH at a flow rate of 10 µL.min-1 before injection of the DNA at 
the same flow rate. An approximate response of 500 RU was set as a target for 
immobilisation and flow cell 1 was left blank. hTeloC was injected over flow cell 2 
(522.0 RU), c-Myc was injected over flow cell 3 (492.9 RU) and DS DNA was injected 
over flow cell 4 (507.1 RU). After immobilisation, the system (excluding the chip 
surface) was washed with a solution of 50% isopropyl alcohol in 50 mM NaOH and 1 
M NaCl. Mitoxantrone and tilorone were tested for binding to each flow cell 
simultaneously using the affinity run wizard in the Biacore T200 software. Both 
compounds were diluted in running buffer from 10 mM stock solutions in water to 
concentrations of 100, 50, 25, 12.5, 6.25, 3.125, 1.56, 0.78, 0.39 and 0 µM by serial 
dilution. The compounds were tested by injecting each concentration starting with the 
lowest and finishing with the highest and measuring the response for each of the four 
flow cells. Samples were injected for 120 s at a flow rate of 30 µL.min-1. After each 
injection the chip surface was regenerated by two 60 s injections of 1 M sodium 
chloride and the chip surface washed with running buffer for 60 s. The flow rate was 
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maintained at 30 µL.min-1 throughout. Before the compounds were injected, 3 startup 
cycles were carried out, these are blank injections of just buffer, followed by 2 
regeneration injections of 1 M NaCl. Each concentration was repeated with a second 
injection to ensure reproducibility and all experiments were carried out at 25°C. The 
response data was double referenced by subtracting the 3 startup cycles and injections 
of just buffer. Non selective binding to the chip surface was accounted for by 
subtracting the response from the blank flow cell. The average equilibrium response 
for each concentration was fitted using the affinity fit from the Biacore T200 evaluation 
software v2.0, assuming a 1:1 binding model. This data was then presented using 
Origin Pro 9.1. The KD’s determined are the average of two experiments. 
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6.4 Experimental for Chapter 4 
 
6.4.1 FRET Melting Experiments 
 
FRET melting procedures were carried out in accordance with the procedure described 
in section 6.1. Silver nitrate and sodium nitrate stock solutions were made up at 1 M in 
water and were diluted in buffer containing 10 mM sodium cacodylate and 5 mM 
sodium chloride at either pH 5.5 or pH 7.4 by serial dilution. Silver nitrate and the 
control sodium nitrate were tested at concentrations of 0.5, 1, 5, 10, 25, 50 and 100 µM. 
For the cation screen, metal salts were also prepared in water at 1 M and diluted in the 
same buffer conditions. The library of salts were tested at concentrations of 10 µM, 100 
µM, 1 mM and 100 mM. Dose response studies on CuCl2 were carried out in 50 mM 
sodium cacodylate buffer at pH 5.5 and 7.4 at concentrations of 1, 5, 10, 20, 40, 60, 80 
and 100 µM. 
 
6.4.2 Circular Dichroism Experiments 
 
CD titrations were carried out following the procedure described in section 6.1. Silver 
(I) ion experiments were carried out in 10 mM sodium cacodylate, 5 mM NaCl buffer at 
pH 7.4. Silver nitrate was titrated into the solution of 10 µM hTeloC by addition of 1 
equivalent aliquots using a Hamilton syringe up to a concentration of 100 µM (10 eq). 
The sample was mixed thoroughly with a pipette and the CD spectrum taken from 220 
to 400 nm. Copper (II) ion experiments were carried out in 50 mM sodium cacodylate 
buffer at pH 5.5 and 7.4. Copper (II) chloride was titrated into the sample in 10 
equivalent aliquots up to a concentration of 1 mM (100 eq), mixed thoroughly and 
scanned from 200 to 400 nm.  
 
6.4.3 Reversibility with Cysteine and EDTA 
 
The reversibility of DNA folding with silver by addition of cysteine was carried out 
using CD as described in section 6.1. AgNO3 was titrated into the sample in 1 equivalent 
steps by addition of 0.2 µL aliquots using a Hamilton syringe. After addition of 10 
equivalents of AgNO3, L-cysteine was titrated into the sample in 1 equivalent steps by 
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addition of 0.2 µL aliquots. The repeat reversibility of folding was shown by sequential 
addition of 10 equivalents of AgNO3 (2 µL) and 10 equivalents of L-cysteine (2 µL) to 
10 µM hTeloC in pH 7.4 buffer. The change in CD was monitored at 250 and 261 nm.  
 
Analogous experiments were carried out to reverse the effects of Cu2+ using 
ethylenediaminetetraacetic acid (EDTA). CuCl2 was titrated into the sample in 10 
equivalent steps by addition of 2 µL aliquots. After addition of 100 equivalents of CuCl2, 
EDTA was titrated into the sample in 10 equivalent steps (0.2 µL) up to a concentration 
of 1.5 mM (150 eq). The repeat reversibility was demonstrated by sequential addition 
of 100 equivalents of CuCl2 (20 µL) and 100 equivalents of EDTA (2 µL) at pH 5.5. The 
change in CD was monitored at 287 nm. 
 
6.4.4 Continuous Variation Binding (Job’s) Analysis 
 
Continuous variation binding analysis was carried out using circular dichroism 
spectroscopy to measure the stoichiometry of the silver-DNA interaction. Samples of 
DNA and AgNO3 were diluted in pH 7.4 buffer, keeping the total concentration of DNA 
+ AgNO3 constant at 20 µM but varying the individual concentrations of DNA and 
AgNO3 between 0 and 20 µM, with the ratio of Ag+:DNA changing in 1 equivalent steps. 
A second set of samples were prepared with the same concentrations of DNA but 
without Ag+ to be used as a control and the molar ellipticity of both sets of data were 
measured. The spectra of the DNA only control samples were subtracted from the DNA 
+ Ag+ samples to give the change in molar ellipticity due to Ag+. The change in CD signal 
at 275 nm was plotted versus the mole fraction of DNA to give a job plot. The inflection 
point of the job plot corresponds to the stoichiometry and was determined by a linear 
fit of the two parts of the graph and solving their equations simultaneously to find the 
intersection point using Microsoft Excel. 
 
Repeat 1: 
𝑦 = −4.4943𝑥 + 1.3168 , 𝑦 = −0.2772𝑥 + 0.5142 
∴ (4.4943 − 0.2772)𝑥 = 1.3168 − 0.5142 
∴ 𝑥 =
0.8026
4.2171
= 0.19 
∴ [𝐷𝑁𝐴] = 20 × 0.19 = 3.8 
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∴ [𝐴𝑔+] = 20 − 3.8 = 16.2 
∴ 𝑆𝑡𝑜𝑖𝑐ℎ𝑖𝑜𝑚𝑒𝑡𝑟𝑦 =
16.2
3.8
= 4.3 
 
Repeat 2: 
𝑦 = −2.9638𝑥 + 1.1213 , 𝑦 = −0.7506𝑥 + 0.6695 
∴ (2.9638 − 0.7506)𝑥 = 1.1213 − 0.6695 
∴ 𝑥 =
0.4518
2.2132
= 0.20 
∴ [𝐷𝑁𝐴] = 20 × 0.20 = 4 
∴ [𝐴𝑔+] = 20 − 4 = 16 
∴ 𝑆𝑡𝑜𝑖𝑐ℎ𝑖𝑜𝑚𝑒𝑡𝑟𝑦 =
16
4
= 4 
 
Average: 
𝑦 = −3.0986𝑥 + 1.1419 , 𝑦 = −0.5527𝑥 + 0.6222 
∴ (3.0986 − 0.5527)𝑥 = 1.1419 − 0.6222 
∴ 𝑥 =
0.5197
2.5459
= 0.20 
∴ [𝐷𝑁𝐴] = 20 × 0.20 = 4 
∴ [𝐴𝑔+] = 20 − 4 = 16 
∴ 𝑆𝑡𝑜𝑖𝑐ℎ𝑖𝑜𝑚𝑒𝑡𝑟𝑦 =
16
4
= 4 
 
6.4.5 UV Titrations and Difference Experiments 
 
UV titrations with Ag+ were carried out on a Hitachi U-3010 spectrophotometer. Either 
hTeloC or C-hairpin unlabelled oligonucleotides were diluted to 2.5 µM in pH 7.4 10 
mM sodium cacodylate 5 mM sodium chloride buffer and used immediately without 
annealing. Up to 6 equivalents of AgNO3 was titrated into the sample in aliquots using 
a Hamilton syringe and the UV absorbance spectra measured from 200 – 400 nm at 
room temperature. An equivalent titration of AgNO3 in buffer alone was also recorded.  
Both titrations were zero corrected at 400 nm and the absorbance spectra of the 
titration of AgNO3 in buffer was subtracted from the spectra of the titration of AgNO3 
in DNA. The UV difference spectrum for silver induced folding was calculated by 
subtracting the folded spectrum (in the presence of 6 equivalents AgNO3) from the 
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unfolded spectrum (DNA in the absence of AgNO3). The resultant spectrum was zero 
corrected at 320 nm and normalised to give a maximum change in absorbance of 1 as 
described in the literature.93 UV titrations with Cu2+ were carried out on an Agilent 
Technologies Cary 60 UV-Vis spectrometer following the same procedure with the HIF-
1α, PDGF-A, hTeloC and C-hairpin sequences. The data was analysed using Microsoft 
Excel and Origin Pro 9.1. 
 
6.4.6 FRET Titration Experiments 
 
Reverse FRET titrations using cysteine were carried out following the procedure 
outlined in section 6.1. Fluorescently labelled oligonucleotide hTeloCFRET was diluted 
to 100 nM in pH 7.4 buffer containing 10 mM sodium cacodylate and 5 mM sodium 
chloride and used immediately without annealing. 5 µM AgNO3 was added immediately 
to fold the DNA before L-cysteine was titrated into the sample in small aliquots up to a 
concentration of 5 µM using a Hamilton syringe. The sample was excited at 490 nm and 
the emission spectrum taken from 500 to 650 nm. This enabled the monitoring of the 
change in fluorescence of both FAM (515 nm) and TAMRA (580 nm). The FRET 
efficiency (EFRET) was calculated for each of 3 repeat experiments using equation 6.1. 
Where 𝐹𝐼𝑑
0 is the fluorescence intensity of FAM in the absence of TAMRA. Repeat 
reversibility was shown by consecutive addition of 5 µM AgNO3 and 5 µM cysteine. 
 
Equation 6.1:   𝐸𝐹𝑅𝐸𝑇 = 1 −
𝐹𝐼𝑑
𝐹𝐼𝑑
0 
 
FRET titrations were also carried out with CuCl2 following the same procedure. 
hTeloCFRET was diluted to 100 nM in 50 mM sodium cacodylate buffer at pH 7.4 before 
CuCl2 was titrated into the sample in small aliquots. First 1 equivalent then in 10 
equivalent portions up to 100 eq and finally in 50 equivalent portions up to a final 
concentration of 500 eq (50 µM).  
 
6.4.7 Biophysical NMR Experiments on Copper (II) ions with hTeloC 
 
Biophysical 1H NMR experiments were carried out in collaboration with Dr. Colin 
MacDonald using a Bruker Avance III 800 MHz spectrometer equipped with an HCN 
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inverse triple resonance z-gradient probe. The resonance signal of the solvent water 
was suppressed using the 1D Watergate sequence consisting of a symmetrical 3 – τ – 9 
– τ – 19 pulse train inversion element with the interpulse delay time (τ) set to achieve 
a maximum in the imino proton region. The solvent resonance which was minimized 
was set on-resonance at the transmitter offset. The hTeloC oligonucleotide sequence 
was diluted to a concentration of 10 µM in pH 5.5 50 mM sodium cacodylate buffer 
containing 5% D2O. The spectrum of hTeloC alone was measured over 1 hour after 
which 1 mM of CuCl2 was added and the spectrum acquired over 2 hours. Finally 1 mM 
EDTA was added and the spectrum taken again for 1 hour. The spectra were acquired 
and processed using Bruker’s TopSpin software package Bruker Biospin for NMR data 
analysis. 
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A.1 FRET Melting Dose Response Curves For Screen Hits 
Example FRET melting curves for human telomeric i-motif with increasing concentration 
of Ligand. [DNA] = 200 nM hTeloC, buffer = 10 mM sodium cacodylate and 100 mM NaCl 
at pH 5.5. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.1.1: Chlorhexidine. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.1.2: Tamoxifen citrate. 
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Figure A.1.3: Hexetidine. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.1.4: Bromocriptine mesylate. 
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Figure A.1.5: Pararosaniline pamoate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.1.6: Tilorone hydrochloride. 
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Figure A.1.7: Aiodarone hydrochloride. 
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A.2 Further Example SPR Binding Curves 
Example binding curves for mitoxantrone and tilorone. Running buffer = 10 mM sodium 
cacodylate, 100 mM NaCl and 0.05% tween 20 at pH 5.5. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.2.1: Mitoxantrone with the human telomeric i-motif. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.2.2: Mitoxantrone with the c-Myc promoter i-motif. 
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Figure A.2.3: Mitoxantrone with duplex DNA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.2.4: Tilorone with the human telomeric i-motif. 
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Figure A.2.5: Tilorone with the c-Myc promoter i-motif. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.2.6: Tilorone with duplex DNA. 
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A.3 FRET Melting Curves For The Cation Screen 
FRET melting curves for human telomeric i-motif with increasing concentrations of 
different metal salts. [DNA] = 200 nM hTeloC, buffer = 10 mM sodium cacodylate and 5 
mM NaCl at pH 7.4 (left) and pH 5.5 (right). 
        
 
 
 
 
 
 
 
Figure A.3.1: AlCl3  
 
 
 
 
 
 
 
 
 
Figure A.3.2: BaCl2 
 
 
 
 
 
 
 
 
 
Figure A.3.3: CaCl2 
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Figure A.3.4: CdCl2 
 
 
 
 
 
 
 
 
Figure A.3.5: CoCl2 
 
 
 
 
 
 
 
Figure A.3.6: CsCl 
 
 
 
 
 
 
 
 
Figure A.3.7: CuCl2 
25 30 35 40 45 50 55 60 65 70 75 80 85 90 95
0
10
20
30
40
50
60
70
80
F
lu
o
re
sc
e
n
ce
 I
n
te
n
si
ty
 (
A
.U
.)
Temperature (oC)
 200 nM hTeloC pH 7.4
 10 M CdCl
2
 100 M CdCl
2
 1 mM CdCl
2
 100 mM CdCl
2
25 30 35 40 45 50 55 60 65 70 75 80 85 90 95
0
10
20
30
40
50
60
70
80
F
lu
o
re
sc
e
n
ce
 I
n
te
n
si
ty
 (
A
.U
.)
Temperature (oC)
 200 nM hTeloC pH 7.4
 10 M CoCl
2
 100 M CoCl
2
 1 mM CoCl
2
 100 mM CoCl
2
25 30 35 40 45 50 55 60 65 70 75 80 85 90 95
0
10
20
30
40
50
60
70
80
F
lu
o
re
sc
e
n
ce
 I
n
te
n
si
ty
 (
A
.U
.)
Temperature (oC)
 200 nM hTeloC pH 7.4
 10 M CsCl
 100 M CsCl
 1 mM CsCl
 100 mM CsCl
25 30 35 40 45 50 55 60 65 70 75 80 85 90 95
0
10
20
30
40
50
60
70
80
F
lu
o
re
sc
e
n
ce
 I
n
te
n
si
ty
 (
A
.U
.)
Temperature (oC)
 200 nM hTeloC pH 7.4
 10 M CuCl
2
 100 M CuCl
2
 1 mM CuCl
2
 100 mM CuCl
2
25 30 35 40 45 50 55 60 65 70 75 80 85 90 95
0
2
4
6
8
10
12
F
lu
o
re
sc
e
n
ce
 I
n
te
n
si
ty
 (
A
.U
.)
Temperature (oC)
 200 nM hTeloC pH 5.5
 10 M CdCl
2
 100 M CdCl
2
 1 mM CdCl
2
 100 mM CdCl
2
25 30 35 40 45 50 55 60 65 70 75 80 85 90 95
0
2
4
6
8
10
12
F
lu
o
re
sc
e
n
ce
 I
n
te
n
si
ty
 (
A
.U
.)
Temperature (oC)
 200 nM hTeloC pH 5.5
 10 M CoCl
2
 100 M CoCl
2
 1 mM CoCl
2
 100 mM CoCl
2
25 30 35 40 45 50 55 60 65 70 75 80 85 90 95
0
2
4
6
8
10
12
F
lu
o
re
sc
e
n
ce
 I
n
te
n
si
ty
 (
A
.U
.)
Temperature (oC)
 200 nM hTeloC pH 5.5
 10 M CsCl
 100 M CsCl
 1 mM CsCl
 100 mM CsCl
25 30 35 40 45 50 55 60 65 70 75 80 85 90 95
0
2
4
6
8
10
12
F
lu
o
re
sc
e
n
ce
 I
n
te
n
si
ty
 (
A
.U
.)
Temperature (oC)
 200 nM hTeloC pH 5.5
 10 M CuCl
2
 100 M CuCl
2
 1 mM CuCl
2
 100 mM CuCl
2
  
 
 
 
 
 
 
 
 
 
Figure A.3.8: FeCl3. 
 
 
 
 
 
 
 
 
Figure A.3.9: Ga(NO3)3. 
 
 
 
 
 
 
 
 
Figure A.3.10: HoCl3. 
 
 
 
 
 
 
 
Figure A.3.11: In(NO3)3. 
25 30 35 40 45 50 55 60 65 70 75 80 85 90 95
0
10
20
30
40
50
60
70
80
90
F
lu
o
re
sc
e
n
ce
 I
n
te
n
si
ty
 (
A
.U
.)
Temperature (oC)
 200 nM hTeloC pH 7.4
 10 M FeCl
3
 100 M FeCl
3
 1 mM FeCl
3
 100 mM FeCl
3
25 30 35 40 45 50 55 60 65 70 75 80 85 90 95
0
10
20
30
40
50
60
70
80
F
lu
o
re
sc
e
n
ce
 I
n
te
n
si
ty
 (
A
.U
.)
Temperature (oC)
 200 nM hTeloC pH 7.4
 10 M Ga(NO
3
)
3
 100 M Ga(NO
3
)
3
 1 mM Ga(NO
3
)
3
 100 mM Ga(NO
3
)
3
25 30 35 40 45 50 55 60 65 70 75 80 85 90 95
0
10
20
30
40
50
60
70
80
F
lu
o
re
sc
e
n
ce
 I
n
te
n
si
ty
 (
A
.U
.)
Temperature (oC)
 200 nM hTeloC pH 7.4
 10 M HoCl
3
 100 M HoCl
3
 1 mM HoCl
3
 100 mM HoCl
3
25 30 35 40 45 50 55 60 65 70 75 80 85 90 95
0
10
20
30
40
50
60
70
80
F
lu
o
re
sc
e
n
ce
 I
n
te
n
si
ty
 (
A
.U
.)
Temperature (oC)
 200 nM hTeloC pH 7.4
 10 M In(NO
3
)
3
 100 M In(NO
3
)
3
 1 mM In(NO
3
)
3
 100 mM In(NO
3
)
3
25 30 35 40 45 50 55 60 65 70 75 80 85 90 95
0
2
4
6
8
10
12
F
lu
o
re
sc
e
n
ce
 I
n
te
n
si
ty
 (
A
.U
.)
Temperature (oC)
 200 nM hTeloC pH 5.5
 10 M FeCl
3
 100 M FeCl
3
 1 mM FeCl
3
 100 mM FeCl
3
25 30 35 40 45 50 55 60 65 70 75 80 85 90 95
0
2
4
6
8
10
12
F
lu
o
re
sc
e
n
ce
 I
n
te
n
si
ty
 (
A
.U
.)
Temperature (oC)
 200 nM hTeloC pH 5.5
 10 M Ga(NO
3
)
3
 100 M Ga(NO
3
)
3
 1 mM Ga(NO
3
)
3
 100 mM Ga(NO
3
)
3
25 30 35 40 45 50 55 60 65 70 75 80 85 90 95
0
2
4
6
8
10
12
F
lu
o
re
sc
e
n
ce
 I
n
te
n
si
ty
 (
A
.U
.)
Temperature (oC)
 200 nM hTeloC pH 5.5
 10 M HoCl
3
 100 M HoCl
3
 1 mM HoCl
3
 100 mM HoCl
3
25 30 35 40 45 50 55 60 65 70 75 80 85 90 95
0
2
4
6
8
10
12
F
lu
o
re
sc
e
n
ce
 I
n
te
n
si
ty
 (
A
.U
.)
Temperature (oC)
 200 nM hTeloC pH 5.5
 10 M In(NO
3
)
3
 100 M In(NO
3
)
3
 1 mM In(NO
3
)
3
 100 mM In(NO
3
)
3
  
 
 
 
 
 
 
 
 
 
Figure A.3.12: MgCl2. 
 
 
 
 
 
 
 
 
Figure A.3.13: MnCl2. 
 
 
 
 
 
 
 
 
Figure A.3.14: NiCl2. 
 
 
 
 
 
 
 
Figure A.3.15: PbAc2 
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Figure A.3.16: KCl. 
 
 
 
 
 
 
 
Figure A.3.17: RbCl. 
 
 
 
 
 
 
 
 
Figure A.3.18: RuCl3. 
 
 
 
 
 
 
 
 
Figure A.3.19: SmCl3. 
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Figure A.3.20: SrCl2. 
 
 
 
 
 
 
 
Figure A.3.21: TbCl3. 
 
 
 
 
 
 
 
 
Figure A.3.22: YbCl3. 
 
 
 
 
 
 
 
 
Figure A.3.23: YCl3. 
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Figure A.3.24: NaAc. 
 
 
 
 
 
 
 
Figure A.3.25: HgAc2 pH 7.4. 
 
 
 
 
 
 
 
 
Figure A.3.26: TlAc pH 7.4. 
 
 
 
 
 
 
 
 
Figure A.3.27: ZnAc2 pH 7.4. 
25 30 35 40 45 50 55 60 65 70 75 80 85 90 95
0
10
20
30
40
50
60
70
80
F
lu
o
re
sc
e
n
ce
 I
n
te
n
si
ty
 (
A
.U
.)
Temperature (oC)
 200 nM hTeloC pH 7.4
 10 M NaAc
 100 M NaAc
 1 mM NaAc
 100 mM NaAc
25 30 35 40 45 50 55 60 65 70 75 80 85 90 95
0
10
20
30
40
50
60
70
80
F
lu
o
re
sc
e
n
ce
 I
n
te
n
si
ty
 (
A
.U
.)
Temperature (oC)
 200 nM hTeloC pH 7.4
 10 M HgAc
2
 100 M HgAc
2
 1 mM HgAc
2
 100 mM HgAc
2
25 30 35 40 45 50 55 60 65 70 75 80 85 90 95
0
10
20
30
40
50
60
70
80
F
lu
o
re
sc
e
n
ce
 I
n
te
n
si
ty
 (
A
.U
.)
Temperature (oC)
 200 nM hTeloC pH 7.4
 10 M TlAc
 100 M TlAc
 1 mM TlAc
 100 mM TlAc
25 30 35 40 45 50 55 60 65 70 75 80 85 90 95
0
10
20
30
40
50
60
70
80
F
lu
o
re
sc
e
n
ce
 I
n
te
n
si
ty
 (
A
.U
.)
Temperature (oC)
 200 nM hTeloC pH 7.4
 10 M ZnAc
2
 100 M ZnAc
2
 1 mM ZnAc
2
 100 mM ZnAc
2
25 30 35 40 45 50 55 60 65 70 75 80 85 90 95
0
2
4
6
8
10
12
14
16
18
20
22
24
F
lu
o
re
sc
e
n
ce
 I
n
te
n
si
ty
 (
A
.U
.)
Temperature (oC)
 200 nM hTeloC pH 5.5
 10 M NaAc
 100 M NaAc
 1 mM NaAc
 100 mM NaAc
  
 
 
Publications based upon work within this thesis can be found at the following links: 
 
http://pubs.rsc.org/en/Content/ArticleLanding/2013/CC/c3cc43495h#!divAbstract 
 
http://www.sciencedirect.com/science/article/pii/S0968089614004064 
 
 
